starter_ID,receiver_ID,relation_type,subtype_name,pathway_source,credibility,weight
hsa:4803,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1385,hsa:2353,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:51378,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:2538,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5534,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C07593,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8321,hsa:1855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:858,hsa:2534,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:5599,hsa:3725,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2917,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:775,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2254,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1234,hsa:2792,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:7317,hsa:7314,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
cpd:C00334,hsa:2565,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:27006,hsa:23439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:89953,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3082,hsa:8600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2556,cpd:C00219,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:5295,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4294,hsa:5609,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:285,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1906,hsa:3355,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27121,hsa:7477,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3665,hsa:64600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:4660,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:80201,hsa:25865,no_relation,no_relation,no_relation,no_relation,0.0
hsa:824,hsa:100506742,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:3030,hsa:8605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,hsa:4217,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:27,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7099,hsa:4843,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:5568,hsa:10488,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:1945,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:808,hsa:57118,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5598,hsa:80201,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:108,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8817,hsa:5567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7048,hsa:5516,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:4915,hsa:331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:221,hsa:8639,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:4790,hsa:3452,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5908,hsa:5606,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5595,hsa:2002,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:3913,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2559,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:51806,hsa:5532,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:815,hsa:7296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284217,hsa:3655,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:8823,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:1813,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:468,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:7423,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5908,hsa:10451,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7422,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3459,hsa:3716,PPrel,binding/association,path:hsa05164 Influenza A,1,0.5
hsa:11345,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2695,hsa:7253,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5601,hsa:8660,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:207,hsa:9586,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:627,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7422,hsa:2948,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:2717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5154,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:28514,hsa:4851,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:2563,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:805,hsa:109,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5781,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3265,hsa:6300,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2250,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6714,hsa:5580,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:208,hsa:4793,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5566,hsa:2309,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5296,hsa:208,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4916,hsa:399694,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2557,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:70,hsa:7170,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:808,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:268,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3454,hsa:3718,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5594,hsa:2002,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:7422,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1558,hsa:8605,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:6416,hsa:5599,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5567,hsa:387,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:11035,hsa:122011,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5529,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5021,hsa:783,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:208,hsa:842,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:4803,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10683,hsa:4855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:26281,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2717,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:842,hsa:836,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:3630,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:27330,hsa:5499,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:2787,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:54331,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3098,hsa:4137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:3091,GErel,expression,path:hsa04919 Thyroid hormone signaling pathway,1,0.5
hsa:5154,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:374,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1943,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3351,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3440,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:801,hsa:84647,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01996,hsa:5021,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4878,hsa:3362,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3688,hsa:60,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:658,hsa:10681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2806,hsa:5053,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
cpd:C00212,hsa:1909,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2932,hsa:3831,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:64764,hsa:2353,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:2771,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55740,hsa:71,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3082,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3551,hsa:8660,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:4790,hsa:7124,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
cpd:C00025,hsa:2746,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2212,hsa:5600,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:6772,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3799,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:3445,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2215,hsa:5579,ECrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:5296,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:10846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3439,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:27,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:2475,hsa:6199,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:92552,hsa:3710,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3265,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:23236,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3265,hsa:5291,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5209,hsa:8789,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:1571,hsa:1559,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:55970,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C00584,hsa:5733,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8321,hsa:1857,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:51806,hsa:816,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:246,hsa:283748,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:818,hsa:1385,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3725,hsa:3576,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:1457,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:440275,hsa:3551,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:5330,cpd:C00165,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7297,hsa:5608,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:56034,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:808,hsa:7479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4902,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4193,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:122809,hsa:3717,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2775,hsa:112,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3661,hsa:3447,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:3458,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:5208,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:100506742,hsa:836,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:10681,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5527,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5524,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:8681,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C15231,hsa:7388,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4790,hsa:3445,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:2793,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7124,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:2562,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:9965,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2917,hsa:51764,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:80310,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8878,hsa:8737,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:3441,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5566,hsa:5604,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2264,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2791,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5894,hsa:5604,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5530,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:25865,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5565,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2308,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:57144,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2250,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:815,hsa:148327,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:8822,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00951,hsa:2100,PCrel,binding/association,path:hsa05224 Breast cancer,3,0.5
cpd:C00334,hsa:2550,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:230,hsa:2790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:3292,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:5567,hsa:1379,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3452,hsa:81029,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2717,hsa:2792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1460,hsa:147700,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1907,hsa:3352,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27102,hsa:3551,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:817,hsa:196883,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1557,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:7139,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:5598,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4615,hsa:51135,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:3716,hsa:6773,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1374,hsa:2180,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:3446,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:8074,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1432,hsa:492,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:391013,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9456,hsa:2915,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:5604,hsa:5595,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4261,hsa:3109,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:5604,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:5879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1908,hsa:3355,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3479,hsa:3460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3459,hsa:3716,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:163688,hsa:5532,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:2535,hsa:492,no_relation,no_relation,no_relation,no_relation,0.0
hsa:356,hsa:355,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,3,0.8
hsa:5605,hsa:80326,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05224 Breast cancer,3,0.8
hsa:90,hsa:92,PPrel,binding/association,path:hsa04350 TGF-beta signaling pathway,2,0.5
hsa:653,hsa:659,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5906,hsa:51196,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10000,hsa:5021,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:5733,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2255,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55102,hsa:55062,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:5295,hsa:478,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
cpd:C00212,hsa:353376,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:1385,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2784,hsa:3798,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2309,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1634,hsa:7042,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5529,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:4087,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5623,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3099,hsa:5236,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
cpd:C15231,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:5139,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:4539,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:3725,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2793,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:283106,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4261,hsa:3118,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:51378,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:650,hsa:659,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:90,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:113,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4233,hsa:8503,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:4902,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6622,hsa:51079,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2773,hsa:3310,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:51378,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5743,cpd:C00584,PCrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:1576,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5214,hsa:229,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2885,hsa:6654,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:3667,hsa:5296,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5291,hsa:10000,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1956,hsa:5295,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
cpd:C00212,hsa:6752,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7976,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:5578,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:6195,hsa:5500,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:3716,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7039,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7422,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1459,hsa:147700,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:291,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5663,hsa:3709,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:581,hsa:824,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:5623,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:2932,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:5335,hsa:801,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5336,hsa:801,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:111,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5599,hsa:10327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:84699,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3716,hsa:6772,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5571,hsa:57521,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:108,cpd:C00575,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2247,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6195,hsa:79660,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:1268,hsa:486,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5530,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2906,hsa:9882,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4902,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1944,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:718,hsa:1379,PPrel,binding/association,path:hsa05140 Leishmaniasis,1,0.5
hsa:1544,hsa:64600,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:4881,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5335,hsa:5580,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6774,hsa:5058,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6778,hsa:5610,GErel,expression,path:hsa04217 Necroptosis,1,0.5
hsa:5291,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:25865,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4914,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2778,hsa:115,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6622,hsa:4705,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6300,hsa:5595,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2773,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:1742,hsa:2905,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1460,hsa:89953,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5331,cpd:C01245,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:816,hsa:5142,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2791,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5567,hsa:7849,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5881,hsa:123745,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3458,hsa:3460,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
cpd:C00788,hsa:7253,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:163688,hsa:113,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3845,hsa:5894,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00334,hsa:2785,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7424,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:53632,hsa:32,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:4916,hsa:25759,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1147,hsa:1128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51378,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:317,hsa:842,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:94235,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4902,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:2998,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4854,hsa:3280,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:284,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3845,hsa:5293,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4804,hsa:3654,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2782,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5519,hsa:481,no_relation,no_relation,no_relation,no_relation,0.0
hsa:102723407,hsa:2209,PPrel,binding/association,path:hsa05140 Leishmaniasis,1,0.5
hsa:7410,hsa:5880,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5599,hsa:147700,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2248,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5521,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9525,hsa:5320,no_relation,no_relation,no_relation,no_relation,0.0
hsa:111,cpd:C00575,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5534,hsa:8681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5291,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2215,hsa:10243,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5979,hsa:23683,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:3265,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5599,hsa:3667,PPrel,inhibition,path:hsa04931 Insulin resistance,2,0.8
hsa:6750,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1907,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1386,hsa:2354,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:2932,hsa:147700,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5604,hsa:3355,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9451,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:4538,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1908,hsa:1129,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3447,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2932,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:91860,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2255,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6776,hsa:5610,GErel,expression,path:hsa04217 Necroptosis,1,0.5
hsa:3717,hsa:6774,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:6772,hsa:3109,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:6775,hsa:8737,GErel,expression,path:hsa04217 Necroptosis,1,0.5
hsa:2248,hsa:3397,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:5170,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:578,hsa:54205,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:7139,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1950,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1460,hsa:3798,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6776,hsa:7054,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:801,hsa:817,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5567,hsa:2892,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5894,hsa:5604,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:84699,hsa:4170,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:805,hsa:111,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:808,hsa:196883,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3630,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3661,hsa:3763,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5516,hsa:6198,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5594,hsa:480,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5571,hsa:2475,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:285,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10411,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56616,hsa:329,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:231,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:5571,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:8503,cpd:C05981,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:25759,hsa:6714,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:3170,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5568,hsa:2892,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:718,hsa:3684,PPrel,binding/association,path:hsa05140 Leishmaniasis,1,0.5
hsa:2783,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3845,hsa:673,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:3082,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:112,cpd:C00575,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:10411,hsa:22800,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:91782,hsa:197259,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:814,hsa:10488,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2787,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6464,hsa:2885,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:3440,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51510,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9306,hsa:6774,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:4804,hsa:998,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:810,hsa:114,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27006,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C01245,hsa:3710,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:805,hsa:5535,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:9456,hsa:8772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:7157,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:208,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3551,hsa:5970,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1460,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,cpd:C01245,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10000,hsa:2932,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:94235,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:25759,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,hsa:2911,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:340156,hsa:10398,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5881,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5598,hsa:6195,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C01312,hsa:4158,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1268,hsa:2771,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8074,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:801,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5894,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:9568,hsa:2782,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:1234,hsa:2770,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:55844,hsa:6772,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:79660,hsa:5173,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9454,hsa:9456,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,2,0.5
hsa:83593,hsa:480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64091,hsa:3776,PPrel,binding/association,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:7039,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:5501,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6774,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10411,hsa:5908,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3082,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:54331,hsa:1558,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7010,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:3164,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:3294,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:7423,hsa:3800,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:823,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:808,hsa:5533,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6300,hsa:2920,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:10000,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1942,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:113,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5568,hsa:2890,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2261,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2770,hsa:84876,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:2209,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:5322,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2247,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1950,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:79602,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:4086,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80201,hsa:5211,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5170,hsa:5586,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6772,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:229,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1392,hsa:4881,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:801,hsa:5533,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:374,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2247,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1499,hsa:51176,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5501,hsa:4637,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:112,cpd:C00575,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:7317,hsa:6233,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:163688,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2324,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5623,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3479,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1571,hsa:50487,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:59345,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2069,hsa:246,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:113,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:2903,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:208,hsa:8517,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00780,hsa:1128,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:805,hsa:57172,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:55844,hsa:6773,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:5566,hsa:840,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:330,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:572,hsa:598,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2535,hsa:7311,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27102,hsa:3551,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:7124,hsa:7132,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:51378,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2771,hsa:5296,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:7423,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:123745,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7039,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1559,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:483,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1946,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2064,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3661,hsa:3445,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
path:hsa00520,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54518,hsa:5217,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1956,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4217,hsa:5609,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5566,hsa:5605,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:92552,hsa:3708,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:22943,hsa:7477,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1944,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:572,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:6774,hsa:7054,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:208,hsa:2932,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
cpd:C00165,hsa:5579,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5296,hsa:1395,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2990,hsa:574537,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:5568,hsa:2906,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5566,hsa:2893,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:340156,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2913,hsa:2792,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2253,hsa:4615,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:7422,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3845,hsa:673,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2252,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9048,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3101,path:hsa00010,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:1943,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3551,hsa:4792,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:5568,hsa:5350,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3105,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5610,no_relation,no_relation,no_relation,no_relation,0.0
hsa:115,cpd:C00575,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:8817,hsa:5586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:340156,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:51135,hsa:1147,PPrel,activation,path:hsa05164 Influenza A,2,0.8
hsa:1908,hsa:1909,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5567,hsa:3778,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:3845,hsa:5603,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1499,hsa:122011,PPrel,binding/association,path:hsa05224 Breast cancer,1,0.5
cpd:C00575,hsa:5568,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:2695,hsa:4881,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4852,hsa:4886,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:30837,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:3667,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:9568,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10379,hsa:3665,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:5595,hsa:4086,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:2263,hsa:783,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1111,hsa:7465,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5499,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:369,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:4790,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5610,hsa:1147,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:842,hsa:836,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2775,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:1907,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2064,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:51806,PCrel,binding/association,path:hsa05031 Amphetamine addiction,2,0.5
hsa:53358,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5594,hsa:1398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3082,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5588,hsa:5601,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:23683,hsa:1147,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C00788,hsa:7479,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:6198,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
cpd:C01312,hsa:2740,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27006,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8322,hsa:4846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:492,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2249,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10023,hsa:1856,PPrel,binding/association,path:hsa05224 Breast cancer,1,0.5
hsa:22808,hsa:9771,PPrel,inhibition,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6772,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2914,hsa:2791,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:8817,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8517,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3098,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:10488,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:5350,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2255,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55970,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5906,hsa:8737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:59285,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4893,hsa:5894,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:26281,hsa:3459,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2914,hsa:2788,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3479,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3479,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55970,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:8074,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:3304,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5770,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:2787,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2249,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:4852,hsa:3354,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8822,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5623,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4878,hsa:3973,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3064,hsa:6390,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5894,hsa:5604,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2784,hsa:2746,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3643,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5228,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:122809,hsa:6776,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:79660,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:64764,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3443,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:4909,hsa:4915,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5579,hsa:3800,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3242,hsa:2805,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:51764,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2917,hsa:2785,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:117145,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:71,hsa:140465,PPrel,binding/association,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:5290,hsa:10000,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2560,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05164 Influenza A,1,0.8
hsa:200186,hsa:10488,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:9965,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26291,hsa:482,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2990,hsa:2561,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5602,hsa:317,PPrel,activation,path:hsa04215 Apoptosis - multiple species,1,0.8
cpd:C00584,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5296,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2246,hsa:5320,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4902,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2550,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:397,hsa:387,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2252,hsa:952,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2785,hsa:6945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:491,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5594,hsa:10488,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:5598,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5571,hsa:5105,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
cpd:C00575,hsa:54205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5209,hsa:5211,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5908,hsa:673,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6300,hsa:2919,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:7852,hsa:3659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5532,hsa:54205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:815,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2787,hsa:2821,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:1909,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3479,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4728,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:652,hsa:90,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,2,0.8
hsa:57818,path:hsa00051,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:1956,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3082,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:627,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6500,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:55970,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5594,hsa:5562,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:493,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5599,hsa:3799,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1559,hsa:9454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2251,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6195,hsa:4893,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3479,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5533,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23710,hsa:2564,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:5579,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6464,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6237,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23493,hsa:4791,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:2277,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5296,hsa:10000,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:1558,hsa:64600,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
cpd:C00076,hsa:9261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5605,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7098,hsa:148022,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:4790,hsa:9021,GErel,expression,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:2475,hsa:8408,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5906,hsa:673,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5170,hsa:6198,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:4780,hsa:2938,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:6655,hsa:3265,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:26291,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2893,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2252,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5906,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3091,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:657,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6774,hsa:5618,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:10411,hsa:5906,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10105,hsa:54205,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:55740,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6195,hsa:8644,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:117,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:134,hsa:2773,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
cpd:C00575,hsa:5566,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:1573,hsa:11145,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:8074,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5507,hsa:2997,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:468,hsa:5468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:805,hsa:816,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4881,cpd:C00942,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:8743,hsa:8797,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:673,hsa:5604,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:1616,hsa:4217,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5533,hsa:2911,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10000,hsa:481,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:4893,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3101,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,cpd:C05981,PCrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:5606,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:650,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:2720,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:10000,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5603,hsa:9261,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3630,hsa:3480,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:4790,hsa:6352,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:2990,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:7494,hsa:1649,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:816,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:10645,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5518,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:200186,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2788,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:10105,hsa:1234,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:2771,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
path:hsa00052,cpd:C02135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:115,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4261,hsa:5322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55844,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:5139,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5601,hsa:64837,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00780,hsa:3351,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2791,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:208,hsa:114,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:1571,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5533,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5979,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3845,hsa:5290,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:810,hsa:111,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:26281,hsa:5143,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:492,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5295,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1573,hsa:5321,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2248,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
cpd:C00076,hsa:5137,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:80310,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8823,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51764,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2668,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2309,hsa:9474,GErel,expression,path:hsa04213 Longevity regulating pathway - multiple species,1,0.5
cpd:C01996,hsa:1128,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:80310,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00584,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5534,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:23643,hsa:7099,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:2251,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4803,hsa:4804,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5228,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00547,hsa:1909,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2932,hsa:2570,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2550,hsa:55970,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
cpd:C00165,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7423,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5534,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:7099,hsa:4615,PPrel,activation,path:hsa05144 Malaria,1,0.8
hsa:2915,hsa:2778,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7424,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:3360,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5605,hsa:5594,PPrel,activation,path:hsa05216 Thyroid cancer,2,0.8
hsa:6868,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2069,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:116444,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:208,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2668,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3099,hsa:2821,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:2805,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7409,hsa:5880,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:208,hsa:84335,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:9048,hsa:5142,no_relation,no_relation,no_relation,no_relation,0.0
hsa:81858,hsa:329,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:3480,hsa:3845,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:1545,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:5211,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5587,hsa:5906,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:817,hsa:6531,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:3665,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:5290,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2776,hsa:3265,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2792,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:27330,hsa:3265,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:285,hsa:6934,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:329,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:7139,hsa:7171,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:816,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:5600,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1965,hsa:468,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6300,hsa:134,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5535,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:54331,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:79660,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:1499,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:1460,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:4916,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
cpd:C00788,hsa:2550,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:818,hsa:5142,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3625,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:808,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5533,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:4916,hsa:3667,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5506,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2737,hsa:64399,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:2771,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:1460,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:177,hsa:3265,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:10000,hsa:1027,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:775,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4915,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
cpd:C07593,hsa:4694,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C13050,hsa:6263,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5211,hsa:230,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:10298,hsa:3985,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C00575,hsa:64208,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4804,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4916,hsa:53358,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2889,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:5606,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:208,hsa:2309,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1942,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2254,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1129,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:56034,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6655,hsa:3845,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:94235,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:284,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2778,hsa:109,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8817,hsa:3350,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:112,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3265,hsa:5894,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3242,hsa:259307,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:1943,hsa:7187,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8743,hsa:8795,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:27,hsa:23683,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:1906,hsa:23439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:6804,hsa:2790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8822,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,hsa:5836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4780,hsa:4257,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:5565,hsa:9103,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5520,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6772,hsa:4261,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:109,cpd:C00575,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:2771,hsa:113,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2254,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:83439,hsa:4609,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:5532,hsa:4776,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:65018,hsa:4719,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:115,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:5143,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C13050,hsa:6262,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5500,hsa:5834,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:51378,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2260,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3643,hsa:3667,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:196883,cpd:C00575,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:8660,hsa:4088,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:8605,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2247,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:53632,hsa:2475,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:805,hsa:111,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2209,hsa:6300,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:1147,hsa:4793,PPrel,activation,path:hsa05164 Influenza A,2,0.8
hsa:3716,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00575,hsa:5568,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:26281,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:814,hsa:5140,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27102,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5535,hsa:4773,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:805,hsa:8536,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4261,hsa:3122,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5565,hsa:6517,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:4902,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8325,hsa:1856,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:3845,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7039,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3099,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2100,hsa:595,GErel,expression,path:hsa05224 Breast cancer,2,0.5
hsa:208,hsa:4193,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:841,hsa:836,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2773,hsa:112,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2475,hsa:6198,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:9252,hsa:468,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:91860,hsa:5970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5155,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2555,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:5595,hsa:6195,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00195,hsa:5595,PCrel,inhibition,path:hsa05140 Leishmaniasis,1,0.8
hsa:5580,hsa:3667,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:7422,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5894,hsa:5604,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4893,hsa:5603,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3693,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3448,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
cpd:C07593,hsa:55967,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:285,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2246,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:54331,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4718,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5156,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2064,hsa:5295,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:1395,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:65018,hsa:4712,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5567,hsa:5141,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:285,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1943,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:5564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:5296,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:815,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22798,hsa:3655,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5606,hsa:6300,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5336,cpd:C00165,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5578,hsa:29904,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:10488,hsa:491,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:3304,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:5290,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5601,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
path:hsa00010,hsa:3101,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
hsa:4893,hsa:4215,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00780,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:255189,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:8822,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:814,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4723,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3714,hsa:2904,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5293,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:27123,hsa:7471,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:805,hsa:817,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5170,hsa:10000,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1944,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3725,hsa:2920,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:5330,hsa:1956,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:11035,hsa:2791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:113,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9048,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2253,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1436,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:801,hsa:3350,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5481,hsa:7416,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3098,hsa:9945,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:65018,hsa:8737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:4660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2309,hsa:3305,GErel,expression,path:hsa04213 Longevity regulating pathway - multiple species,1,0.5
hsa:9455,hsa:2915,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:5021,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8817,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4773,hsa:5997,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:3845,hsa:5599,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5499,hsa:84699,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:53632,hsa:5733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3101,hsa:5236,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
hsa:85366,hsa:8313,no_relation,no_relation,no_relation,no_relation,0.0
hsa:154,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5154,hsa:5834,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7416,hsa:54205,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:26281,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9103,hsa:5603,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:2246,hsa:5021,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90,hsa:4086,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:5595,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5610,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:7471,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:246,hsa:64600,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:3953,hsa:10645,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:2889,hsa:5908,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:207,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:196883,cpd:C00575,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2247,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:207,PCrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:3106,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:3355,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6885,hsa:5601,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5154,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51196,cpd:C01245,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5241,hsa:54361,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:7186,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:55967,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:51,hsa:30,ECrel,compound,path:hsa00592 alpha-Linolenic acid metabolism,2,0.5
hsa:4916,hsa:5499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4696,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2550,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1459,hsa:3798,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:100137049,cpd:C00219,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:10000,hsa:64764,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5293,hsa:51478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:3164,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5608,hsa:5321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23493,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:3551,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3265,hsa:673,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3451,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5563,hsa:84335,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:285,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2253,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:4715,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3593,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5501,hsa:468,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:2247,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55970,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:11345,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:8737,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:55970,hsa:5144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3099,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:9965,hsa:6775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1460,hsa:3800,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
cpd:C00334,hsa:9568,PCrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:2277,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2247,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C01312,hsa:1394,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51806,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:482,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3626,hsa:7042,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:27330,hsa:468,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2247,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2248,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5601,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:109,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:816,hsa:5140,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1435,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:53358,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2549,hsa:5290,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:1950,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:26100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5579,hsa:5594,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7074,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:1909,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C11310,hsa:4697,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:10062,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:5834,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4893,hsa:673,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:5568,hsa:387,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3447,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:4772,hsa:5743,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:7332,hsa:7316,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:2793,hsa:2906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:4093,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2982,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:154,PCrel,activation,path:hsa04024 cAMP signaling pathway,2,0.8
hsa:1385,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,cpd:C05981,PCrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:5564,hsa:32,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:7010,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00195,hsa:5580,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:51806,hsa:5533,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:2247,hsa:5320,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2717,hsa:8972,ECrel,compound,path:hsa00052 Galactose metabolism,3,0.5
hsa:2771,hsa:23533,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3480,hsa:5295,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:3630,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2778,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2775,hsa:3765,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5071,hsa:5330,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2081,hsa:7494,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:2786,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2250,hsa:6778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25805,hsa:7046,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:2778,hsa:114,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10000,hsa:90993,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2066,hsa:2790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:6199,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1557,hsa:84647,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:22943,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:2906,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C22381,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:673,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6776,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:3798,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:3765,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5330,cpd:C00165,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3479,hsa:5142,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79660,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:84699,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2791,hsa:6548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5414,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:3800,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80201,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:54539,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7424,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3665,hsa:5908,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5154,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57818,hsa:55276,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5338,cpd:C00416,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5481,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,hsa:4772,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1942,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7139,hsa:7137,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
cpd:C07593,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:10000,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5296,hsa:10000,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2990,hsa:2806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3098,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:2776,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:51378,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2775,hsa:146850,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:7039,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6622,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:148327,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:26291,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:4659,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:7410,hsa:5879,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:815,hsa:112,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1742,hsa:2902,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5906,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:7386,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:115,cpd:C00575,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:655,hsa:659,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
cpd:C21014,hsa:177,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:9021,hsa:6772,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:7976,hsa:1857,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:208,hsa:7417,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1544,hsa:123745,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:1131,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:841,hsa:836,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:9048,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2309,hsa:92579,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
cpd:C00165,hsa:5141,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1544,hsa:8399,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5617,hsa:5618,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:163688,hsa:815,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:219,hsa:51733,ECrel,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:5608,hsa:5603,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C07593,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4804,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5532,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:9568,hsa:8399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:84699,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
cpd:C03758,hsa:3355,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2912,hsa:59345,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:808,hsa:6752,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57121,hsa:3655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:3265,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:1559,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8600,hsa:4846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:23236,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:808,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
cpd:C00780,hsa:4158,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4254,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5516,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5603,hsa:2921,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:7533,hsa:673,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:7855,hsa:1856,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2776,hsa:5332,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:90,hsa:4088,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:7358,path:hsa00053,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:5156,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1908,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4724,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00547,hsa:1812,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5414,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:130589,hsa:134,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5021,hsa:59284,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:9048,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2788,hsa:3800,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4217,hsa:5608,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:9475,hsa:5500,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:26291,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:222,hsa:293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3099,path:hsa00010,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:2776,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00575,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2264,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:718,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5601,hsa:3725,PPrel,activation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:5568,hsa:1080,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2717,hsa:2548,ECrel,compound,path:hsa00052 Galactose metabolism,3,0.5
hsa:116,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5836,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4909,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3459,path:hsa00400,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2821,hsa:80201,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:1147,hsa:255189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5331,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:1945,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:5562,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:135,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7852,hsa:3170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4794,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5522,hsa:9456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:25759,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:64764,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:2912,hsa:2782,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1026,hsa:1021,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:5970,hsa:3763,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:3292,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:2323,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7099,hsa:2891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27330,hsa:5500,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:815,hsa:468,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:816,hsa:6531,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:2775,hsa:5293,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5332,cpd:C01245,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:7039,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7099,hsa:5879,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7098,hsa:148022,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1558,hsa:93,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:5319,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:801,hsa:5530,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:1943,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5526,hsa:3973,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:84790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283106,hsa:147700,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5571,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,path:hsa00051,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2354,hsa:3725,PPrel,binding/association,path:hsa05031 Amphetamine addiction,1,0.5
hsa:8517,hsa:4794,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:11345,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2253,hsa:5021,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:207,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:64600,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5155,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5604,hsa:483,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2668,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:11211,hsa:1857,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2793,hsa:5321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:3576,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
cpd:C00788,hsa:1909,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:5610,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1944,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2787,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2550,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:5143,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5906,hsa:1870,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:150084,hsa:7082,PPrel,binding/association,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:7424,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5562,hsa:92579,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:8517,hsa:2911,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5606,hsa:6300,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:1374,hsa:23305,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:627,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2778,hsa:112,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
cpd:C00547,hsa:134,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00076,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3718,hsa:5293,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:572,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2255,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:7157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2720,path:hsa00051,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:53358,hsa:2885,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:4893,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9021,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:781,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:29110,hsa:10645,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2720,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2905,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:134,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8717,hsa:6517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:7480,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5518,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283748,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:71,hsa:4637,PPrel,binding/association,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:55526,hsa:6654,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:779,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2261,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:207,hsa:1385,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8517,hsa:4793,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
cpd:C00095,hsa:22877,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:2277,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:208,hsa:2309,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:2322,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4659,hsa:10398,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3845,hsa:4541,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5468,hsa:5139,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:2512,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:5291,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:218,hsa:8639,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:3625,hsa:7040,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:2069,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:90993,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5535,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:3280,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5587,hsa:3683,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1435,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:6464,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:2990,hsa:3362,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54567,hsa:4851,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:80310,hsa:3352,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:11035,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2905,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2247,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:130399,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:4301,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:329,hsa:836,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:5900,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:5894,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2790,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2264,hsa:3446,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,hsa:1956,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:207,hsa:4193,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2252,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1559,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:3107,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:3576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3626,hsa:7040,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:6885,hsa:53358,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2260,hsa:25759,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:9170,hsa:2778,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3643,hsa:5293,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5295,cpd:C05981,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:8792,hsa:3107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:4886,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,hsa:3688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:208,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3320,hsa:11035,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5294,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:53358,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5021,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:3447,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1908,hsa:1128,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5518,hsa:6772,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:5970,hsa:3447,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:3354,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:817,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:816,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5500,hsa:5618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7531,hsa:2309,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51135,hsa:7189,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5154,hsa:5321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:196883,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:91860,hsa:2782,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2549,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:4882,no_relation,no_relation,no_relation,no_relation,0.0
hsa:200186,hsa:148327,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5208,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:90993,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2805,hsa:5053,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:5880,hsa:5058,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:94235,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6197,hsa:5501,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:1375,hsa:23305,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:6622,hsa:4696,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3479,hsa:805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5330,cpd:C00165,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:112,cpd:C00575,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:5530,hsa:4773,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:27183,hsa:197259,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:2248,hsa:10891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3551,hsa:4793,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:283106,hsa:3831,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:284,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9586,hsa:5173,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:2771,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:1436,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C07593,hsa:4710,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:115,cpd:C00575,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27330,hsa:25759,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23710,hsa:2567,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:7852,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6195,hsa:5509,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5925,hsa:5781,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5499,hsa:92579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:8471,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:1545,hsa:2053,ECrel,compound,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:9965,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:4541,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5520,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2917,hsa:5618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:652,hsa:658,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,2,0.8
hsa:1742,hsa:2903,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2309,hsa:8536,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2778,hsa:115,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2645,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:163688,hsa:4638,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3845,hsa:5296,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2770,hsa:146850,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:23533,hsa:1956,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:9568,hsa:55970,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:55970,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3242,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:5836,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:2782,hsa:100137049,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2990,hsa:7363,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:2247,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5170,hsa:207,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5290,cpd:C05981,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:1435,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2783,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:207,hsa:7360,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6752,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5500,hsa:5609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:8605,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:4853,hsa:1109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:112,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5526,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:801,hsa:2569,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00240,hsa:1806,maplink,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:5518,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:108,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:207,hsa:3551,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2821,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:79861,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5532,hsa:6513,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:814,hsa:1869,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,hsa:4775,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:284,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7424,hsa:153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2775,hsa:115,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4803,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5663,hsa:3708,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2791,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:596,hsa:581,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:7855,hsa:1857,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:1268,hsa:2770,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:810,hsa:5532,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5602,hsa:54979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:147700,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5906,hsa:23683,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4908,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5154,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:817,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:842,hsa:836,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:91860,hsa:5535,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:26508,hsa:1026,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:3912,hsa:3688,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
cpd:C00212,hsa:3362,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3101,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2998,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:208,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5216,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:92579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:108,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10000,hsa:2308,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:94235,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5021,hsa:786,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2260,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5566,hsa:1080,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2793,hsa:581,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5290,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:1459,hsa:3798,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:2775,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:2771,hsa:5144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:7849,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:6772,hsa:5021,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2475,hsa:6198,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:1435,hsa:163688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:596,hsa:801,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2064,hsa:53358,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:3845,hsa:369,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:1856,hsa:2932,PPrel,inhibition,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:6774,hsa:3659,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:3265,hsa:3716,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:4137,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8823,hsa:4088,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:5564,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:1435,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05224 Breast cancer,3,0.8
hsa:5568,hsa:2905,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2209,hsa:5579,ECrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:3265,hsa:80201,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6195,hsa:3265,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:808,hsa:814,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
cpd:C00025,hsa:2891,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5598,hsa:4208,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:3479,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:637,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3099,hsa:2203,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:6237,hsa:1869,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4261,hsa:3119,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:6300,hsa:9261,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1644,hsa:6898,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:3480,hsa:5291,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:2324,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:3831,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6752,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5579,hsa:23683,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51806,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2821,hsa:3101,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:3643,hsa:2558,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3280,hsa:1026,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:10062,hsa:6720,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:1950,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5879,hsa:57144,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C00212,hsa:339896,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:10488,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:59345,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:4217,hsa:1432,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:7297,hsa:6778,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1559,hsa:246,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:1571,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2550,hsa:2783,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:2913,hsa:8399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:1909,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:801,hsa:1812,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4722,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:817,hsa:108,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4908,hsa:9945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1436,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:10000,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2932,hsa:3799,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2309,hsa:6648,GErel,expression,path:hsa04213 Longevity regulating pathway - multiple species,3,0.5
hsa:50487,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:6773,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2214,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:4089,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2353,hsa:7124,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5293,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2932,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1956,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5170,hsa:10000,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:3458,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:6416,hsa:5601,PPrel,activation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:3082,hsa:4233,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:805,hsa:109,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C01312,hsa:5732,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6934,hsa:595,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:5518,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7139,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5331,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:8074,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:90,hsa:4088,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:11211,hsa:1857,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:317,hsa:842,PPrel,activation,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:8772,hsa:841,PPrel,activation,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:5601,hsa:7157,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4854,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5605,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:3630,hsa:6720,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:4158,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27121,hsa:26007,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:4137,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2793,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:8737,hsa:11035,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1946,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2309,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11211,hsa:1855,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:1571,hsa:26279,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:207,hsa:2932,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:10000,hsa:572,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:10000,hsa:8605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2641,hsa:1812,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3481,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:491,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11211,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:842,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4254,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3452,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5533,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1945,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:2052,ECrel,compound,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:2081,hsa:4637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:657,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:116444,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:219,hsa:51380,ECrel,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:3667,hsa:22800,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:3091,GErel,expression,path:hsa04919 Thyroid hormone signaling pathway,1,0.5
hsa:3909,hsa:3688,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:6750,hsa:5733,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5519,hsa:6773,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:6934,hsa:38,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2323,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2787,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5173,hsa:2902,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00212,hsa:3352,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:231,hsa:2717,ECrel,compound,path:hsa00052 Galactose metabolism,4,0.5
hsa:5335,cpd:C00165,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1147,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00010,hsa:2645,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
hsa:8822,hsa:5210,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:5565,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:6655,hsa:4893,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1081,hsa:154,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
hsa:5567,hsa:1385,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:4909,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6714,hsa:27,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2785,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:27006,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5535,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:1435,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4793,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:10376,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:91860,hsa:91860,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5170,hsa:10110,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1081,hsa:7253,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
cpd:C11310,hsa:100532726,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:23236,cpd:C01245,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5293,hsa:207,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:4780,hsa:8644,GErel,expression,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:627,hsa:4790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:572,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:5159,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9456,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4729,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:148327,hsa:4170,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:3626,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:113026,cpd:C01245,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5506,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:114,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:207,hsa:1388,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9103,hsa:1432,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:5595,hsa:5743,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:65018,hsa:51079,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00076,hsa:91860,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2773,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:5590,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5566,hsa:7849,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:57016,hsa:2717,ECrel,compound,path:hsa00052 Galactose metabolism,4,0.5
hsa:1558,hsa:59345,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5579,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3455,hsa:7297,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:8797,hsa:8737,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2254,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3626,hsa:4838,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
cpd:C05981,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8945,hsa:920,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6932,hsa:4609,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:4254,hsa:7222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2914,hsa:8600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1459,hsa:147700,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:79444,hsa:836,PPrel,inhibition,path:hsa05145 Toxoplasmosis,1,0.8
hsa:9817,hsa:4780,PPrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:834,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2744,hsa:2747,ECrel,compound,path:hsa04964 Proximal tubule bicarbonate reclamation,1,0.5
hsa:5566,hsa:775,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2793,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:51378,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:3760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6720,hsa:8660,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:3479,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3352,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2353,hsa:595,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:4902,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5571,hsa:4881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3845,hsa:5603,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5599,hsa:6300,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5053,path:hsa00400,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:3717,hsa:5879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:130589,hsa:2720,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5228,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2475,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:4137,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:26291,hsa:4660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:60,hsa:4193,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:5595,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:108,hsa:6513,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:5587,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4780,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5595,hsa:148327,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:26291,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3397,hsa:7057,PPrel,inhibition,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:146850,hsa:1956,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:116,hsa:4881,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:207,hsa:5565,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:916,hsa:356,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:23683,hsa:3683,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1945,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:7137,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5908,hsa:5290,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2787,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:5906,hsa:3397,PPrel,inhibition,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:11035,hsa:2560,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:208,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3480,hsa:4893,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5566,hsa:5143,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2912,hsa:2784,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2255,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5533,hsa:5141,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:53358,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:116444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1385,hsa:1958,GErel,expression,path:hsa05020 Prion disease,1,0.5
hsa:5906,hsa:1395,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5564,hsa:1827,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25805,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5605,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2793,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:814,hsa:5140,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:369,hsa:5604,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:6237,cpd:C00044,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
hsa:2911,hsa:6514,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:5296,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2771,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:9965,hsa:3283,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2695,hsa:117,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:26291,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:53632,hsa:6513,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:9965,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1544,hsa:5320,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05224 Breast cancer,3,0.8
hsa:2785,hsa:4694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:817,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4878,hsa:3360,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51764,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:51806,hsa:4638,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:27123,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:1388,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5600,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:476,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3480,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:3135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3912,hsa:3655,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:1392,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7139,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6934,hsa:4609,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:1950,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6774,hsa:2099,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5170,hsa:207,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5600,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3627,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:4233,hsa:5290,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:56034,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6622,hsa:7314,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5530,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:80310,hsa:4615,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:4853,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4793,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23710,hsa:2554,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:5532,hsa:2911,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:22800,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2052,hsa:8644,ECrel,compound,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:355,hsa:8772,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
cpd:C00025,hsa:2890,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3661,hsa:3444,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:2770,hsa:3760,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2535,hsa:1857,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:808,hsa:4137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C01312,hsa:139760,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4780,hsa:9446,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:4803,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1536,hsa:598,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:815,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2209,hsa:5600,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:4916,hsa:7157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:23533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55276,path:hsa00010,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5602,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2784,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2249,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1460,hsa:89953,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:808,hsa:85366,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5594,hsa:2002,PPrel,phosphorylation,path:hsa05140 Leishmaniasis,1,0.8
hsa:2770,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:25865,hsa:5908,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51378,hsa:1616,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:5879,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:80310,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:3778,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
cpd:C00334,hsa:5144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85366,hsa:4637,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1571,hsa:5320,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:106821730,hsa:3984,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5566,hsa:492,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1457,hsa:5336,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:27330,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00212,hsa:3355,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:91860,hsa:5532,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:11211,hsa:6654,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2902,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3481,hsa:10243,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3667,hsa:8503,PPrel,activation,path:hsa04931 Insulin resistance,3,0.8
hsa:4803,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3439,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:2771,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3714,hsa:4855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
cpd:C07593,hsa:4294,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54106,hsa:4615,PPrel,activation,path:hsa05144 Malaria,1,0.8
hsa:7186,hsa:2475,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5155,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:27330,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:5781,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:2475,hsa:6199,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:4804,hsa:397,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2773,hsa:8972,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4914,hsa:2775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:5295,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5500,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:5733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5562,hsa:6517,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5579,hsa:5594,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:8817,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:2787,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,cpd:C05981,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2889,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:207,hsa:9882,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:8074,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:94235,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:2321,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6772,hsa:10379,PPrel,binding/association,path:hsa05160 Hepatitis C,1,0.5
hsa:2771,hsa:3593,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:1943,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:27006,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:229,hsa:26007,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5908,hsa:8503,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2785,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5894,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54518,hsa:375189,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7132,hsa:5602,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:2790,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:285,hsa:3460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7534,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:596,hsa:2512,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29082,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1856,hsa:23305,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23462,hsa:4609,GErel,expression,path:hsa05224 Breast cancer,1,0.5
cpd:C00788,hsa:2561,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5535,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:91860,hsa:815,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5295,hsa:3265,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2790,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:9048,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5294,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:1395,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:51703,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51764,hsa:1027,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5580,hsa:23683,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5228,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3815,hsa:23439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2081,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05216 Thyroid cancer,2,0.8
hsa:3480,hsa:5296,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:80310,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6622,hsa:100532726,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5296,hsa:598,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5530,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3661,hsa:3456,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:810,hsa:5530,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3454,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:6773,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:5600,hsa:3576,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:10488,hsa:1958,GErel,expression,path:hsa05020 Prion disease,1,0.5
hsa:5578,hsa:5594,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2247,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3064,hsa:441925,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:91860,hsa:108,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1435,hsa:54205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:2353,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2277,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2064,hsa:8503,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:6622,hsa:4725,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:10379,hsa:4939,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6804,hsa:779,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1398,hsa:2889,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5291,cpd:C05981,PCrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:7186,hsa:2767,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1234,hsa:2790,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2251,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4792,hsa:2534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:55970,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3452,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:817,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8823,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1956,hsa:399694,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:2770,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:1950,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:80310,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3831,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:1234,hsa:55970,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5970,hsa:3443,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:2932,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:116443,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1907,hsa:3354,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:391013,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:200186,hsa:10000,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1945,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:3627,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:5500,hsa:90993,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2550,hsa:6752,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1892,hsa:1962,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:2254,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:80310,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2918,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:5590,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:2791,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2776,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:3845,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5170,hsa:3451,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:3725,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6622,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1388,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:2253,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5578,hsa:8399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:841,hsa:836,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:6199,hsa:3667,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:1392,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5602,hsa:7157,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5468,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:5565,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1942,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9568,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2251,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:657,hsa:4090,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:2277,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:5530,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10488,hsa:596,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:5579,hsa:84699,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:341208,hsa:3162,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:8503,hsa:3091,GErel,expression,path:hsa04919 Thyroid hormone signaling pathway,1,0.5
hsa:109,hsa:490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:3798,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25865,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5170,hsa:208,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:814,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,hsa:4659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:10846,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8795,hsa:8737,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:9568,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80201,hsa:55276,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:3630,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5601,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1857,hsa:57118,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5443,hsa:1394,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4803,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C01996,hsa:9568,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2246,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5595,hsa:468,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:54205,hsa:842,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:4790,hsa:7124,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:5609,hsa:5599,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:1499,hsa:51176,PPrel,activation,path:hsa05216 Thyroid cancer,1,0.8
cpd:C11310,hsa:4714,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00575,hsa:5836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1813,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6196,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:112,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5154,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9568,hsa:2792,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:5894,hsa:5021,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4916,hsa:153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1855,hsa:2932,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8503,hsa:57118,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27330,hsa:5509,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
cpd:C11310,hsa:4724,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:27121,hsa:54361,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1950,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:57118,hsa:2919,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:5879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:10000,PCrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:1557,hsa:5322,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:3265,hsa:5296,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:1944,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:823,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:60,hsa:4637,PPrel,binding/association,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:3443,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4780,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5533,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:810,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1111,hsa:7465,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1946,hsa:3444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:779,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C05981,hsa:208,PCrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:218,hsa:4128,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:468,hsa:596,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:208,hsa:7249,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5970,hsa:80326,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:1816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1457,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11211,hsa:1856,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:2277,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C21642,hsa:9817,PCrel,inhibition,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:3551,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2308,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5579,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:107,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5601,hsa:3798,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5170,hsa:207,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:8817,hsa:1398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:4301,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:1026,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10379,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:477,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:805,hsa:340156,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6199,hsa:6194,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:3592,GErel,expression,path:hsa05164 Influenza A,2,0.5
cpd:C00076,hsa:91860,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
hsa:3448,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6198,hsa:1975,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55844,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:627,hsa:7849,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1950,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1379,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:5053,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:2944,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:11211,hsa:482,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:10381,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:3709,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:10235,hsa:5906,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:91860,hsa:113,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1958,hsa:54539,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:5208,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5567,hsa:116443,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:1855,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3717,hsa:6774,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:3565,hsa:4843,PPrel,inhibition,path:hsa05140 Leishmaniasis,1,0.8
hsa:53632,hsa:2538,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:2250,hsa:8737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2534,hsa:8503,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:801,hsa:3449,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2214,hsa:1432,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:5568,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2264,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3716,hsa:6778,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:8517,hsa:5908,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:7249,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1956,hsa:5595,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:7529,hsa:369,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:5608,hsa:54979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3569,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:2252,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3479,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:91,hsa:4087,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,2,0.8
hsa:5290,hsa:10000,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2775,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:4853,hsa:23493,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:5582,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3265,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5522,hsa:1649,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90,hsa:2891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:5213,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5580,hsa:8681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3910,hsa:3655,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:1892,hsa:3033,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:5623,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1392,hsa:154,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5578,hsa:5594,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:11345,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:107,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5568,hsa:2904,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:4638,hsa:10398,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:841,hsa:11035,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:4909,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:673,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10379,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4301,hsa:5319,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:3265,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5602,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:808,hsa:817,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:808,hsa:816,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2247,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:54331,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1435,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2782,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:9965,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5533,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3397,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01312,hsa:4881,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2263,hsa:59345,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5296,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1385,hsa:10891,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:9020,hsa:64600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2914,hsa:94235,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3551,hsa:5213,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:9021,GErel,expression,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:5228,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:23493,hsa:2064,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:2790,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5566,hsa:1557,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1571,hsa:8399,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:208,hsa:84699,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3714,hsa:4854,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:816,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa05164 Influenza A,1,0.8
hsa:1906,hsa:9474,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:112,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4803,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1459,hsa:3799,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2775,hsa:113,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5155,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2788,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5594,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8324,hsa:1855,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:3630,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5594,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,hsa:2890,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2324,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:94235,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:7039,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:4773,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5563,hsa:5105,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5792,hsa:3643,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:26291,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:718,hsa:1378,PPrel,binding/association,path:hsa05140 Leishmaniasis,1,0.5
hsa:5566,hsa:148327,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:2249,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4803,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05216 Thyroid cancer,2,0.8
hsa:5241,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:398,hsa:387,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8517,hsa:8660,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:1571,hsa:64600,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:3265,hsa:5894,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5241,hsa:8600,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:5290,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:5908,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5136,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5532,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54518,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:2997,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:2261,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6654,hsa:4893,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:6654,hsa:3265,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00780,hsa:1812,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:5610,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:57521,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:2770,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3716,hsa:5290,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3718,hsa:5291,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:59345,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:3355,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5610,hsa:8517,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:10000,hsa:1386,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1943,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5296,hsa:8605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1375,hsa:2182,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:3242,hsa:6898,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:8772,hsa:841,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:207,hsa:4193,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5608,hsa:3973,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8074,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7533,hsa:369,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:55970,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:146850,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
cpd:C00533,hsa:2983,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:51378,hsa:1573,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3446,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:2744,hsa:3134,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80201,hsa:7043,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51176,hsa:595,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:56034,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4803,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:208,hsa:1385,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3099,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3695,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:284,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9021,hsa:6772,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:7422,hsa:92,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1907,hsa:4886,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3665,hsa:155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:490,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2792,hsa:57818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,hsa:440275,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3625,hsa:5834,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:816,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2778,hsa:111,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C01996,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4776,hsa:5997,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:6655,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:387,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2052,hsa:4088,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:805,hsa:5534,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:7852,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79660,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4712,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1374,hsa:81616,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:146850,hsa:9254,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:4793,PPrel,phosphorylation,path:hsa05164 Influenza A,2,0.8
hsa:2788,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5501,hsa:493,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27330,hsa:79660,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:1557,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1388,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:4914,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6652,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5159,hsa:25865,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,path:map00960,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:2550,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7976,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3791,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:572,hsa:3763,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2249,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6300,hsa:3576,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:5894,hsa:5500,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6197,hsa:468,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3082,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:572,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1459,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:3667,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:9048,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5524,hsa:208,PPrel,inhibition,path:hsa04931 Insulin resistance,2,0.8
hsa:2308,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:5236,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:208,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:4804,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:11345,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:1385,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:2475,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5058,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3725,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:80310,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5567,hsa:492,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:148327,hsa:2353,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa04917 Prolactin signaling pathway,1,0.8
cpd:C07593,hsa:4702,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5608,hsa:2911,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5214,path:hsa00010,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2778,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:90993,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:818,hsa:5142,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:3283,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:109,cpd:C00575,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5071,hsa:5332,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:10971,hsa:7476,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6772,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:7039,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:53358,hsa:6714,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:4843,cpd:C00533,PCrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:5154,hsa:3354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:2563,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:4088,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:5331,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2775,hsa:7364,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4803,hsa:5564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1946,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:818,hsa:113,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2246,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1234,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:1432,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C00575,hsa:64600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2913,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01996,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:196883,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1432,hsa:3725,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5500,hsa:140465,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3479,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:54776,hsa:4637,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2782,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:4215,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1573,hsa:779,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:5535,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3134,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2911,hsa:2906,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5568,hsa:492,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9451,hsa:5500,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1234,hsa:2785,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:207,hsa:1388,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5499,hsa:140465,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:801,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5532,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:7098,hsa:148022,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:207,hsa:572,PPrel,phosphorylation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:55740,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5571,hsa:2538,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:7531,hsa:572,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1576,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:130399,hsa:4088,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:4137,hsa:84790,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2251,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5290,hsa:5747,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5443,hsa:2740,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5970,hsa:92,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2904,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:10000,hsa:2475,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:2773,hsa:8639,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:3350,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:6196,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1459,hsa:51806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5335,cpd:C01245,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
cpd:C00025,hsa:2891,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:2770,hsa:111,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:26007,hsa:229,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5519,hsa:6198,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:2770,hsa:107,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2990,hsa:5335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:2903,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:5290,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:163688,hsa:112,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7852,hsa:2717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4638,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:2892,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:7168,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1499,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:135,hsa:51380,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57121,hsa:2778,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C05981,hsa:5170,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3815,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5499,hsa:317,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5728,cpd:C05981,PCrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:5906,hsa:5290,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:26291,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1644,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:3725,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:5335,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2064,hsa:2891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2906,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:7422,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:54979,hsa:3350,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:26279,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:1234,hsa:2793,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1945,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:2904,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5777,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:2247,hsa:3442,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23291,hsa:920,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:163688,hsa:492,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8322,hsa:1856,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1544,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:7385,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:94235,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5566,hsa:5587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:375189,hsa:60,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2248,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3845,hsa:5295,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C01312,hsa:3362,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5908,hsa:6770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:2559,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3448,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3440,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1460,hsa:3799,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4254,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2785,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:2554,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:2475,hsa:6199,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:1942,hsa:6775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:5291,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:6195,hsa:468,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:657,hsa:4093,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:2069,hsa:3800,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1950,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4908,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:814,hsa:468,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4909,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8074,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6772,hsa:3113,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:51806,hsa:5532,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3717,hsa:6464,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:1559,hsa:5319,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:10000,hsa:572,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:2308,hsa:92579,GErel,expression,path:hsa04931 Insulin resistance,1,0.5
hsa:2914,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3355,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1946,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C22381,hsa:1147,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C00547,hsa:1128,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5331,cpd:C00165,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:4660,hsa:140465,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1942,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8823,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:26508,hsa:2064,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:8322,hsa:5236,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:51806,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:5894,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:816,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:637,hsa:581,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3326,hsa:11035,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5207,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7132,hsa:841,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:7424,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5587,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:834,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3447,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:2323,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2771,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:80310,hsa:2203,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23710,hsa:157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26291,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3082,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2889,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5499,hsa:148327,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5296,hsa:5879,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2744,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:491,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3442,hsa:3455,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5579,hsa:3643,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:1571,hsa:5319,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
cpd:C05981,hsa:207,PCrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:998,hsa:60,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4158,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:658,hsa:4090,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:5296,hsa:2997,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:5732,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1128,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:841,hsa:1540,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:5534,hsa:572,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:5534,hsa:4773,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2695,hsa:10891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5105,cpd:C00031,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:374,hsa:7277,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4915,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:2998,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:810,hsa:85366,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5566,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4287,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5293,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:11337,hsa:2557,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:6416,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:5295,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:207,hsa:4793,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:26291,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4638,hsa:4637,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1460,hsa:3800,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00076,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1020,hsa:4137,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4902,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2783,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:200186,hsa:4694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22926,hsa:1649,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:5608,hsa:1432,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5567,hsa:7137,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2776,hsa:10645,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:177,hsa:1536,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6622,hsa:4710,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8651,hsa:6772,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
cpd:C00780,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1544,hsa:1558,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:1559,hsa:6272,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7010,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10379,hsa:103,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:5170,hsa:100533105,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1460,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5293,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:815,hsa:25865,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1459,hsa:3831,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:7074,hsa:4708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2912,hsa:2787,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2248,hsa:847,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:4217,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:8321,hsa:1856,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5335,hsa:51806,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6654,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:7124,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
cpd:C00076,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:30837,hsa:2002,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2324,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1956,hsa:116443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5623,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6195,hsa:5507,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:4893,hsa:1432,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5228,hsa:30,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:6392,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:816,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5335,hsa:399694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1855,hsa:2932,PPrel,inhibition,path:hsa05224 Breast cancer,1,0.8
hsa:5228,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6195,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:207,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5588,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:3445,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:163688,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2932,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:26281,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:208,hsa:64764,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3717,hsa:6772,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:1128,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2783,hsa:230,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6196,hsa:5499,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
cpd:C03758,hsa:5733,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:154,hsa:3800,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6195,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:9586,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51806,hsa:10645,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5598,hsa:27330,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4790,hsa:6347,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:814,hsa:148327,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5602,hsa:4694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:4772,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2246,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1958,hsa:6352,GErel,expression,path:hsa05020 Prion disease,1,0.5
hsa:7419,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23586,hsa:57506,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:3320,hsa:26508,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5321,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:5566,hsa:84699,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:627,hsa:5618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2321,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2081,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8326,hsa:1856,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5565,hsa:32,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:440275,hsa:8517,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:1906,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:123745,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:7423,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:53632,hsa:57521,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:4254,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5595,hsa:2053,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:53358,no_relation,no_relation,no_relation,no_relation,0.0
hsa:114,cpd:C00575,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1499,hsa:51176,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:1436,hsa:779,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:85366,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:163688,hsa:5532,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1956,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5534,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:2776,hsa:4694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9454,hsa:3710,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:10000,hsa:3164,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7423,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7039,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55012,hsa:5565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:8678,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7186,hsa:25759,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6196,hsa:5499,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:1386,hsa:4170,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:5295,cpd:C05981,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:65018,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:8605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:146850,hsa:5170,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:3326,hsa:5465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:218,hsa:4129,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:4853,hsa:2740,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:5594,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5520,hsa:491,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:5321,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:1557,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C22381,hsa:5728,PCrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3091,hsa:5214,GErel,expression,path:hsa04919 Thyroid hormone signaling pathway,1,0.5
cpd:C00780,hsa:4638,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:4215,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4902,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00334,hsa:1234,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:119391,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2903,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1234,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:64764,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5208,hsa:3553,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:5321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:5908,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7046,hsa:3762,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5579,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5595,hsa:123745,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00575,hsa:123745,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:5608,hsa:6300,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3444,hsa:3454,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:8074,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5155,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6772,path:hsa00400,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9843,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:54205,hsa:842,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2773,hsa:108,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00076,hsa:808,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:4780,hsa:2949,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:200186,hsa:90993,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
cpd:C01245,cpd:C13050,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7048,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:9103,hsa:5600,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:3716,hsa:823,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5562,hsa:84335,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2695,hsa:1394,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2309,hsa:659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5563,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2535,hsa:1855,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:259307,path:hsa00400,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:84699,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5021,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5465,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5781,hsa:5747,PPrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5296,hsa:54776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:399694,hsa:2885,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:163688,hsa:5743,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:5105,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:80310,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4878,hsa:1080,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:57118,hsa:4846,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3099,hsa:5970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:4696,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5567,hsa:2902,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00195,hsa:5579,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:4909,hsa:4804,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:51284,hsa:4615,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:816,hsa:5141,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00334,hsa:5733,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C07593,hsa:4715,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C04549,hsa:5925,no_relation,no_relation,no_relation,no_relation,0.0
hsa:226,hsa:2203,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:9586,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00095,hsa:6945,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5337,hsa:5587,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2246,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3481,hsa:2554,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1388,hsa:4170,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:4137,hsa:10381,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5594,hsa:4208,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:7074,hsa:5880,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2212,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6197,hsa:4893,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2641,hsa:117,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1956,hsa:5293,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C00575,hsa:5567,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:4254,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4217,hsa:490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6885,hsa:8681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:128866,hsa:197259,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:5599,hsa:3799,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:27006,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9586,hsa:596,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:7132,hsa:8717,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2771,hsa:5294,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:3479,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2773,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:8822,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:808,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
hsa:4893,hsa:5894,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4615,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:5530,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5523,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:11337,hsa:2563,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:7297,hsa:6775,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2309,hsa:2538,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:6622,hsa:4729,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:200186,hsa:1385,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:207,hsa:107,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
cpd:C01996,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:7709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:2353,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:7010,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00575,hsa:5566,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:1459,hsa:3800,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5608,hsa:1432,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3661,hsa:3442,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:6622,hsa:56901,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5568,hsa:2308,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:3716,hsa:6772,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:8823,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00076,hsa:824,PCrel,activation,path:hsa04217 Necroptosis,2,0.8
hsa:4790,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:135,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
hsa:207,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2253,hsa:51196,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:387,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:80310,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01312,hsa:154,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5594,hsa:90993,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4780,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:4093,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:331,hsa:836,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:207,hsa:9706,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1460,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4708,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:817,hsa:115,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5155,hsa:4633,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3101,hsa:5210,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5567,hsa:2308,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:4908,hsa:4804,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:816,hsa:468,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4775,hsa:1827,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:2253,hsa:7384,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:255189,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:801,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:1499,hsa:83439,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:673,hsa:5605,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00025,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3695,hsa:60,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:5567,hsa:493,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C03758,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27,hsa:25865,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:658,hsa:4093,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:5214,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:816,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5566,hsa:1586,GErel,expression,path:hsa04913 Ovarian steroidogenesis,2,0.5
hsa:8822,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2771,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:2770,hsa:108,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2251,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3630,hsa:4725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:369,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:2252,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5154,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9451,hsa:1965,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2932,hsa:4609,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4638,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:779,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2255,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3693,hsa:60,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:284,hsa:7476,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:5578,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5291,hsa:207,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1558,hsa:5321,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:9945,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10319,hsa:3655,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5532,hsa:2891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:134,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7124,hsa:7133,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8651,hsa:6777,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:4909,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:70,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:5350,no_relation,no_relation,no_relation,no_relation,0.0
hsa:154,hsa:2778,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:4780,hsa:7296,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:2790,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5331,cpd:C01245,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:1234,hsa:94235,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:805,hsa:114,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4254,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7532,hsa:369,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:2069,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2255,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5209,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:11345,hsa:2563,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:1234,hsa:3444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2915,hsa:2747,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4916,hsa:1586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C15231,hsa:7386,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5601,hsa:2353,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5336,cpd:C01245,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4909,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5894,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5228,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:163688,hsa:816,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:369,hsa:3133,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4909,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2549,hsa:5296,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:27006,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:51733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:9586,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:291,hsa:54205,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4893,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5602,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5906,hsa:5900,PPrel,inhibition,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00334,hsa:3354,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:958,hsa:3592,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:1942,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5534,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5609,hsa:3460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5515,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:51079,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5595,hsa:90993,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9456,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9456,hsa:3708,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
cpd:C21012,hsa:177,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:650,hsa:658,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,2,0.8
hsa:816,hsa:4637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:842,hsa:6494,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:329,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5608,hsa:1432,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8660,hsa:90673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:5173,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:27102,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5170,hsa:208,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:5579,hsa:9586,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:208,hsa:113,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2247,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6500,hsa:920,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1147,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8321,hsa:1856,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:55102,hsa:26100,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
cpd:C00788,hsa:139760,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5053,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:5330,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5579,hsa:6548,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:4804,hsa:2746,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5520,hsa:6773,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:9103,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283106,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:652,hsa:659,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5595,hsa:4893,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:30837,hsa:7481,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3133,hsa:440275,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1234,hsa:2767,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1081,hsa:4881,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
hsa:2770,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2778,hsa:109,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5568,hsa:775,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1435,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3643,hsa:91807,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6932,hsa:595,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:5507,hsa:5836,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:6464,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:468,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
cpd:C00334,hsa:2560,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
cpd:C00575,hsa:5566,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:7167,hsa:230,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,2,0.5
hsa:2260,hsa:5296,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:817,hsa:10846,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4790,hsa:3552,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:816,hsa:3688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1460,hsa:3798,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:3479,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8822,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1944,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1945,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:468,hsa:4170,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:2918,hsa:23683,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:7482,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5530,hsa:4773,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5532,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9586,hsa:2353,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:2053,hsa:1645,ECrel,compound,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:801,hsa:5530,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:3454,hsa:7297,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1978,hsa:8789,no_relation,no_relation,no_relation,no_relation,0.0
hsa:123745,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:64764,hsa:3725,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:2784,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:11145,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:817,hsa:5140,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3101,path:hsa00010,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:7422,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2064,hsa:5290,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:207,hsa:5211,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3725,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2002,hsa:2353,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:113026,cpd:C00165,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1945,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51806,hsa:5533,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:22800,hsa:5337,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:208,hsa:50487,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:90993,hsa:627,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:9586,hsa:1958,GErel,expression,path:hsa05020 Prion disease,1,0.5
hsa:4851,hsa:2324,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:7409,hsa:5879,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:842,hsa:836,PPrel,activation,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:6934,hsa:595,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:5594,hsa:3725,PPrel,phosphorylation,path:hsa05140 Leishmaniasis,1,0.8
hsa:5881,hsa:5063,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1571,hsa:1573,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:805,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1020,hsa:4137,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:163688,hsa:5535,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:4908,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23533,hsa:5170,PPrel,compound,path:hsa05145 Toxoplasmosis,1,0.5
hsa:6885,hsa:1147,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:153,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9048,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:817,hsa:331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:5296,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3265,hsa:5600,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2918,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5580,hsa:2567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:814,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:817,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:8851,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:5320,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
cpd:C05981,hsa:208,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5566,hsa:1588,GErel,expression,path:hsa04913 Ovarian steroidogenesis,2,0.5
hsa:10000,hsa:2309,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5623,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26281,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2053,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22926,hsa:1649,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:5599,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4254,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5465,hsa:1374,GErel,expression,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:23710,hsa:2561,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:2912,hsa:2791,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:53632,hsa:6517,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:83439,hsa:4609,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:5601,hsa:5600,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:8823,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00547,hsa:5598,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8717,hsa:7188,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:7529,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64131,hsa:11285,ECrel,compound,path:hsa00532 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,1,0.5
hsa:207,hsa:10488,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3107,hsa:482,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5533,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:637,hsa:581,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1544,hsa:8681,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:10000,hsa:1026,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:3661,hsa:3446,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:2255,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1081,hsa:11035,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:5139,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:959,hsa:958,PPrel,binding/association,path:hsa05144 Malaria,1,0.5
hsa:1571,hsa:1544,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:7534,hsa:572,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5908,hsa:51196,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2786,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:4261,hsa:2550,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:824,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5071,hsa:5335,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4902,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5595,hsa:4539,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4659,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3458,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:65018,hsa:4538,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1944,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:801,hsa:122011,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2776,hsa:5330,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5155,hsa:7416,no_relation,no_relation,no_relation,no_relation,0.0
hsa:841,hsa:637,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:7424,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:25,hsa:5236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2538,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9021,hsa:6514,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:55276,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9568,hsa:51764,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:8822,hsa:6513,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:134,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1906,hsa:134,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3845,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4702,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5595,hsa:5880,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11345,hsa:2559,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:3460,hsa:3716,PPrel,binding/association,path:hsa05164 Influenza A,1,0.5
hsa:5578,hsa:148327,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:9021,hsa:3953,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:1558,hsa:50487,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:163688,hsa:5530,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
cpd:C05981,hsa:100137049,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:2785,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:805,hsa:2785,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1742,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7534,hsa:673,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:4659,hsa:4637,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5211,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:4846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2277,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5594,hsa:9586,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:23236,cpd:C01245,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:627,hsa:4915,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1943,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:10975,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:818,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5600,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6622,hsa:229,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:8737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25805,hsa:657,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:10603,hsa:2885,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2771,hsa:5293,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6195,hsa:3716,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2902,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5155,hsa:782,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2990,hsa:54578,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:1544,hsa:1576,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:3265,hsa:369,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5170,hsa:208,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:2770,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
cpd:C07593,hsa:126328,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:9843,hsa:3162,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:2778,hsa:114,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51733,hsa:1807,ECrel,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:6197,hsa:5499,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:22943,hsa:7473,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1946,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5563,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C21641,hsa:9817,PCrel,inhibition,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:23462,hsa:2064,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:5578,hsa:7132,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4916,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:8398,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:51176,hsa:801,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4724,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3914,hsa:1958,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:3710,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:55811,hsa:3351,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5156,hsa:3351,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1907,hsa:5733,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:65018,hsa:4725,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1457,hsa:3831,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3630,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5331,hsa:5908,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4720,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2321,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:54205,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5155,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:163688,hsa:818,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3452,hsa:3455,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5566,hsa:2905,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27006,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2913,hsa:2791,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:57506,hsa:8517,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
cpd:C20640,hsa:340061,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5579,hsa:468,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:83660,hsa:3690,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5894,hsa:5605,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1459,hsa:3831,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4790,hsa:598,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:2277,hsa:3460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:3265,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:3815,hsa:5296,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:2773,hsa:6093,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:111,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:54205,hsa:842,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:5319,hsa:3460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5331,cpd:C01245,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6654,hsa:3845,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:4261,hsa:5509,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:5321,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2776,hsa:23236,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5228,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:11345,hsa:2560,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:3665,hsa:3441,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:2889,hsa:5908,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:11035,hsa:816,PPrel,phosphorylation,path:hsa04217 Necroptosis,1,0.8
hsa:2790,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5623,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3098,hsa:55276,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:2246,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5053,path:map00960,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:163688,hsa:5530,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:130399,hsa:4087,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5532,hsa:4773,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:22943,hsa:1812,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4878,hsa:7278,no_relation,no_relation,no_relation,no_relation,0.0
hsa:28514,hsa:4853,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5290,hsa:5170,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
cpd:C16844,hsa:9817,PCrel,inhibition,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:116,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51176,hsa:4609,GErel,expression,path:hsa05216 Thyroid cancer,1,0.5
hsa:28227,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:8398,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:4902,hsa:317,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:3643,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
cpd:C00533,hsa:2977,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:374,hsa:5580,no_relation,no_relation,no_relation,no_relation,0.0
hsa:50848,hsa:7082,PPrel,binding/association,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
cpd:C00547,hsa:3354,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2775,hsa:108,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:283106,hsa:64837,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:26291,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:284,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00788,hsa:3973,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2247,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2255,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4915,hsa:6464,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5900,hsa:5898,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5594,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5777,hsa:8737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6652,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:572,PPrel,inhibition,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:3454,hsa:3717,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2250,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7297,hsa:6776,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:80201,path:hsa00051,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:818,hsa:51135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:2776,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3447,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51422,hsa:6513,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:6655,hsa:3845,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:5535,hsa:2915,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:9048,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5578,hsa:5894,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:2323,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:283106,hsa:3800,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1234,hsa:59345,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2247,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5524,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4794,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:26291,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2784,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7043,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5156,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10241,hsa:29110,PPrel,inhibition,path:hsa05164 Influenza A,1,0.8
hsa:2250,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:3451,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:27330,hsa:90673,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:4893,hsa:5601,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2260,hsa:659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:196883,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5582,hsa:7849,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5623,hsa:126328,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00212,hsa:5021,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:113,cpd:C00575,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:80201,hsa:2821,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:810,hsa:5322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:817,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:578,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4855,hsa:26508,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:84699,hsa:1958,GErel,expression,path:hsa05020 Prion disease,1,0.5
cpd:C00780,hsa:1816,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:116,hsa:5880,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2916,hsa:2775,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2475,hsa:5607,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:26279,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:8325,hsa:1857,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:208,hsa:468,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:283106,hsa:3799,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
cpd:C00212,hsa:1394,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1942,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5330,hsa:4090,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5602,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
cpd:C00076,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7424,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:10243,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1499,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:5140,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1050,hsa:8864,GErel,expression,path:hsa05202 Transcriptional misregulation in cancer,1,0.5
hsa:10379,hsa:4600,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:208,hsa:148327,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5594,path:map00960,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:4193,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3480,hsa:25759,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2550,hsa:2563,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:2554,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:3309,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2641,hsa:5732,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:285,hsa:54979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:5296,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3479,hsa:255189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:5321,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:5607,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2309,hsa:51384,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:5321,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:25759,hsa:2885,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
cpd:C00780,hsa:4881,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6794,hsa:5562,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:818,hsa:6531,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:2912,hsa:2793,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:91860,hsa:2977,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6197,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3460,hsa:3717,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:4790,hsa:7124,GErel,expression,path:hsa04931 Insulin resistance,2,0.5
cpd:C00584,hsa:3352,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5581,hsa:3643,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:112,cpd:C00575,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:6093,hsa:4659,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1906,hsa:6752,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4090,hsa:54776,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4538,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3134,hsa:6093,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:3284,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:1943,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:91807,hsa:10398,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2250,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2782,hsa:139760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4233,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:3762,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:11337,hsa:2565,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:10681,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:596,hsa:578,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:26291,hsa:8789,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5524,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:53632,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4915,hsa:2885,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:208,hsa:1027,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00780,hsa:4886,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00212,hsa:2550,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6197,hsa:5507,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:808,hsa:111,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2990,hsa:10941,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:117145,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1813,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6750,hsa:492,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26508,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:2639,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:801,hsa:5534,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2932,hsa:1499,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1557,hsa:8399,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:7423,hsa:134,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:84152,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3718,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:637,hsa:581,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:2549,hsa:7278,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1965,hsa:2550,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83439,hsa:595,GErel,expression,path:hsa05216 Thyroid cancer,1,0.5
hsa:2783,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:627,hsa:7476,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7010,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2064,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:2775,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2915,hsa:2776,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3106,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:89869,cpd:C00165,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:65018,hsa:490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3098,hsa:2821,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:356,hsa:355,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2771,hsa:3760,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:7422,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:54331,hsa:50487,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3661,hsa:3451,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:116,hsa:3107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:4843,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:2475,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5217,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:4793,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2912,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:114,cpd:C00575,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:207,hsa:2309,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2885,hsa:3973,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5606,hsa:5600,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:718,hsa:5587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C00076,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7074,hsa:5879,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3718,hsa:6778,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2786,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6655,hsa:5211,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5610,hsa:8737,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:4909,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5155,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:1026,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:1432,hsa:5594,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2786,hsa:8398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5159,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1950,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6654,hsa:3845,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:2558,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:4803,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4902,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3725,hsa:2919,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:208,hsa:114112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3280,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:7137,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3551,hsa:3667,PPrel,phosphorylation,path:hsa04931 Insulin resistance,2,0.8
hsa:91860,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:3798,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:5170,hsa:3352,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2247,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4093,hsa:10327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5604,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4803,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51378,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:814,hsa:64764,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:6750,hsa:2550,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5588,hsa:3667,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:2717,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5562,hsa:2475,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:817,hsa:2906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3456,hsa:3455,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:4916,hsa:5335,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:7099,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:3845,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:116,hsa:5565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:109,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2915,hsa:9455,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:5295,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:107,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:4790,hsa:3576,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:1946,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2214,hsa:6300,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:134,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:3133,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5321,PCrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:9965,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:94235,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:8503,hsa:5580,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:4790,hsa:3688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:54658,no_relation,no_relation,no_relation,no_relation,0.0
hsa:200186,hsa:84699,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:3717,hsa:5781,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:1965,hsa:468,PPrel,activation,path:hsa05020 Prion disease,1,0.8
cpd:C05981,hsa:207,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2058,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5605,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:10379,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7039,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5516,hsa:6773,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:5499,hsa:10488,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:816,hsa:4137,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1543,hsa:2053,ECrel,compound,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:5521,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5293,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283106,hsa:89953,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5594,hsa:283748,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2254,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2260,hsa:53358,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:10000,hsa:57521,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:3444,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
cpd:C07593,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:656,hsa:659,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:2248,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:441282,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:146850,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:673,hsa:5604,PPrel,phosphorylation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:3064,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:6548,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:805,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3460,hsa:3717,PPrel,binding/association,path:hsa05164 Influenza A,1,0.5
hsa:1379,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2891,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3449,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:673,hsa:5604,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:6777,hsa:8600,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
cpd:C00165,hsa:3552,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7317,hsa:7316,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:285,hsa:5880,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:5141,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C01996,hsa:3350,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:2906,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2249,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5330,cpd:C00165,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5170,hsa:3688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5533,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5295,hsa:5170,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:4915,hsa:3667,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5443,hsa:7253,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4254,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5295,hsa:6352,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11345,hsa:2566,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:2248,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1576,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:3553,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2791,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3481,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7422,hsa:6195,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C22381,hsa:5770,PCrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:817,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:163688,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:7494,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:7480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:5213,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:1398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2778,hsa:112,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5500,hsa:9586,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:51378,hsa:84335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5290,cpd:C05981,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:2247,hsa:3441,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3459,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:116444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2821,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:111,PPrel,inhibition,path:hsa04924 Renin secretion,1,0.8
hsa:3717,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5563,hsa:5106,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
cpd:C07593,hsa:4705,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7039,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1374,hsa:51703,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:7297,hsa:6777,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:3908,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3592,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:842,hsa:836,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5595,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:641371,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5530,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1544,hsa:8605,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
cpd:C00212,hsa:9568,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6258,hsa:5468,PPrel,binding/association,path:hsa05202 Transcriptional misregulation in cancer,1,0.5
hsa:283106,hsa:3800,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:1576,hsa:5322,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:3098,hsa:2720,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5728,hsa:57818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:817,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3953,hsa:6794,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:208,hsa:5587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:1385,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2778,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:92579,hsa:55276,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5567,hsa:2890,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:8822,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5880,hsa:106821730,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3791,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5601,hsa:2920,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5598,hsa:2353,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:11345,hsa:255189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:81858,hsa:331,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:2053,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8737,hsa:83447,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:4792,hsa:2740,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:5603,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:80310,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3791,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:9252,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8324,hsa:5566,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283106,hsa:8644,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5336,hsa:163688,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4790,hsa:3442,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:8074,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5295,hsa:208,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:801,hsa:816,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:1945,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2253,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:10379,PPrel,binding/association,path:hsa05164 Influenza A,1,0.5
hsa:208,hsa:2932,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00788,hsa:1813,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:10110,no_relation,no_relation,no_relation,no_relation,0.0
hsa:60,hsa:140465,PPrel,binding/association,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:815,hsa:123745,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27243,hsa:54979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1374,hsa:6776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:10846,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5582,hsa:8681,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:23710,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:107,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:5520,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C03758,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:229,hsa:2203,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5293,hsa:208,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5499,hsa:1839,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1634,hsa:7043,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:801,hsa:123745,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25759,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2264,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3265,hsa:5295,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4909,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:1499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5580,hsa:5587,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2534,hsa:5295,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:5587,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:107,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C01245,hsa:3709,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2990,hsa:54600,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:6195,hsa:5506,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:805,hsa:85366,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:102723407,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:3066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:9048,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5601,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
cpd:C05981,hsa:5728,PCrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2785,hsa:9020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:8503,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6655,hsa:3117,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:6237,hsa:673,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:207,hsa:8517,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1386,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6898,hsa:4193,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:776,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1944,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3799,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:2783,hsa:5350,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6776,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:5595,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7422,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5906,hsa:5293,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2253,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3661,hsa:3452,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:6195,hsa:1544,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:572,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:5610,hsa:3551,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:6804,hsa:2905,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2052,hsa:4712,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3355,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:808,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3441,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:3991,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2641,hsa:153,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6655,hsa:4893,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:369,hsa:5605,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2069,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:4193,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2806,path:map00960,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:7855,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1965,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10616,hsa:331,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:2053,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2903,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:627,hsa:5021,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5604,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:3688,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:4843,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
cpd:C00025,hsa:2905,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:6199,hsa:3667,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:84335,hsa:6199,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5604,hsa:5594,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4624,hsa:4633,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:6258,hsa:6464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:5602,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:2791,hsa:9456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:2740,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5524,hsa:3350,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,cpd:C05981,PCrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:4909,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:2915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:218,hsa:314,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:5594,hsa:5321,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00547,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5534,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6195,hsa:468,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5747,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2064,hsa:6464,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:2846,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:5291,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:6197,hsa:3845,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2254,hsa:5321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4893,hsa:3122,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:3800,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:91860,hsa:340156,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:9451,hsa:1965,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:11035,hsa:818,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:116,hsa:5582,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3098,hsa:5213,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5468,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:177,hsa:50507,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5567,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:6197,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:1500,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:3688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:113,hsa:3456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:5894,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5295,cpd:C05981,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
cpd:C00212,hsa:805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2917,hsa:2787,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7422,hsa:1813,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2914,hsa:51764,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6774,hsa:50487,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:3592,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:7039,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2792,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:673,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5602,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5521,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:25759,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1234,hsa:2783,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1559,hsa:255189,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:1945,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2775,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:8823,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4790,hsa:3456,GErel,expression,path:hsa05164 Influenza A,2,0.5
cpd:C00025,hsa:2917,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:9170,hsa:2776,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5228,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:369,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26007,hsa:230,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:284,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8074,hsa:3115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:10243,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4914,hsa:10603,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:7976,hsa:1855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:2791,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:285,hsa:2737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:23236,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5979,hsa:958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:107,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2790,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:10000,hsa:842,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:90673,hsa:4706,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:10587,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:7039,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:136,hsa:10645,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6655,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C00575,hsa:10965,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
cpd:C00575,hsa:100137049,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:3082,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3695,hsa:71,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:5970,hsa:3443,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:1460,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5291,cpd:C05981,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5568,hsa:6770,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:283106,hsa:3798,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:3064,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:673,hsa:5604,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:23683,hsa:5908,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3661,hsa:4089,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6464,hsa:2885,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2668,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2912,hsa:2775,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:117145,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2890,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6885,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5600,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2065,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5290,hsa:486,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:53632,hsa:5105,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:7297,hsa:6773,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:3630,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9965,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:816,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1557,hsa:283748,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:1536,hsa:818,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:9965,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:330,hsa:842,PPrel,inhibition,path:hsa05145 Toxoplasmosis,1,0.8
hsa:51806,hsa:116444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8822,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:70,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:1459,hsa:26279,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,cpd:C05981,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2806,hsa:4282,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:1147,hsa:7043,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5568,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
cpd:C00575,hsa:5566,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:6794,hsa:57144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:776,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:4137,hsa:7846,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:53358,hsa:2549,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:11035,hsa:51085,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:51478,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:6464,hsa:6714,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
cpd:C00165,hsa:3551,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:3845,hsa:5296,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4261,hsa:3111,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:5566,hsa:1812,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9965,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00575,hsa:5566,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C05981,hsa:4706,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2773,hsa:5837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7533,hsa:3778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4720,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:9568,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4719,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3667,hsa:5295,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5594,hsa:4087,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:818,hsa:7137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:3845,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:1576,hsa:123745,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5595,hsa:4090,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:4915,hsa:7186,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27102,hsa:8517,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:80310,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3455,hsa:3717,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:10379,hsa:4938,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:5605,hsa:5595,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1906,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6198,hsa:6194,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5524,hsa:51085,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:2915,hsa:2904,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5564,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:7253,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:2782,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:57521,hsa:6199,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:163688,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:1386,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:3458,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1392,hsa:117,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5217,hsa:71,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
path:hsa00520,hsa:3099,maplink,compound,path:hsa00051 Fructose and mannose metabolism,2,0.5
hsa:5291,hsa:476,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:7423,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:2932,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:657,hsa:6416,no_relation,no_relation,no_relation,no_relation,0.0
hsa:185,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3953,hsa:5465,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:1956,hsa:399694,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:23236,cpd:C00165,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:4233,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4878,hsa:2906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2821,hsa:3098,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
cpd:C00076,hsa:810,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5336,cpd:C00165,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5970,hsa:3592,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:1943,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:816,hsa:90993,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:1460,hsa:3800,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:283106,hsa:3799,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3910,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2990,hsa:7365,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:7532,hsa:673,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:94235,hsa:7297,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:572,PPrel,inhibition,path:hsa05145 Toxoplasmosis,1,0.8
hsa:10645,hsa:51422,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:9455,hsa:9454,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,2,0.5
hsa:816,hsa:109,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:65018,hsa:4700,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5331,hsa:4791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5568,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:7360,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:84699,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2793,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00951,hsa:2099,PCrel,binding/association,path:hsa05224 Breast cancer,3,0.5
hsa:2252,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3985,hsa:1073,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6197,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1392,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:5970,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2791,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2264,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5600,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8817,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3845,hsa:6300,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2784,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2821,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:3091,GErel,expression,path:hsa04919 Thyroid hormone signaling pathway,1,0.5
hsa:163688,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5506,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5535,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8605,cpd:C00219,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:374,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:1080,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4706,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:54331,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:9451,hsa:8517,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:56034,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5021,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:284,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1559,hsa:283748,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5567,hsa:2902,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00334,hsa:2568,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:5291,hsa:207,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2915,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:818,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6777,hsa:894,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:94235,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:572,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:387,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:2903,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:486,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5333,hsa:140465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11337,hsa:2566,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:1942,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4638,hsa:10398,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2990,hsa:54575,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:2255,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1813,hsa:255189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3449,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:4780,hsa:10327,GErel,expression,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:4851,hsa:26508,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:4803,hsa:4938,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:5836,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:2771,hsa:3762,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4852,hsa:9568,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8822,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5500,hsa:5732,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5332,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:6196,hsa:79660,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:4137,hsa:81027,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5228,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:54776,hsa:140465,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5568,hsa:84876,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6750,hsa:3351,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5970,hsa:3439,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:2309,hsa:57818,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:2914,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:4790,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:283106,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:122809,hsa:134,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7189,hsa:5599,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:374,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:11035,hsa:197259,PPrel,phosphorylation,path:hsa04217 Necroptosis,1,0.8
hsa:284,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8517,hsa:4793,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5170,hsa:4170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:859,hsa:2534,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:25,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:91807,hsa:10398,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5581,hsa:5601,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:3133,hsa:567,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:10023,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00704,hsa:4790,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:146850,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C07593,hsa:4717,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:59345,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2214,hsa:2915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2261,hsa:5321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:468,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:1557,hsa:3115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:3107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2917,hsa:5580,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:115,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:2737,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2773,hsa:3765,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1234,hsa:57118,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7424,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2793,hsa:5142,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:5294,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:2550,hsa:2788,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:6772,hsa:3125,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:2911,hsa:5321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:10398,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:8822,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1558,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:4301,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:673,hsa:59345,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:775,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:8823,hsa:478,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5578,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5568,hsa:2891,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C11310,hsa:55967,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00076,hsa:5579,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:1374,hsa:2181,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:27006,hsa:314,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:4881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5900,hsa:5879,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:22943,hsa:80326,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5567,hsa:116444,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:6416,hsa:5601,PPrel,phosphorylation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:3064,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2308,hsa:39,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:5516,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5209,hsa:1544,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9103,hsa:5579,ECrel,compound,path:hsa05140 Leishmaniasis,1,0.5
hsa:1944,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1499,hsa:1452,PPrel,binding/association,path:hsa05224 Breast cancer,1,0.5
hsa:5599,hsa:8660,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:7423,hsa:10975,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:207,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:55102,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2890,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5500,hsa:90993,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5293,hsa:10000,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2250,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5970,hsa:25865,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:3284,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:4804,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7097,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5155,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2069,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5606,hsa:2565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5336,hsa:805,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C11310,hsa:4539,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4261,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:5618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4233,hsa:5293,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
path:hsa00051,hsa:3098,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,3,0.5
cpd:C00076,hsa:810,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C03758,hsa:3360,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5588,hsa:3551,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:4908,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00780,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:4886,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6195,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2913,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5209,hsa:5214,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2475,hsa:6199,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:109,cpd:C00575,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:801,hsa:816,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:10000,hsa:4792,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:51806,hsa:8536,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2771,hsa:5332,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2916,hsa:2771,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:94235,hsa:7187,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6720,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:246,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:2778,hsa:113,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:2771,hsa:108,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5604,hsa:5594,PPrel,activation,path:hsa05216 Thyroid cancer,2,0.8
hsa:285,hsa:2645,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:7249,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1946,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6655,hsa:4893,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
cpd:C00334,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:89953,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2252,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2261,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:8503,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:27006,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00584,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:468,hsa:330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:2920,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:1945,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:815,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8823,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4254,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5894,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,path:hsa00400,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4088,hsa:4729,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9370,hsa:5141,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C07593,hsa:2950,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5604,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3630,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5588,hsa:5602,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:2668,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C22381,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:2645,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5565,hsa:1558,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:122809,hsa:221357,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:208,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C13050,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5530,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2793,hsa:3458,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4695,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8074,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:111,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:51806,hsa:5532,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:85366,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:778,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:91860,hsa:5208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2550,hsa:627,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5228,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5607,hsa:5598,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5499,hsa:90993,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5594,hsa:6197,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1558,hsa:246,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:7422,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2695,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6196,hsa:4893,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2784,hsa:51806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:815,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8517,hsa:4794,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:2246,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9456,hsa:2911,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:7422,hsa:492,no_relation,no_relation,no_relation,no_relation,0.0
hsa:857,hsa:2534,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:27123,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7422,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5534,hsa:4776,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C11310,hsa:4707,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2247,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2782,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:25805,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23710,hsa:7042,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:816,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:808,hsa:5534,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5777,hsa:5595,PPrel,inhibition,path:hsa05140 Leishmaniasis,1,0.8
hsa:468,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:3973,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5170,hsa:5578,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8074,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C15231,hsa:1537,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5296,hsa:23439,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2309,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:369,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:5623,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3354,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1111,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:7253,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:2902,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2785,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C00212,hsa:3360,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05164 Influenza A,1,0.8
hsa:1950,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10000,hsa:2932,PPrel,phosphorylation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:7124,hsa:7132,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:7422,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:5141,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2770,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:2250,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C01312,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5894,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5335,hsa:5509,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:2947,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:4854,hsa:26508,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:7139,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:80326,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2778,hsa:108,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2770,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:26291,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:2559,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:51378,hsa:492,no_relation,no_relation,no_relation,no_relation,0.0
hsa:650,hsa:657,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,2,0.8
hsa:8737,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2673,hsa:3101,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:51806,hsa:112,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:818,hsa:5139,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00547,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:5580,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:815,hsa:9586,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:818,hsa:468,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
cpd:C00547,hsa:657,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:135,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1457,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7046,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2215,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:1388,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:3099,hsa:2673,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:27006,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:494551,hsa:983,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2918,hsa:255189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:10846,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5623,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:5291,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:815,hsa:134,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2209,hsa:1432,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:9451,hsa:1965,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:283106,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3576,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
cpd:C01996,hsa:4258,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3309,hsa:2081,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2561,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:2990,hsa:54576,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:8817,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2475,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3107,hsa:2354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5443,hsa:117,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:374,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55626,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2668,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:801,hsa:815,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3480,hsa:3667,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:4852,hsa:2550,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4790,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3451,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:5595,hsa:64764,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1950,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2773,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5602,hsa:64837,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1576,hsa:81579,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2277,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5781,hsa:5291,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:6654,hsa:3845,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:90673,hsa:5834,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:283106,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91807,hsa:5607,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:818,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:25780,hsa:5906,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:841,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1386,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:2770,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:26281,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00025,hsa:2902,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7849,hsa:6258,PPrel,binding/association,path:hsa05216 Thyroid cancer,1,0.5
hsa:10379,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5894,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:5154,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1644,hsa:5053,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
cpd:C00788,hsa:155,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:284,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:815,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8822,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:958,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:4158,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2069,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:5894,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C05981,hsa:10000,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:285,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3479,hsa:3480,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
cpd:C00165,hsa:5579,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3661,hsa:3451,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:5608,hsa:5603,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:54331,hsa:27330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2069,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2250,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:5564,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:3716,hsa:6772,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:54331,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:817,hsa:4137,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2720,hsa:4193,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8681,cpd:C00219,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3448,hsa:3455,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:4261,hsa:3117,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5533,hsa:5021,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:10603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:596,hsa:578,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:801,hsa:814,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3630,hsa:1958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2247,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2549,hsa:5293,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:4886,hsa:2889,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,cpd:C00575,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:1571,hsa:11145,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5604,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:3442,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:151056,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:3098,hsa:8789,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:808,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:5747,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:816,hsa:23683,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:1388,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
cpd:C00076,hsa:163688,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5566,hsa:84876,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4893,hsa:369,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:5970,hsa:3446,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:3480,hsa:3449,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:468,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
path:hsa00520,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:657,hsa:4093,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:7423,hsa:1394,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:5601,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:8660,hsa:5290,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5728,hsa:5143,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4615,hsa:2512,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5580,hsa:25865,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2253,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148022,hsa:1147,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:7422,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2566,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:2911,hsa:2902,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C00780,hsa:5338,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3643,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5608,hsa:1432,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:627,hsa:8864,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4090,hsa:4089,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:2324,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5213,hsa:3659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2913,hsa:54657,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5336,hsa:153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,hsa:2915,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4254,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4625,hsa:4634,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:3667,hsa:5291,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:4790,hsa:3448,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:2782,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:1573,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3447,hsa:4846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5321,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9655,hsa:6772,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5879,hsa:6263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:2512,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:5594,hsa:283748,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3442,hsa:3454,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:2778,hsa:115,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:7098,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:810,hsa:5534,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
cpd:C00780,hsa:3362,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7252,hsa:1816,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3082,hsa:6513,no_relation,no_relation,no_relation,no_relation,0.0
hsa:81858,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:5140,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1499,hsa:6934,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5594,hsa:2099,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:10000,hsa:4193,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2787,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:56034,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00584,hsa:3351,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5501,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:80201,hsa:55276,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
hsa:5290,cpd:C05981,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:3630,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8399,hsa:5836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:5562,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5579,hsa:283748,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3445,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
cpd:C00334,hsa:2555,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:1950,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2253,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00025,hsa:2903,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7849,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3452,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:54776,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00704,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4878,hsa:4158,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:810,hsa:817,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:1902,hsa:490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1020,hsa:4794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4792,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:65018,hsa:4697,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:22926,hsa:2906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:4193,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4793,hsa:4137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3105,hsa:567,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:55844,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5141,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2251,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3439,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7137,hsa:10846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1385,hsa:5972,GErel,expression,path:hsa04924 Renin secretion,1,0.5
hsa:9048,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4852,hsa:3352,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3454,hsa:3716,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:3717,hsa:5579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2912,hsa:2790,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:859,hsa:398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2912,hsa:2770,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:2535,hsa:1855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:6196,hsa:5501,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:356,hsa:355,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:285,cpd:C00031,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83447,hsa:54205,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5568,hsa:6262,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:64764,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:6652,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:4794,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:27102,hsa:8517,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2911,hsa:9455,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:5606,hsa:5600,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:8823,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:4217,hsa:5603,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5906,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5604,PPrel,phosphorylation,path:hsa05216 Thyroid cancer,3,0.8
hsa:91860,hsa:5534,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:801,hsa:109,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8503,hsa:477,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:51422,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:2953,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:345456,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4254,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2255,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7253,hsa:2778,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
cpd:C00076,hsa:810,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,2,0.8
hsa:808,hsa:5535,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2253,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2788,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5526,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:3716,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:65018,hsa:4706,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:815,hsa:5141,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2260,hsa:25865,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:128866,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:5290,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2277,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5595,hsa:10488,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2917,hsa:2770,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:9568,hsa:10681,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:2255,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51806,hsa:5532,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:3643,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:11337,hsa:2562,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:8817,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:207,hsa:2905,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:284,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9048,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54518,hsa:5837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:2740,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83700,hsa:6195,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6464,hsa:2885,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:374,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3661,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55276,hsa:3760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64764,hsa:596,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:3815,hsa:6464,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:2252,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:6300,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5566,hsa:4637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3091,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:7477,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:53632,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:3352,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:163688,hsa:814,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:219,path:hsa00640,maplink,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:5568,hsa:2902,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:1634,hsa:5500,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:5139,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:4696,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:107,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2778,hsa:196883,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:109,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6197,hsa:5500,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:1435,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1907,hsa:5021,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9454,hsa:9454,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,2,0.5
hsa:2776,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:27121,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:5599,PPrel,phosphorylation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
cpd:C00212,hsa:1813,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4893,hsa:3125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2912,hsa:94235,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2250,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00788,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3105,hsa:93432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2906,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:3845,cpd:C00044,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
hsa:3791,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:90673,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5519,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa05224 Breast cancer,3,0.8
hsa:163688,hsa:7417,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2323,hsa:5881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:3725,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5566,hsa:116444,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:1459,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3351,hsa:4791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:111,cpd:C00575,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5507,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23411,hsa:2309,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:2645,hsa:2720,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:2786,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:1234,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3831,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4915,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9103,hsa:5743,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:9456,hsa:9455,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,2,0.5
hsa:27429,hsa:332,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:4790,hsa:3351,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:25865,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2793,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1573,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5142,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27330,hsa:7168,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5623,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5601,hsa:8660,PPrel,inhibition,path:hsa04931 Insulin resistance,2,0.8
hsa:5970,hsa:3441,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:4804,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5880,hsa:5062,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:55626,hsa:441925,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5499,hsa:5610,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:2791,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1956,hsa:2885,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:1536,hsa:816,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:4780,hsa:3973,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,cpd:C05981,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:8822,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5908,hsa:5295,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8517,hsa:4793,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:3661,hsa:3973,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:673,PPrel,activation,path:hsa05216 Thyroid cancer,2,0.8
hsa:5155,hsa:4137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:117,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
hsa:1558,hsa:1573,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:10000,hsa:7043,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3552,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:84152,hsa:5499,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2982,cpd:C00942,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:26281,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5532,hsa:4775,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:818,hsa:111,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:10327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6195,hsa:5507,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:10379,hsa:4939,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:5604,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:4793,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5525,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:775,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:114,cpd:C00575,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:2913,hsa:2785,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:9568,hsa:5587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,path:map00960,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1855,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3798,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:3449,hsa:3455,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:284,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3630,hsa:3643,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2911,hsa:2903,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2787,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7422,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5608,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:2977,no_relation,no_relation,no_relation,no_relation,0.0
hsa:113,cpd:C00575,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:208,hsa:148327,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:572,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8503,hsa:23439,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
cpd:C00575,hsa:5566,PCrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:56034,hsa:5610,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:2099,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:208,hsa:1385,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2254,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:8681,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10379,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6774,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:8823,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5777,hsa:3716,PPrel,inhibition,path:hsa05140 Leishmaniasis,1,0.8
hsa:84699,hsa:596,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:2249,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2786,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5154,hsa:10243,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5228,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5320,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:4914,hsa:25759,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:815,hsa:1386,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2251,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4878,hsa:135,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5595,hsa:27330,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5571,hsa:32,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:4803,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:572,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:6300,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:3101,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,cpd:C00044,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2903,hsa:1742,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:2252,hsa:4660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54518,hsa:7408,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3718,hsa:6776,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:4852,hsa:5021,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:6548,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4803,hsa:4914,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2783,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:7134,hsa:7137,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:2254,hsa:59345,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:4709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:1432,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:810,hsa:3119,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:3630,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:2771,hsa:3592,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5894,hsa:5295,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5335,hsa:163688,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:109,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,hsa:2746,PPrel,phosphorylation,path:hsa04217 Necroptosis,1,0.8
hsa:5501,hsa:3630,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:64764,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5228,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6776,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:6352,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:817,hsa:5143,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3448,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2248,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2668,hsa:2906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1460,hsa:3831,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:5526,hsa:51094,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5140,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7318,hsa:7316,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:6416,hsa:5601,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:51764,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:54331,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:3630,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4878,hsa:4882,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:54331,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1945,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5228,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3661,hsa:25939,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:815,hsa:107,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00334,hsa:116443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:8605,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5606,hsa:6300,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:25865,hsa:8517,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2252,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5567,hsa:2890,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8600,hsa:8792,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:4804,hsa:387,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6885,cpd:C00219,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5335,cpd:C01245,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3098,path:hsa00010,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:9965,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5602,hsa:8660,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:8717,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5970,hsa:3444,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:1432,hsa:2353,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:810,hsa:5532,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5567,hsa:491,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27006,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4804,hsa:5290,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5594,hsa:255189,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:27165,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7855,hsa:1855,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2916,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:116443,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:4916,hsa:6464,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:197259,hsa:8536,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5894,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2788,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:54979,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:7039,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7094,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:10243,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:8605,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:805,hsa:814,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:26291,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3101,hsa:8789,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:26291,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2246,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:207,hsa:2932,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:5154,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2782,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3911,hsa:3655,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:808,hsa:107,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:816,hsa:114,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3312,hsa:7097,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:64764,hsa:627,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:3911,hsa:3688,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5925,hsa:230,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:572,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2550,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:2248,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5520,hsa:6772,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:6654,hsa:3845,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:7252,hsa:4158,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4233,hsa:5295,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:55970,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:163688,hsa:5532,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4793,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10683,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9568,hsa:3716,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1576,hsa:5506,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2309,hsa:5934,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:369,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:5337,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5970,hsa:3569,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:3551,hsa:8660,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:5908,hsa:100506742,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1392,hsa:139760,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5970,hsa:3445,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:65018,hsa:4711,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:117145,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6237,hsa:5894,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:26291,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1950,hsa:3973,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25865,hsa:3684,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1147,hsa:4792,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:1950,hsa:2354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:5319,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2249,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5595,hsa:100137049,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5568,hsa:490,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00334,hsa:54979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3718,hsa:2903,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:8517,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5894,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9306,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7976,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3918,hsa:3688,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5568,hsa:116444,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2247,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00334,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:998,hsa:2783,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5228,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:126129,hsa:23305,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:2914,hsa:2782,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1544,hsa:3760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8200,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:5587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4915,hsa:25759,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:9475,hsa:4659,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3242,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:1394,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:29904,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C03758,hsa:1394,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:284,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4776,hsa:1827,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:673,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2566,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9655,hsa:9945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:1386,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
cpd:C00076,hsa:805,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
hsa:2475,hsa:6199,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:5154,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5595,hsa:100137049,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5500,hsa:10398,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2248,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:815,hsa:114,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3460,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3626,hsa:92,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:91860,hsa:1813,no_relation,no_relation,no_relation,no_relation,0.0
hsa:581,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:375189,hsa:3800,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3280,hsa:4609,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:1906,hsa:3354,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3170,hsa:6648,GErel,expression,path:hsa04213 Longevity regulating pathway - multiple species,1,0.5
hsa:5532,hsa:572,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:2246,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:1026,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:5530,hsa:4775,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5296,hsa:5747,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C00547,hsa:117,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:54567,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6311,hsa:3708,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:834,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:6548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3065,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3099,hsa:4539,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2550,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1386,hsa:6257,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3452,path:hsa00051,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:4637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:11069,hsa:4615,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1460,hsa:64837,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:5579,hsa:90993,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5295,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00051,hsa:3101,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,3,0.5
hsa:5568,hsa:330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:114,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5603,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:1081,hsa:3973,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:27006,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:27006,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:2904,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23462,hsa:1026,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:3449,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2357,hsa:2776,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2277,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2668,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2792,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C00165,hsa:5582,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:10000,hsa:3551,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5578,hsa:8605,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3082,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:27123,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:7167,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:3800,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4233,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7423,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5296,hsa:10000,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6776,hsa:894,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:1946,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:91860,hsa:5532,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:998,hsa:4087,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:51384,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6652,hsa:163688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:2997,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:1576,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5443,hsa:4535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8536,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:5618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2668,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:10000,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:1147,hsa:4792,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:6776,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:107,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:208,hsa:572,PPrel,phosphorylation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:6772,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:5837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:2737,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00076,hsa:8681,PCrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5609,hsa:5599,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:3624,hsa:7040,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:2775,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:2253,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3098,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5770,hsa:4233,PPrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:9261,hsa:468,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:80201,hsa:2673,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:5970,hsa:490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5906,hsa:5608,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:801,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:255189,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:8322,hsa:2903,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2309,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:5335,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:3099,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1459,hsa:3798,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:3064,hsa:5601,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:4804,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:5143,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8074,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1558,hsa:1544,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:2534,hsa:5290,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:1813,hsa:2775,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5602,hsa:5565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,cpd:C00165,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5293,hsa:208,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
cpd:C01245,hsa:3708,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3480,hsa:25759,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:5501,hsa:64764,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:246,hsa:4705,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:116,hsa:5837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:107,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:56034,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5499,hsa:1386,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:116444,hsa:1742,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:2915,hsa:7220,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1435,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3630,hsa:5140,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:84335,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5906,hsa:5587,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2911,hsa:7220,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2641,hsa:2720,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:673,hsa:5605,PPrel,phosphorylation,path:hsa05224 Breast cancer,3,0.8
hsa:3265,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:6688,hsa:3684,GErel,expression,path:hsa05202 Transcriptional misregulation in cancer,1,0.5
hsa:329,hsa:842,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:5566,hsa:5143,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:2902,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00575,hsa:8605,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:27006,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2770,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11273,hsa:3708,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5623,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:657,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6195,hsa:1435,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10488,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2717,hsa:2595,ECrel,compound,path:hsa00052 Galactose metabolism,3,0.5
cpd:C07593,hsa:4700,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3099,cpd:C00031,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5535,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5601,hsa:5562,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:387,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10000,hsa:2475,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:27121,hsa:7476,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5524,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2913,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2260,hsa:5290,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:208,hsa:3351,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5366,hsa:598,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:2771,hsa:5291,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8717,hsa:8772,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:1756,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5970,hsa:5743,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:10645,hsa:53632,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5566,hsa:3098,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:5732,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:91860,hsa:5533,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5602,hsa:4842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:1385,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1944,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5594,hsa:4853,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:3354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:207,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1435,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5609,hsa:5601,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:7423,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51378,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:163688,hsa:1395,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:25865,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2785,hsa:3689,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1544,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,path:hsa00051,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:114,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:10681,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5533,hsa:4775,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00195,hsa:7099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4792,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2775,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:135,hsa:2776,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:25759,hsa:2885,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:7161,hsa:7157,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:51422,hsa:84335,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:94235,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10379,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2793,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:23236,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4916,hsa:3667,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3551,hsa:230,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4914,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2914,hsa:10681,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:292,hsa:54205,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:817,hsa:2784,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:80201,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27330,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:1544,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:2550,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1460,hsa:3831,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7046,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1234,hsa:2775,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2247,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:1958,GErel,expression,path:hsa05020 Prion disease,1,0.5
hsa:3101,hsa:5209,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:8772,hsa:841,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2550,hsa:2787,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:1559,hsa:11145,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
cpd:C00575,hsa:90673,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:117,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2785,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8822,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10379,hsa:6775,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:5908,hsa:2747,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:3763,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1459,hsa:3799,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:5170,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:658,hsa:4090,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,3,0.8
cpd:C00788,hsa:5732,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5567,hsa:6262,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10000,hsa:572,PPrel,inhibition,path:hsa05145 Toxoplasmosis,1,0.8
hsa:2695,hsa:153,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51764,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5566,hsa:468,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:8517,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:340156,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2249,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8325,hsa:153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5623,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26281,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5533,hsa:4772,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:148022,hsa:3551,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5606,hsa:1432,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7531,hsa:369,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:332,hsa:840,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:7855,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374,hsa:1536,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2263,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9771,hsa:5908,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C07593,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6773,hsa:10379,PPrel,binding/association,path:hsa05160 Hepatitis C,1,0.5
hsa:2064,hsa:399694,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:208,hsa:90993,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3440,hsa:3455,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:6195,hsa:90673,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:332,hsa:836,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:2264,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2918,hsa:2784,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:54205,hsa:842,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:2069,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:80310,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4254,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:64837,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:1544,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:91860,hsa:817,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2914,hsa:54331,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2250,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:116,hsa:1812,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2535,hsa:1856,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3479,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5295,hsa:477,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:6777,hsa:5509,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2893,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:2906,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6494,hsa:5908,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5894,hsa:1812,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7189,hsa:5602,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5154,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7099,hsa:4615,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:816,hsa:5144,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3064,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1111,hsa:5371,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4878,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3694,hsa:60,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:5565,hsa:84335,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5595,hsa:2512,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:5579,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5605,hsa:5594,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2215,hsa:6300,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:5170,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8737,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:3763,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2783,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5609,hsa:5599,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5332,hsa:1956,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5594,hsa:6772,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:26291,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:3689,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1385,hsa:5320,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2891,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10645,hsa:51422,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5293,hsa:5747,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1950,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9103,hsa:3765,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:9261,cpd:C00704,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:208,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:5293,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4893,hsa:6300,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1374,hsa:23205,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:51735,hsa:5908,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5599,hsa:147700,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5578,hsa:5894,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:51378,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:108,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5595,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4893,hsa:673,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:1026,hsa:1019,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:2567,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:8324,hsa:1856,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00334,hsa:134,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:11035,hsa:817,PPrel,phosphorylation,path:hsa04217 Necroptosis,1,0.8
hsa:5605,hsa:4215,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:126328,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3265,hsa:5603,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:54331,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:57506,hsa:8517,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:5623,hsa:324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5582,hsa:468,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:6197,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1909,hsa:2776,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:1956,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2771,hsa:140465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:2495,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5518,hsa:6198,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:818,hsa:10488,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1969,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3845,hsa:1432,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5568,hsa:493,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:116444,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:91860,hsa:1129,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5604,PPrel,activation,path:hsa05216 Thyroid cancer,3,0.8
hsa:5568,hsa:84699,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5567,hsa:2890,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:25759,hsa:2885,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:4804,hsa:3656,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5213,hsa:5058,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:154,PCrel,activation,path:hsa04024 cAMP signaling pathway,2,0.8
hsa:5566,hsa:2893,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5601,hsa:3725,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1956,hsa:5290,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5295,hsa:3091,GErel,expression,path:hsa04919 Thyroid hormone signaling pathway,1,0.5
hsa:2248,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3760,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:387,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5295,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2773,hsa:6714,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5296,cpd:C05981,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:3360,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9306,hsa:6772,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:3082,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00165,hsa:5582,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:8823,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:7249,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:10000,hsa:107,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2557,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90,hsa:4087,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:1962,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:5578,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4254,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51806,hsa:91807,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:9021,hsa:6772,PPrel,inhibition,path:hsa05164 Influenza A,1,0.8
hsa:7423,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8321,hsa:1856,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:1392,hsa:4158,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5582,hsa:5338,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:9568,hsa:54331,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:801,hsa:196883,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9568,hsa:2793,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:6772,hsa:3108,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:5211,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5481,hsa:293,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C03758,hsa:4717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:2786,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11337,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6750,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5582,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:657,hsa:659,PPrel,binding/association,path:hsa04350 TGF-beta signaling pathway,2,0.5
hsa:1907,hsa:9568,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00076,hsa:163688,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:116,hsa:4158,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2770,hsa:3592,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
cpd:C00788,hsa:4158,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:657,hsa:92,PPrel,binding/association,path:hsa04350 TGF-beta signaling pathway,2,0.5
hsa:27006,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5566,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5970,hsa:3448,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
cpd:C00212,hsa:3350,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5906,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:114,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2773,hsa:23533,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5155,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7424,hsa:84335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:126129,hsa:2182,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:8823,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:810,hsa:817,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4855,hsa:23493,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:3717,hsa:6772,PPrel,phosphorylation,path:hsa05140 Leishmaniasis,1,0.8
hsa:5601,hsa:317,PPrel,activation,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:3082,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:84699,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:6197,hsa:5506,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:3481,hsa:3684,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5021,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:130589,hsa:231,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:808,hsa:108,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5499,hsa:4637,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2791,hsa:2538,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5523,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5296,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5021,hsa:2775,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
path:hsa00010,hsa:4713,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2066,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6196,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:572,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5578,hsa:774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:810,hsa:816,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4909,hsa:4804,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3099,hsa:55276,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2785,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:246,hsa:6775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2911,hsa:2778,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2249,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5443,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9568,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:7476,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3716,hsa:5608,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5296,PPrel,activation,path:hsa04931 Insulin resistance,3,0.8
hsa:27429,hsa:330,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:5602,hsa:3725,PPrel,activation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:2778,hsa:109,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:9965,hsa:27089,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3439,hsa:3454,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:3716,hsa:6776,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5608,hsa:5600,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5021,hsa:93589,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:113,hsa:7054,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4792,PPrel,phosphorylation,path:hsa04931 Insulin resistance,2,0.8
hsa:51764,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:805,hsa:815,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8310,hsa:30,ECrel,compound,path:hsa00592 alpha-Linolenic acid metabolism,2,0.5
hsa:2770,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2773,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:8792,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6197,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01996,hsa:3355,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:22943,hsa:7484,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2247,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:814,hsa:107,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5732,hsa:3776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:1559,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:818,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2052,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1573,hsa:255189,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:207,hsa:106821730,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:801,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5021,hsa:9254,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00334,hsa:1909,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3913,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2308,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
cpd:C07593,hsa:4541,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2932,hsa:1499,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:4878,hsa:1816,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7042,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9223,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3458,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:816,hsa:5879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:6548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8851,hsa:4137,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7423,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2308,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:1559,hsa:54979,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
cpd:C11310,hsa:4537,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3576,hsa:3577,PPrel,activation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:4846,cpd:C00533,PCrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:2786,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C15231,hsa:7384,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5604,hsa:5320,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2558,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2932,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5481,hsa:7417,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00788,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,path:hsa00020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:107,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:200186,hsa:207,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:84152,hsa:5500,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C03758,hsa:3973,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:11337,hsa:2561,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:6777,hsa:1154,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:91860,hsa:5533,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:155,hsa:2778,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:1906,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4902,hsa:4886,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:5322,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:3643,hsa:3667,PPrel,phosphorylation,path:hsa04931 Insulin resistance,3,0.8
hsa:2773,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10616,hsa:329,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:4086,hsa:1398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3320,hsa:197259,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5295,hsa:4701,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:10000,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:11337,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5521,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6712,hsa:2911,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:27121,hsa:89780,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1147,hsa:5970,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3265,hsa:673,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:5579,hsa:5894,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:27123,hsa:7483,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:208,hsa:2932,PPrel,phosphorylation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:8325,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1027,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1944,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3265,hsa:52,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:3759,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:80310,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1944,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2247,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3661,hsa:3443,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:4254,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4915,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1944,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:22800,hsa:11145,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,cpd:C05981,PCrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:26281,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2914,hsa:2783,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4893,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1392,hsa:2182,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51422,hsa:32,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:207,hsa:5970,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5598,hsa:6196,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1081,hsa:139760,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
cpd:C00076,hsa:810,PCrel,binding/association,path:hsa05031 Amphetamine addiction,2,0.5
hsa:2641,hsa:3973,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1945,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:26281,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26291,hsa:10975,no_relation,no_relation,no_relation,no_relation,0.0
hsa:111,cpd:C00575,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2932,hsa:64837,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3551,hsa:4793,PPrel,phosphorylation,path:hsa05164 Influenza A,2,0.8
hsa:54331,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3099,hsa:9945,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:5516,hsa:3133,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:2556,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:5236,hsa:4729,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:1544,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:2787,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:26291,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5606,hsa:259307,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2917,hsa:2788,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C00410,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7039,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:374,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5605,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:9586,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5534,hsa:4775,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5500,hsa:2998,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:4915,hsa:25,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:80310,hsa:4659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1385,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:4792,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5894,hsa:8503,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:814,hsa:115,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2668,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:91860,hsa:108,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:28227,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2904,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5567,hsa:5605,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1576,hsa:8398,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:1944,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00165,hsa:5582,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2787,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:10000,hsa:51422,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
cpd:C01996,hsa:3352,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5208,hsa:23683,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:7097,hsa:4615,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:7039,hsa:8600,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C15231,hsa:7385,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3449,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
cpd:C01245,hsa:3708,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5568,hsa:4854,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1460,hsa:64837,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:91860,hsa:5530,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6772,hsa:2100,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:10000,hsa:9882,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1856,hsa:10023,PPrel,binding/association,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:208,hsa:5894,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2549,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:91860,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:4881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2323,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5414,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3458,hsa:340156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3625,hsa:4087,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2321,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5295,hsa:207,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5579,hsa:5594,PPrel,phosphorylation,path:hsa05140 Leishmaniasis,1,0.8
hsa:2277,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2535,hsa:1856,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5523,hsa:92579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7124,hsa:7133,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:10379,hsa:6776,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
cpd:C00025,hsa:3460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22926,hsa:3309,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:65018,hsa:374291,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4893,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5594,hsa:255189,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00025,hsa:2918,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:808,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8323,hsa:1855,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5330,hsa:5465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,cpd:C05981,PCrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:3458,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:26279,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1543,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:5881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3630,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3815,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:208,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4780,hsa:1646,GErel,expression,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:2538,path:hsa00051,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:7099,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:5594,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1943,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5605,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3443,hsa:5213,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5578,hsa:2002,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5777,hsa:3717,PPrel,inhibition,path:hsa05140 Leishmaniasis,1,0.8
hsa:2308,hsa:57818,GErel,expression,path:hsa04931 Insulin resistance,1,0.5
hsa:5207,hsa:1129,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:5170,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:332,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90,hsa:4093,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:2550,hsa:51764,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:387,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10379,hsa:4940,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
cpd:C01245,hsa:3708,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:7852,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3553,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
path:hsa00520,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:30814,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:10000,hsa:2309,PPrel,phosphorylation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:7039,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:293,hsa:54205,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00780,hsa:2550,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:387,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1807,hsa:1806,ECrel,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:5293,cpd:C05981,PCrel,activation,path:hsa05164 Influenza A,1,0.8
cpd:C00334,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:2550,PCrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:5594,hsa:483,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5579,hsa:5595,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1576,hsa:3162,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:284,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5021,hsa:2770,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:7424,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:3592,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:4854,hsa:23462,GErel,expression,path:hsa05224 Breast cancer,1,0.5
cpd:C00076,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4701,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5608,hsa:1432,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2255,hsa:2785,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:64764,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:1906,hsa:1909,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8823,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4893,hsa:5894,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00547,hsa:3355,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:207,hsa:1386,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5581,hsa:5602,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:1908,hsa:2550,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5173,hsa:2905,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:163688,hsa:5564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:1956,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:9525,hsa:197259,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:1956,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2549,hsa:5293,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2260,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5563,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:3725,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
cpd:C00334,hsa:154,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:808,hsa:1374,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3440,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:9945,hsa:3101,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:11035,hsa:1536,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:10000,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:8605,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:284,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:54331,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C22381,hsa:3091,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5565,hsa:5106,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:4803,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:91807,hsa:140465,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:56034,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:29904,hsa:1573,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:182,hsa:3459,no_relation,no_relation,no_relation,no_relation,0.0
hsa:200186,hsa:3760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:10411,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8323,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1459,hsa:147700,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5568,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23533,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3791,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:817,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:23533,cpd:C05981,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26291,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2214,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:477,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:8325,hsa:1855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:57506,hsa:3551,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:6772,hsa:3592,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:1950,hsa:54579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,cpd:C05981,PCrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
cpd:C00076,hsa:5587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:115004,cpd:C20640,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:9586,hsa:2353,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:5154,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:3098,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:4090,no_relation,no_relation,no_relation,no_relation,0.0
hsa:113,cpd:C00575,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1234,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:51384,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:5143,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9945,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:91860,hsa:113,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1946,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:815,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5062,hsa:3985,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:208,hsa:3444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5294,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:7419,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6804,hsa:776,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2248,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:192111,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8651,hsa:3716,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:3064,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8823,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C01996,hsa:3351,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3082,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4915,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5906,hsa:5139,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:108,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4790,hsa:3443,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:208,hsa:5894,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3099,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8651,hsa:3717,PPrel,inhibition,path:hsa05145 Toxoplasmosis,1,0.8
hsa:207,hsa:2549,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:5568,hsa:163688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4916,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:842,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5598,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5894,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5604,hsa:26279,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4731,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5518,hsa:6773,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:5781,hsa:84647,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:10488,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:9965,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:4843,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:5564,hsa:32,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:3717,hsa:6772,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:2787,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C05981,hsa:208,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5532,hsa:572,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2263,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:208,hsa:1026,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2770,hsa:5618,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:3448,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5321,cpd:C00219,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5527,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5600,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00575,hsa:5566,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
cpd:C11310,hsa:4696,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3098,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:3265,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:1902,hsa:5590,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7074,hsa:339896,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2904,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1559,hsa:81579,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:801,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:55970,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5582,hsa:6531,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:3665,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5601,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C00025,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:5501,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:7852,hsa:94235,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3064,hsa:4519,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:23462,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2309,hsa:847,GErel,expression,path:hsa04213 Longevity regulating pathway - multiple species,2,0.5
hsa:5567,hsa:776,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:9021,hsa:6773,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:2252,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:208,hsa:4794,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:10681,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5566,hsa:5139,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2251,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2252,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6750,hsa:9568,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00584,hsa:4881,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3135,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3593,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:11069,hsa:1649,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8323,hsa:1856,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:2253,hsa:4697,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:64600,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:3033,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:317,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:3091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2209,hsa:5565,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01312,hsa:6548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91,hsa:4088,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,2,0.8
hsa:5605,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3643,hsa:8660,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:4660,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2321,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55811,cpd:C00575,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5534,hsa:4772,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6654,hsa:51384,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2064,hsa:2740,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2905,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5154,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3911,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4893,hsa:5603,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2787,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:285,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3630,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2914,hsa:59345,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4233,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:330,hsa:4698,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2905,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:23683,hsa:2889,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:64837,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6622,hsa:4704,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2550,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3576,hsa:3579,PPrel,activation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:4804,hsa:5293,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5228,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,hsa:816,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2913,hsa:2775,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:6622,hsa:4722,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2790,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2251,hsa:6714,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:65018,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3101,hsa:55276,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:8503,hsa:10000,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6772,hsa:3111,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:7531,hsa:5894,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:2695,hsa:1812,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:805,hsa:5532,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:6093,hsa:54776,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2253,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:27330,hsa:5507,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:1965,hsa:468,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
cpd:C04549,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6311,hsa:3710,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2778,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8322,hsa:1856,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:3481,hsa:3354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:196883,cpd:C00575,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:6714,hsa:5296,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:3665,hsa:7124,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:5595,hsa:3725,PPrel,phosphorylation,path:hsa05140 Leishmaniasis,1,0.8
hsa:6772,hsa:3112,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:3665,hsa:3456,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:3725,hsa:2921,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:2912,hsa:2788,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C00584,hsa:5732,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51196,cpd:C00165,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2475,hsa:8471,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:7252,hsa:3360,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4909,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:91860,hsa:5530,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:7423,hsa:55967,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6199,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9021,hsa:3717,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5566,hsa:775,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:91860,hsa:5534,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5527,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5443,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3665,hsa:3451,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:815,hsa:153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1459,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1813,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5291,hsa:5563,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9568,hsa:1816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3355,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10000,hsa:3551,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2918,hsa:2787,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:284,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:816,hsa:108,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8817,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2252,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7422,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2932,hsa:2998,PPrel,inhibition,path:hsa04931 Insulin resistance,3,0.8
hsa:116,hsa:135,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C03758,hsa:1395,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5564,hsa:6517,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:8717,hsa:7186,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:4915,hsa:53358,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4909,hsa:5506,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2246,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1978,hsa:9470,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1457,hsa:4193,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,cpd:C05981,PCrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:2251,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3845,hsa:5747,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:8605,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:83593,hsa:4708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4772,hsa:2149,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:3099,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7534,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4916,hsa:10603,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6885,hsa:5728,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2932,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:32,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5894,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:5155,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5296,cpd:C05981,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3444,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1956,hsa:5295,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:8660,hsa:5295,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:808,hsa:4638,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2673,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:30814,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:4233,hsa:2549,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
cpd:C00212,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5210,hsa:9882,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2990,hsa:54577,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:8822,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00035,hsa:5906,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
hsa:5906,hsa:5296,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10379,hsa:6778,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:8822,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:113,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5599,hsa:3667,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:94235,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:9252,hsa:468,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00584,hsa:134,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1392,hsa:1395,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2252,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:284,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00095,hsa:51085,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:65018,cpd:C00044,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:196883,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5605,hsa:4794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5159,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5501,hsa:5837,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:814,hsa:1386,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2791,hsa:477,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:5291,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2786,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7423,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5521,hsa:6772,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:2668,hsa:5881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2645,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80201,hsa:5236,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
hsa:5580,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:2353,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1944,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1956,hsa:5291,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:9817,hsa:4780,PPrel,inhibition,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:163688,hsa:816,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2778,hsa:1813,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:54776,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2249,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:3445,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1969,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5594,hsa:486,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5582,hsa:5594,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:208,hsa:2309,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:627,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2773,hsa:3760,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:91860,hsa:818,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5524,hsa:331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2069,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1908,hsa:9568,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5925,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3439,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:5566,hsa:2890,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:1644,path:map00960,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:8074,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C11310,hsa:4536,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:1435,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:1558,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:6237,hsa:51196,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2324,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:814,hsa:5143,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:54518,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4914,hsa:10603,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5335,hsa:810,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5623,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:5319,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:1459,hsa:89953,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:56616,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3918,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3696,hsa:71,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:151449,hsa:659,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5500,hsa:5836,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:2247,hsa:4137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8737,hsa:292,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:6622,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:147700,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5155,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:116443,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1943,hsa:94235,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:2793,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:4775,hsa:30814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:823,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:7124,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:2776,hsa:5331,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5894,hsa:5605,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:22926,hsa:5585,no_relation,no_relation,no_relation,no_relation,0.0
hsa:226,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:4893,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2250,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C01312,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:109,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:2903,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01471,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:917,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:4090,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:5970,hsa:3553,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:4804,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3479,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2775,hsa:3762,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3630,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1644,hsa:54361,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8323,hsa:1857,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2786,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:285,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5228,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2786,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3481,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5606,hsa:1432,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C15231,hsa:27089,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1907,hsa:3355,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5154,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00212,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3625,hsa:658,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:56034,hsa:823,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9451,hsa:1147,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2264,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5522,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2066,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:2932,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4137,hsa:113457,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2263,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:808,hsa:196883,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9586,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5532,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:26291,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C07593,hsa:4711,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1950,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:23683,hsa:3688,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3716,hsa:2890,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2253,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3716,hsa:491,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3101,hsa:5590,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:6300,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:26291,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5443,hsa:1812,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2250,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5601,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1559,hsa:8398,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:90,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:486,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:6195,hsa:79660,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
cpd:C00584,hsa:154,PCrel,activation,path:hsa04024 cAMP signaling pathway,2,0.8
hsa:3265,hsa:5603,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1943,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80201,hsa:5207,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2246,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27,hsa:25865,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:9048,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:805,hsa:115,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4914,hsa:51764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5335,hsa:808,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2771,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:1742,hsa:2906,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:673,hsa:1378,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5524,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2323,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3265,hsa:5509,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3458,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:6416,hsa:5602,PPrel,activation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:2254,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9978,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:6199,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:163688,hsa:5532,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:7186,hsa:3689,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3449,hsa:3454,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:208,hsa:2308,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:1436,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:55970,hsa:4853,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:5595,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5566,hsa:3991,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1388,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:841,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:9252,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6197,hsa:5499,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:5021,hsa:10891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4878,hsa:139760,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4301,hsa:1500,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:57118,hsa:9817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:224,hsa:51380,ECrel,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:6195,hsa:3845,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:91860,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2891,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5567,hsa:2905,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:1435,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00575,hsa:5568,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10000,hsa:84699,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8517,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:130589,path:hsa00520,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:177,hsa:27035,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:441282,hsa:6652,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2773,hsa:23533,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:26281,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:134,hsa:2771,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5609,hsa:5599,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3630,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3667,hsa:8503,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2770,hsa:23533,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:207,hsa:1385,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:5208,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5582,hsa:3360,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:7472,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5601,hsa:3798,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:283106,hsa:3800,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:30837,hsa:6777,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5970,hsa:3553,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:6655,hsa:4893,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1558,hsa:8398,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:1435,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6655,hsa:3265,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:396,hsa:387,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6772,hsa:7054,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5571,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5290,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5525,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3449,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:2773,hsa:146850,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:4878,hsa:4881,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:2906,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2915,hsa:9456,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:5579,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:5781,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9048,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:70,hsa:4624,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:7465,hsa:983,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5567,hsa:116443,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:2308,hsa:1645,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:2775,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5567,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3630,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1147,hsa:4792,PPrel,activation,path:hsa05160 Hepatitis C,2,0.8
hsa:5568,hsa:2904,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:3479,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:805,hsa:815,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2252,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5335,hsa:5834,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2911,hsa:2776,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:57016,hsa:6652,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:80310,hsa:3576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10411,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6898,path:hsa00400,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:5595,hsa:51703,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:8503,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5567,hsa:5500,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4726,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:331,hsa:6898,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6772,hsa:2920,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,hsa:5834,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:4908,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1234,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2891,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
cpd:C22381,hsa:5781,PCrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C00212,hsa:4193,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,hsa:6752,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5604,hsa:4089,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:4712,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25805,hsa:91,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
path:hsa00640,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5604,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,2,0.8
hsa:1945,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2321,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5595,hsa:148327,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:25865,hsa:3688,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8074,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:51806,hsa:801,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:207,hsa:2932,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3551,hsa:4792,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:27330,hsa:3845,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:80201,hsa:490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:115,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3718,hsa:5290,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6196,hsa:3265,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4775,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:54331,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2645,hsa:55276,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:2251,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:23130,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5603,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1950,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5366,hsa:596,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:3082,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2215,hsa:5579,ECrel,compound,path:hsa05140 Leishmaniasis,1,0.5
hsa:5601,hsa:3800,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3082,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5443,hsa:4881,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3459,hsa:3716,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:815,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01996,hsa:134,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2081,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1942,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2248,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5335,cpd:C01245,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4780,hsa:1728,GErel,expression,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:65018,hsa:4540,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2773,hsa:112,PPrel,inhibition,path:hsa04924 Renin secretion,1,0.8
hsa:7424,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:163688,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
hsa:23236,cpd:C01245,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6197,hsa:3845,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1944,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5335,hsa:91860,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:11337,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:32,hsa:1375,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:8503,hsa:5879,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2249,hsa:7481,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:114,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:805,hsa:112,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51806,hsa:814,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5564,hsa:6513,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:4804,hsa:8772,PPrel,activation,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:3099,hsa:5209,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:3667,hsa:5290,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:7252,hsa:7253,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5532,hsa:2915,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:9306,hsa:4137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5228,hsa:51735,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7424,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2251,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7532,hsa:5894,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:90993,hsa:2353,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:7074,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:89953,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5535,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2550,hsa:2773,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:23236,hsa:5144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1017,hsa:5925,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:11337,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5520,hsa:478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:89953,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1907,hsa:1128,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:208,hsa:1026,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:5609,hsa:5599,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3693,hsa:71,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:208,hsa:10488,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2550,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:8605,PCrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:801,hsa:114,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2785,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:10000,hsa:148327,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5021,hsa:55799,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3630,hsa:6196,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:1956,hsa:25759,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:596,hsa:581,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:6622,hsa:4709,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:330,hsa:1812,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,cpd:C05981,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:5170,hsa:207,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:5155,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:4790,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:27123,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5534,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2645,path:hsa00051,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:4790,hsa:7124,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:10000,hsa:7316,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:8660,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:54331,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2309,hsa:3304,GErel,expression,path:hsa04213 Longevity regulating pathway - multiple species,1,0.5
hsa:208,hsa:2309,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:810,hsa:5533,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:7186,hsa:100506742,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5595,hsa:255189,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5568,hsa:490,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C05981,hsa:208,PCrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:85366,hsa:4637,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3242,hsa:4282,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:2916,hsa:2773,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:627,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5600,hsa:2353,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2249,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25865,hsa:5906,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:60,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112,cpd:C00575,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5296,cpd:C05981,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:10298,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6237,hsa:7249,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3643,hsa:5291,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2251,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2260,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8743,hsa:8797,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:817,hsa:23205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:91860,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:2695,hsa:3360,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2918,hsa:8789,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:468,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:23710,hsa:4537,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3625,hsa:657,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:4790,hsa:3553,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:1945,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5294,hsa:5170,PPrel,compound,path:hsa05145 Toxoplasmosis,1,0.5
hsa:207,hsa:196883,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:1558,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:2778,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5595,hsa:23401,no_relation,no_relation,no_relation,no_relation,0.0
hsa:637,hsa:598,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:4893,hsa:673,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4803,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4254,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3845,hsa:1649,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:5337,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:23462,hsa:595,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:1111,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5518,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:842,hsa:836,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5605,hsa:5594,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C00025,hsa:2892,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:2776,hsa:814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:2353,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:5296,cpd:C05981,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2918,hsa:2782,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:84812,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4773,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5533,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:51422,hsa:92579,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:673,hsa:5604,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00584,hsa:53632,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:2792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5566,hsa:4772,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3845,hsa:51196,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3064,hsa:481,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5534,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3480,hsa:6464,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:1571,hsa:81579,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5332,cpd:C01245,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2792,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5515,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:5608,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:3354,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10971,hsa:572,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2249,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3265,hsa:8503,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:54331,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2770,hsa:115,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:59345,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:6794,hsa:1027,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:208,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3441,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:8823,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5216,hsa:60,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2253,hsa:1909,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27429,hsa:54205,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3451,hsa:3454,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5781,hsa:8503,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:23401,hsa:3362,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5338,hsa:23683,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:4852,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:808,hsa:114,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9002,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4909,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:805,hsa:816,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:808,hsa:5532,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:9454,hsa:9455,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,2,0.5
hsa:6772,hsa:8600,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:3280,hsa:2064,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:90,hsa:3354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2892,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3815,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5568,hsa:5604,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:10616,hsa:330,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:2324,hsa:1374,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:3362,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23683,hsa:3684,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:80310,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1573,hsa:5970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2538,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4793,hsa:1073,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2215,hsa:5600,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:5213,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:6262,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3082,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:22943,hsa:81029,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C01312,hsa:2538,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3447,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5600,hsa:5595,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2792,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2277,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:25865,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2250,hsa:5499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3689,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4723,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5501,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5291,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3326,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:2557,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
cpd:C00195,hsa:5594,PCrel,inhibition,path:hsa05140 Leishmaniasis,1,0.8
hsa:2770,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:10000,hsa:572,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:810,hsa:5530,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:51806,hsa:818,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4914,hsa:2885,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
cpd:C00076,hsa:5578,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5623,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2323,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:8660,PPrel,phosphorylation,path:hsa04931 Insulin resistance,2,0.8
hsa:8822,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2250,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3458,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:207,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1432,hsa:3725,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:91860,hsa:817,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1557,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:5837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:815,hsa:468,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:91,hsa:4088,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,2,0.8
hsa:26291,hsa:4846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:116,hsa:1395,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9568,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:148327,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1950,hsa:1956,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:7186,hsa:4217,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5566,hsa:2905,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:399694,hsa:2885,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2247,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5608,hsa:5603,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3082,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5607,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7132,hsa:8772,PPrel,activation,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:219,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:70,hsa:6196,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:1816,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2916,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:4780,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6774,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
cpd:C00212,hsa:2740,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00025,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:135,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2323,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2913,hsa:51764,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5879,hsa:5063,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5579,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:57818,hsa:2566,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2914,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:2913,hsa:54331,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10000,hsa:4846,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5970,hsa:6347,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:246,hsa:391013,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5605,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:10451,hsa:5881,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5336,cpd:C00165,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5521,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:65018,hsa:100532726,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2770,hsa:3973,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5566,hsa:84152,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00076,hsa:5582,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:387,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:208,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:54518,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6654,hsa:3265,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:673,hsa:5605,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:115,cpd:C00575,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5565,hsa:32,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5908,hsa:7074,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5499,hsa:5834,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:2912,hsa:2771,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:5533,hsa:572,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:627,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4780,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5465,hsa:51,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:808,hsa:5532,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2770,hsa:5881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4853,hsa:2324,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:5290,hsa:207,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:107,hsa:2002,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:816,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:8074,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:126129,hsa:81616,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:57144,hsa:3984,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2770,hsa:23236,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5535,hsa:4772,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:27330,hsa:5506,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5336,hsa:1128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:196883,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:808,hsa:5534,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8737,hsa:11035,PPrel,phosphorylation,path:hsa04217 Necroptosis,1,0.8
hsa:51764,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2915,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5207,hsa:5213,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:818,hsa:8605,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:3763,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3445,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5566,hsa:2890,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2249,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:207,hsa:57521,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:51764,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5580,hsa:5587,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:51806,hsa:816,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2782,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
cpd:C00584,hsa:7253,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2773,hsa:107,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:841,hsa:4846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4086,hsa:4089,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:3082,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6622,hsa:4711,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00575,hsa:5567,PCrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:5601,hsa:3831,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:91860,hsa:3973,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2323,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4914,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2260,hsa:5295,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
cpd:C00780,hsa:1394,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3460,hsa:3716,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:8324,hsa:1855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5228,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51806,hsa:5534,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:6196,hsa:3265,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:51378,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51806,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:5580,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:84699,hsa:2354,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
cpd:C00025,hsa:356,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:90993,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:817,hsa:468,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2246,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:801,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:6300,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6622,hsa:4713,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8792,hsa:5970,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1558,hsa:5319,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:808,hsa:115,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8792,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4878,hsa:154,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5594,hsa:1386,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:7422,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11337,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:4893,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5155,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:824,hsa:637,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2252,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5295,hsa:476,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:10645,hsa:5563,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:7139,hsa:7170,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:5781,hsa:5295,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:7424,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4902,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6464,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2773,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:5209,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:5733,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3064,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:111,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:284,hsa:51733,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:1816,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:374,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:112,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:1644,hsa:3763,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5228,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3439,hsa:5173,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:148327,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4254,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7423,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00547,hsa:9568,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1459,hsa:3831,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:3350,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8326,hsa:1857,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:2932,hsa:3800,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5500,hsa:9586,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2069,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5908,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00640,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26508,hsa:4609,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:1942,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1234,hsa:2776,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2246,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1944,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4803,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:817,hsa:468,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:9965,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:329,hsa:329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:572,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5295,hsa:208,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:285,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5582,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4803,hsa:7482,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4914,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:5142,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2783,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4893,hsa:5894,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:5291,hsa:5580,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:5566,hsa:2891,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4893,hsa:5894,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:90993,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:2770,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:6688,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:109,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:130399,hsa:4088,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:1950,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2357,hsa:2778,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1435,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4909,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:85366,hsa:10398,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:50507,cpd:C00704,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3481,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2535,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:56034,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2668,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:116443,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8823,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1147,hsa:4792,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:200186,hsa:9586,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
cpd:C00575,hsa:5566,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:6776,hsa:3973,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:7097,hsa:4843,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:842,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5594,hsa:478,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:7529,hsa:572,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6196,hsa:79660,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
path:hsa00250,hsa:51380,maplink,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:2773,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:5579,hsa:5595,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:91860,hsa:109,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2534,hsa:5291,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:5579,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2535,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:10000,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4792,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2309,PPrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2535,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:84335,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:857,hsa:5836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:8503,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:1906,hsa:2645,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,hsa:7133,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2064,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3452,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:27121,hsa:7475,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5970,hsa:7124,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:2770,hsa:111,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6776,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2309,hsa:6195,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3444,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2771,cpd:C00076,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:572,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:91860,hsa:779,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:3760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:3440,no_relation,no_relation,no_relation,no_relation,0.0
hsa:102723407,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:808,hsa:113,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5605,hsa:5594,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8322,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:1128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2977,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:122809,hsa:6774,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:4607,hsa:4625,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:5501,hsa:1385,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
cpd:C15231,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:3831,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3845,hsa:5894,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:11035,hsa:2906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:492,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1942,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7534,hsa:5894,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:5228,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3480,hsa:5295,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
cpd:C11310,hsa:5732,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:3710,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2787,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01996,hsa:1129,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00076,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:27121,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3098,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2990,hsa:10720,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:5567,hsa:775,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:2668,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2786,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:4886,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51764,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:7252,hsa:5732,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:374,hsa:2941,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2932,hsa:4709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:817,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:578,hsa:54205,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5535,hsa:4775,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6772,hsa:3123,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:1945,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00025,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10023,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90673,hsa:2998,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:283106,hsa:3831,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:2254,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4908,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2793,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5568,hsa:3354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7332,hsa:7314,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:8503,cpd:C05981,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:54331,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2248,hsa:810,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:7472,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:10683,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:572,hsa:2890,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7039,hsa:1956,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5578,hsa:468,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:80201,path:hsa00010,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:2790,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:1909,hsa:55811,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1536,hsa:815,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1460,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:7040,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8503,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:10846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5335,cpd:C00165,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
cpd:C11310,hsa:56901,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7039,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2251,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2250,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:810,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:486,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1813,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:3716,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:196883,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2773,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2788,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2906,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1081,hsa:4158,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
hsa:126129,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54518,hsa:55740,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4803,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:79660,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2069,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:392255,hsa:659,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
cpd:C00584,hsa:4158,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:122809,hsa:6777,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1499,hsa:6932,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:3107,hsa:567,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:1943,hsa:3456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:1147,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4638,hsa:140465,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2932,hsa:2997,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2549,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:106821730,hsa:3985,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:26281,hsa:2559,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:2354,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:27006,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C07593,hsa:4716,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2248,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55970,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:4790,hsa:3383,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:4803,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:4793,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3551,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9586,hsa:4170,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
cpd:C00547,hsa:5733,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4893,hsa:369,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:51422,hsa:25865,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:2905,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:8704,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:1394,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8823,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5578,hsa:7222,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5609,hsa:2950,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3456,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:920,no_relation,no_relation,no_relation,no_relation,0.0
hsa:578,hsa:4540,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2904,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:673,hsa:5605,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1234,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2641,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:3105,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:3991,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:5618,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:23236,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:53632,hsa:32,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:5906,hsa:83593,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2932,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:148327,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5228,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:5534,PCrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:1945,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3551,hsa:4794,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2248,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5154,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:56034,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C03758,hsa:1909,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2246,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3448,hsa:3454,PPrel,activation,path:hsa05164 Influenza A,1,0.8
cpd:C00575,hsa:5568,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5906,hsa:7410,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5443,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:53358,hsa:2885,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2791,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2639,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8878,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:779,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:23710,hsa:2563,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:83729,hsa:92,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5500,hsa:1388,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:1945,hsa:5836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5336,hsa:399694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2550,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2775,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2215,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1540,hsa:8737,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:10379,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:163688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4217,hsa:5606,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4804,hsa:5295,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:3481,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:801,hsa:111,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6196,hsa:3845,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3082,hsa:983,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:2997,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:6300,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
cpd:C00076,hsa:5578,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:10681,hsa:8399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:1388,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:6416,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5587,hsa:3689,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2778,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:10681,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4803,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00025,hsa:2916,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4908,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8503,cpd:C05981,PCrel,activation,path:hsa05160 Hepatitis C,1,0.8
cpd:C00195,hsa:5524,PCrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:10681,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:26281,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1435,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:22943,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6196,hsa:468,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00334,hsa:3351,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:23401,hsa:51806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5881,hsa:106821730,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5608,hsa:567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:398,hsa:5880,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4915,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5335,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2911,hsa:598,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:3352,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4261,hsa:3115,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:4790,hsa:2353,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C05981,hsa:10000,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:2277,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:387,hsa:6093,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:6198,hsa:3667,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:2668,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3665,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00334,hsa:2566,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:5290,cpd:C05981,PCrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:4915,hsa:6464,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3480,hsa:2892,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3448,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5571,hsa:3659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10298,hsa:3984,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5499,hsa:84699,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4851,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2720,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5524,hsa:22877,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
cpd:C01996,hsa:1909,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:5894,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2248,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5603,hsa:93432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3242,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:3123,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4540,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:810,hsa:801,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10411,hsa:5599,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:816,hsa:64764,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5155,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3440,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:5509,hsa:5836,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:5908,hsa:4088,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:8503,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:1944,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6195,hsa:5506,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:4909,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2252,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5608,hsa:317,no_relation,no_relation,no_relation,no_relation,0.0
hsa:230,hsa:2203,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:7529,hsa:2309,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26281,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5296,cpd:C05981,PCrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:6772,hsa:3630,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:2932,hsa:89953,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:27330,hsa:5506,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:8324,hsa:1856,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5594,hsa:10488,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C11310,hsa:4702,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1943,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2932,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:59345,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:8823,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:5894,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5028,hsa:2778,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7252,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:1258,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:285,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5499,hsa:1385,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
cpd:C01312,hsa:1816,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1943,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8074,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8823,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:4193,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:23683,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5894,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1457,hsa:89953,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:51764,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3630,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00083,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5336,hsa:810,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:4254,hsa:6655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:4793,PPrel,phosphorylation,path:hsa05164 Influenza A,1,0.8
hsa:1942,hsa:116444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27,hsa:5587,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5567,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4714,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8660,hsa:5293,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:6093,hsa:4659,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3456,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6196,hsa:4893,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5970,hsa:3441,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:5623,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:22943,hsa:2893,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:135,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5578,hsa:6548,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:6195,hsa:6648,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:108,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7039,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26291,hsa:9706,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1019,hsa:5925,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:9475,hsa:4659,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5501,hsa:5105,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7039,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2069,hsa:814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2309,hsa:5105,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:83439,hsa:4609,GErel,expression,path:hsa05216 Thyroid cancer,1,0.5
hsa:1557,hsa:151056,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:26281,hsa:492,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:5106,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:10235,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5291,cpd:C05981,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6850,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:25759,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374,hsa:598,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1644,path:hsa00400,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:5154,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2246,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05216 Thyroid cancer,2,0.8
hsa:54331,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55526,hsa:51166,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:2475,hsa:3655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:1537,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6654,hsa:3845,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6752,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5606,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:123745,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7318,hsa:3627,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1907,hsa:3776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4217,hsa:5609,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:54331,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3911,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:5594,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:627,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2550,hsa:2775,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:1908,hsa:4725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:116,hsa:329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5506,hsa:5834,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:1392,hsa:3362,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:808,hsa:112,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1907,hsa:154,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:10846,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:91860,hsa:5534,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5599,hsa:3798,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5534,hsa:2915,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:818,hsa:4846,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:136,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283106,hsa:3831,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5563,hsa:2475,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:2254,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8817,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2783,hsa:641371,no_relation,no_relation,no_relation,no_relation,0.0
hsa:340156,hsa:140465,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2053,hsa:7481,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5579,hsa:3351,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:3762,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:3360,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2673,hsa:80201,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:5567,hsa:658,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3718,hsa:10846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:5293,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:5534,hsa:4776,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:7332,hsa:6233,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:285,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2277,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5520,hsa:6548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4909,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:2932,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:2788,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2782,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1111,hsa:995,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5601,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1915,hsa:5777,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:5568,hsa:84152,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2248,hsa:5139,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27330,hsa:5501,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:9048,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:27121,hsa:81029,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1234,hsa:54331,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5567,hsa:90993,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:2792,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5021,hsa:785,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1946,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1944,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6195,hsa:134,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:5332,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2932,hsa:3831,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2778,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:5733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:572,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3135,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2917,hsa:54331,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10379,hsa:6777,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:5293,hsa:207,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2641,hsa:4158,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4137,hsa:7278,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:51764,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:10451,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:369,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5595,hsa:2099,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:6772,hsa:3033,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5295,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:998,hsa:4214,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1956,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:5587,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:468,hsa:779,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:65018,hsa:4717,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6416,hsa:5602,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2913,hsa:2783,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:91860,hsa:85366,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5213,hsa:229,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:283106,hsa:147700,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:2475,hsa:8660,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5595,hsa:3725,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C00575,hsa:122970,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:5568,hsa:5465,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1459,hsa:3800,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:10681,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:3454,hsa:3716,PPrel,binding/association,path:hsa05164 Influenza A,1,0.5
hsa:84812,cpd:C01245,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5516,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3280,hsa:4791,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:5567,hsa:5732,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:30837,hsa:4697,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:2889,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:5507,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:5321,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1392,hsa:482,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00051,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:208,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:3265,hsa:5291,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:4233,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4914,hsa:5337,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3444,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:79660,hsa:5836,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
cpd:C03758,hsa:6752,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:369,hsa:5605,PPrel,phosphorylation,path:hsa05224 Breast cancer,3,0.8
hsa:56034,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5880,hsa:5058,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1576,hsa:1557,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5595,hsa:824,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2788,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
cpd:C03758,hsa:2740,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3716,hsa:8503,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:222,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:135,hsa:2778,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:4893,hsa:5291,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:6714,hsa:5293,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:6093,hsa:1605,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4696,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1942,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6622,hsa:4700,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5747,hsa:2185,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C07593,hsa:4706,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1388,hsa:2354,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:5568,hsa:778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5170,hsa:6198,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:27006,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3665,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6898,path:map00960,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:2668,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5336,hsa:51806,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2246,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9945,hsa:3098,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:7422,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1459,hsa:1816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7318,hsa:2776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2932,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:3643,hsa:7170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:4915,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5623,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5208,hsa:5211,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:6850,hsa:930,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:3099,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9568,hsa:2775,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:4915,hsa:3667,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:7167,hsa:441282,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:114,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2773,hsa:3441,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:57521,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:114,cpd:C00575,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5568,hsa:6548,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5579,hsa:2002,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:4804,hsa:5295,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:345456,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283106,hsa:3831,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:23401,hsa:1856,PPrel,binding/association,path:hsa05224 Breast cancer,1,0.5
hsa:5515,hsa:5837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:8536,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:808,hsa:3627,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2563,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:5836,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00533,hsa:2982,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:51378,path:hsa00400,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2913,hsa:10681,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2782,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:10645,hsa:5564,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1942,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7132,hsa:2890,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4909,hsa:391013,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1026,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2778,hsa:115,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:55276,hsa:7360,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:8454,hsa:920,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:814,hsa:1743,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2308,hsa:6648,GErel,expression,path:hsa04213 Longevity regulating pathway - multiple species,1,0.5
hsa:818,hsa:115,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1962,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:2771,hsa:114,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:89869,cpd:C01245,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:7097,hsa:4615,PPrel,activation,path:hsa05144 Malaria,1,0.8
cpd:C00575,hsa:3445,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:8660,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5579,hsa:5894,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5568,hsa:627,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:4087,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:207,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1499,hsa:6934,PPrel,activation,path:hsa05216 Thyroid cancer,1,0.8
hsa:6464,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2917,hsa:54979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6932,hsa:4609,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:23710,hsa:2557,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
cpd:C00212,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:81858,hsa:330,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:5500,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:283748,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:2915,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5604,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27123,hsa:7480,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5594,hsa:8605,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2917,hsa:2782,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1950,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:111,PPrel,inhibition,path:hsa04924 Renin secretion,1,0.8
hsa:4638,hsa:140465,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2913,hsa:11149,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:107,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5602,hsa:8313,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2932,hsa:89953,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:1571,hsa:391013,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:3099,path:hsa00010,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:8817,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:109,cpd:C00575,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:5908,hsa:6464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:8600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:3460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:5603,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:9655,hsa:6774,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1950,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:219,hsa:339896,ECrel,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:6714,hsa:64600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:2354,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:1459,hsa:5143,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2323,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C22381,hsa:2791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5578,hsa:5321,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2778,hsa:3576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5580,hsa:25865,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2914,hsa:3440,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2913,hsa:2793,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
path:hsa00010,hsa:2821,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:4804,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:3446,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:6300,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:27121,hsa:7471,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5519,hsa:6199,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5881,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:1907,hsa:3351,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:23411,hsa:2308,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:4261,hsa:3122,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:54331,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:6199,hsa:6194,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7424,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1942,hsa:493,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:283748,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00788,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3164,hsa:6256,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7410,hsa:5881,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5207,hsa:2203,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:3064,hsa:29796,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:627,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5770,hsa:51094,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4902,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2253,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3164,hsa:596,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00547,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10683,hsa:4854,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5970,hsa:779,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:3350,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:117,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1459,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5610,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:113,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:355,hsa:8772,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:109,cpd:C00575,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:163688,hsa:196883,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1459,hsa:5562,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:4193,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:816,hsa:7157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2915,hsa:2902,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:11035,hsa:7484,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5332,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2069,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26291,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:387,hsa:6093,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7297,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:5880,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:5321,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5880,hsa:5063,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:91860,hsa:5533,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5781,hsa:3643,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:4908,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8322,hsa:1857,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:27006,hsa:3033,no_relation,no_relation,no_relation,no_relation,0.0
hsa:658,hsa:4093,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:4261,hsa:5564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:283748,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
cpd:C00212,hsa:4158,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1908,hsa:2906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1544,hsa:1559,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:4908,hsa:4914,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:1978,hsa:1977,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9475,hsa:5500,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1435,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5155,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6622,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2917,hsa:2775,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:2249,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:207,hsa:1386,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00025,hsa:2904,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:9475,hsa:4659,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:65018,hsa:80201,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5516,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4804,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55072,hsa:331,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:2248,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:816,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3643,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5568,hsa:10846,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2246,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1908,hsa:3350,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8835,hsa:3717,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5606,hsa:5600,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:55526,hsa:4170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4804,hsa:5291,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:111,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5568,hsa:3552,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:4846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,hsa:4772,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2770,hsa:5290,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1906,hsa:154,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:284,hsa:1812,no_relation,no_relation,no_relation,no_relation,0.0
hsa:53632,hsa:92579,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:146850,hsa:5170,PPrel,compound,path:hsa05145 Toxoplasmosis,1,0.5
hsa:2776,hsa:5332,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:91860,hsa:5534,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:1950,hsa:1956,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5518,hsa:6199,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5908,hsa:673,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2775,hsa:153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4704,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3630,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7855,hsa:1857,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:4855,hsa:388585,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:3455,hsa:3718,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2771,hsa:8503,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3551,hsa:4792,PPrel,activation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:2695,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:3354,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10000,hsa:2309,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C01312,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:399694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7167,hsa:229,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,2,0.5
hsa:5293,hsa:207,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:55970,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2260,hsa:8503,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
cpd:C00547,hsa:4881,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2717,hsa:6476,ECrel,compound,path:hsa00052 Galactose metabolism,3,0.5
hsa:27330,hsa:4893,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8074,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:2203,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:27330,hsa:5499,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:8823,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:80310,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:284,hsa:5582,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:8398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:8737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5058,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:85366,hsa:10398,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5894,hsa:5605,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5567,hsa:493,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2069,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:805,hsa:815,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
cpd:C22381,hsa:5338,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:208,hsa:2309,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2250,hsa:7297,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:1378,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:5170,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2773,hsa:5294,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1544,hsa:1557,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:4261,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C22381,hsa:9020,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:4233,hsa:50507,no_relation,no_relation,no_relation,no_relation,0.0
hsa:229,hsa:483,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5291,cpd:C05981,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6300,hsa:2921,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:208,hsa:572,PPrel,inhibition,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:4803,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5598,hsa:490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:834,hsa:90865,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:2889,hsa:5906,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2550,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00547,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:255189,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2788,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:7042,hsa:4843,PPrel,inhibition,path:hsa05140 Leishmaniasis,1,0.8
hsa:51378,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5336,hsa:91860,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C03758,hsa:1813,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1460,hsa:3799,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1558,hsa:1576,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
cpd:C00076,hsa:5579,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1944,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2255,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3716,hsa:6772,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:57506,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27429,hsa:329,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:5579,hsa:29904,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:958,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:115,cpd:C00575,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2791,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:4790,hsa:3446,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5535,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2069,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7424,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7852,hsa:2785,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2249,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2248,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2773,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:1460,hsa:3351,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1459,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4215,hsa:5607,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5599,hsa:64837,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2793,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5881,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:331,hsa:842,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:80310,hsa:4843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51176,hsa:4609,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:2773,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:5321,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5509,hsa:2997,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:51764,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:5144,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:673,hsa:5605,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,2,0.8
cpd:C07593,hsa:4731,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8503,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1460,hsa:64837,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:805,hsa:5530,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5609,hsa:5601,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:7423,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3445,hsa:30814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5290,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:472,hsa:1111,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:810,hsa:2890,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3105,hsa:6898,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:5499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11211,hsa:1855,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2261,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2778,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2550,hsa:54331,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:102723407,hsa:2215,PPrel,binding/association,path:hsa05140 Leishmaniasis,1,0.5
hsa:8074,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5578,hsa:8681,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:207,hsa:64764,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2248,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:231,hsa:6652,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2251,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3455,hsa:3716,PPrel,binding/association,path:hsa05164 Influenza A,1,0.5
hsa:4261,hsa:3117,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:126129,hsa:2740,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:5590,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:3845,hsa:673,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:5501,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:1432,hsa:3592,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:163688,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55072,hsa:330,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:9020,hsa:4790,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:810,hsa:340156,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1111,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5522,hsa:2558,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5777,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:5600,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3265,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:5579,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5602,hsa:2512,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:2254,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3845,hsa:5296,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:207,hsa:2309,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:5970,hsa:3447,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:1147,hsa:8471,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:6714,hsa:8503,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2254,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:83593,hsa:3684,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10000,hsa:90993,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51378,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:805,hsa:5533,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5170,hsa:55970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64764,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:5582,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:10000,hsa:2309,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:2249,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2254,hsa:345456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3449,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:208,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:10645,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00547,hsa:2550,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51735,hsa:5906,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:814,hsa:5139,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5579,hsa:1385,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:8822,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2252,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:8536,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2250,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:23683,hsa:4137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,cpd:C05981,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:51764,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:8074,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2668,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2309,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2309,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:27123,hsa:7472,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2911,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4838,hsa:92,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:810,hsa:107,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:90993,hsa:596,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:810,hsa:112,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C15231,hsa:4519,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2788,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:598,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:2917,hsa:2773,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
cpd:C05981,hsa:208,PCrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:2771,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:2782,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6776,hsa:1154,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5906,hsa:51764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5623,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5781,hsa:3667,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:22926,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:6609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa05164 Influenza A,1,0.8
hsa:57144,hsa:3985,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6622,hsa:4541,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5567,hsa:84152,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:207,hsa:842,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5578,hsa:90993,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:3107,hsa:25865,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26508,hsa:6464,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5598,hsa:4615,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4851,hsa:2064,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:1432,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10645,hsa:5564,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5062,hsa:3984,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1392,hsa:2740,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5524,hsa:10000,PPrel,inhibition,path:hsa04931 Insulin resistance,2,0.8
hsa:26281,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:11345,hsa:2565,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:5605,hsa:5595,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3716,hsa:5291,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:9882,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:51806,hsa:111,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00584,hsa:1394,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8398,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5594,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:3164,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2771,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:108,cpd:C00575,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2535,hsa:2805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:5293,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:3098,hsa:1573,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1392,hsa:7253,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3479,hsa:3480,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:27006,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9103,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:207,hsa:2932,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5155,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5568,hsa:5141,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5335,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:388585,hsa:4791,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:2246,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:808,hsa:5530,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:6093,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:4215,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C07593,hsa:2791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3953,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:57521,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2695,hsa:3362,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C05981,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:3799,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5566,hsa:5139,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1147,hsa:493,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8743,hsa:2915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:1154,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5601,hsa:3667,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:26281,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25,hsa:5587,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2253,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5587,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2323,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2913,hsa:2784,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5170,hsa:100533105,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:30837,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5562,hsa:32,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5595,hsa:6197,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:7186,hsa:8517,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:208,hsa:842,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5894,hsa:4855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10018,hsa:598,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:2783,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3630,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:27006,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3661,hsa:3444,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:3718,hsa:6772,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:8074,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:2941,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:1945,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5602,hsa:2495,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:5566,hsa:776,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:7422,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:56034,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2149,hsa:2778,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:90993,hsa:2550,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7408,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:4843,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:7424,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9965,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5970,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:8660,PPrel,inhibition,path:hsa04931 Insulin resistance,2,0.8
hsa:53632,hsa:3309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5515,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4893,hsa:6300,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:7423,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5900,hsa:5881,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:90,hsa:7360,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,hsa:2932,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:55970,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5566,hsa:2891,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:1500,hsa:999,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5566,hsa:6548,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4893,hsa:1432,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3098,hsa:399694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:123745,cpd:C00219,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:468,hsa:1649,GErel,expression,path:hsa05020 Prion disease,1,0.5
hsa:1081,hsa:399694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:5294,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:4660,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5443,hsa:135,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2252,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6093,hsa:5500,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:7132,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:3439,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:2782,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5925,hsa:53358,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2550,hsa:2793,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:5321,hsa:5142,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:5879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:3064,hsa:4158,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51378,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:100532726,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:3709,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8312,hsa:10297,PPrel,binding/association,path:hsa05224 Breast cancer,1,0.5
hsa:3082,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:2793,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1944,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:331,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5582,hsa:5236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10000,hsa:4846,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:1908,hsa:6464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283106,hsa:3799,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1946,hsa:2495,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5535,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:1945,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1559,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:1080,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6714,hsa:4715,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:4794,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2770,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2249,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00584,hsa:153,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7317,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:123745,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1234,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:7222,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5331,cpd:C00165,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:7297,hsa:6773,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:51806,hsa:5535,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3661,hsa:3441,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:3551,hsa:4792,PPrel,activation,path:hsa05164 Influenza A,2,0.8
hsa:2550,hsa:59345,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:1234,hsa:2775,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:26281,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4852,hsa:134,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:441282,hsa:2720,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5523,hsa:2920,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2695,hsa:1395,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3717,hsa:399694,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:5228,hsa:2737,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:139760,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5599,hsa:3798,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1460,hsa:10327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1234,hsa:2784,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:285,hsa:25,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8325,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:9706,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:650,hsa:6352,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7422,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:778,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:91860,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:494551,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3439,hsa:3455,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5499,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:226,hsa:26007,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:4914,hsa:399694,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5567,hsa:5465,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3170,hsa:1576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:2919,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:4804,hsa:8503,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:285,hsa:5140,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:4792,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:284,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5443,hsa:3460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5142,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2673,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1392,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5567,hsa:84152,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5293,cpd:C05981,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:7422,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5747,hsa:5296,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2990,hsa:2495,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5602,hsa:3831,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:23493,hsa:595,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:197259,hsa:114548,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1950,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00584,hsa:3362,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51806,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4804,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4914,hsa:25,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5781,hsa:5290,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:65018,hsa:4694,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5568,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4287,hsa:3710,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:208,hsa:4792,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:51764,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:51422,hsa:6517,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:8822,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10379,hsa:4940,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:9223,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6667,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:4780,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:1385,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:1559,hsa:84647,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5566,hsa:8644,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:5293,hsa:5321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:5296,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:3696,hsa:60,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:200186,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:3709,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5894,hsa:5604,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:23683,hsa:4881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1855,hsa:6197,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4705,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7424,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2791,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3452,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3309,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:117,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3630,hsa:140465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:5144,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1147,hsa:4792,PPrel,phosphorylation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:1559,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55012,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1942,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:331,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2069,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5330,cpd:C00165,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:163688,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2260,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5562,hsa:5105,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5594,hsa:1388,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:5500,hsa:491,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:185,hsa:3798,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27330,hsa:4893,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1571,hsa:8398,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:2214,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9564,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,hsa:5837,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2913,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5609,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27,hsa:1544,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3101,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:52,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:805,hsa:5533,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:2773,hsa:113,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:207,hsa:5562,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:7252,hsa:920,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:6654,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2247,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9223,hsa:51735,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2792,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:208,hsa:572,PPrel,inhibition,path:hsa05145 Toxoplasmosis,1,0.8
hsa:3452,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:3800,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8817,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C05981,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6714,hsa:8503,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2720,hsa:57818,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
cpd:C00533,hsa:2982,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:3695,hsa:84152,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:5608,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5155,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7532,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9655,hsa:6777,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1576,hsa:100506742,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2767,hsa:5335,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8322,hsa:3352,no_relation,no_relation,no_relation,no_relation,0.0
hsa:116,hsa:3360,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:11337,hsa:55879,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:5606,hsa:5603,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5568,hsa:775,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2775,hsa:109,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C01996,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:109,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4803,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:808,hsa:10645,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:9475,hsa:4660,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3551,hsa:3667,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5594,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:3798,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6654,hsa:9223,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2261,hsa:4615,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5530,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:2251,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5290,hsa:10000,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:10488,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:3127,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:4804,hsa:5879,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:80310,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5290,hsa:481,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:10379,hsa:4599,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:6794,hsa:51422,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:285,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:2903,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:83729,hsa:93,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:7852,hsa:2792,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2792,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5293,hsa:483,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:4915,hsa:10846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3695,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2904,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:4254,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6775,hsa:5610,GErel,expression,path:hsa04217 Necroptosis,1,0.5
hsa:5582,hsa:1394,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2323,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5580,hsa:5605,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C07593,hsa:4701,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:9568,hsa:2771,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:1459,hsa:147700,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:6196,hsa:5879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3791,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3667,hsa:5295,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7424,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:6196,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1943,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4615,hsa:3654,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:1571,hsa:84647,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:3101,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:841,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:115,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3716,hsa:6777,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5777,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:115,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27121,hsa:51384,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:208,hsa:572,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6714,hsa:5290,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:2776,hsa:139760,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:55811,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3643,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2791,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57818,hsa:6654,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:317,hsa:4170,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:1812,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5515,hsa:6772,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:26291,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3953,hsa:3717,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:8321,hsa:1855,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05216 Thyroid cancer,2,0.8
cpd:C00788,hsa:154,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:8325,hsa:1856,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7010,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8823,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2787,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:4638,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11337,hsa:2554,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:2784,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C00584,hsa:3973,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1457,hsa:3800,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5211,hsa:226,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:6622,hsa:126328,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5970,hsa:10645,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7134,hsa:399694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:1394,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:810,hsa:109,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C03758,hsa:1129,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5603,hsa:3725,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6195,hsa:5501,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:6776,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3439,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:1459,hsa:3799,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:107,cpd:C00575,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:627,hsa:4728,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:9261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3448,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:6885,hsa:8517,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:3694,hsa:8789,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:2740,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
hsa:6196,hsa:26279,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5335,hsa:5970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54106,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:100137049,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5333,cpd:C00165,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:10000,hsa:572,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:4137,hsa:7280,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2249,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2771,hsa:112,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:148327,hsa:2353,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:4233,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4790,hsa:2556,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:84699,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3481,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:9586,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:284217,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5582,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:808,hsa:57172,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5214,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:26279,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:4915,hsa:7189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4708,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7167,hsa:480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2892,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4804,hsa:7189,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,2,0.5
hsa:3265,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:207,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:810,hsa:109,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2771,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:5568,hsa:4794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8605,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:3082,hsa:2002,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:23533,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2784,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1234,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1969,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3098,hsa:2203,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:4893,hsa:5603,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:154,hsa:5728,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:808,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,2,0.8
hsa:2778,hsa:108,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:814,hsa:100532726,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3446,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5565,hsa:32,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:4254,hsa:3552,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:27330,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:808,hsa:100137049,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4851,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2215,hsa:3716,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3439,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:808,hsa:814,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5970,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:399694,hsa:2885,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5594,hsa:123745,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:284217,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:148327,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:207,hsa:2475,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:7424,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3480,hsa:5291,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
cpd:C01312,hsa:3360,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:57521,hsa:4090,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6464,hsa:2885,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
cpd:C00334,hsa:1128,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5601,hsa:3667,PPrel,phosphorylation,path:hsa04931 Insulin resistance,2,0.8
hsa:5602,hsa:147700,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5236,hsa:7360,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:2793,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:4790,hsa:441925,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:2793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7039,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:2891,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:4854,hsa:388585,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:5567,hsa:2904,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:581,hsa:823,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:9103,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:197259,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:55879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:65018,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51806,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:810,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1945,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9455,hsa:3708,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:3309,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:163688,hsa:817,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4773,hsa:1827,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:5566,hsa:116444,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:815,hsa:10488,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:4790,hsa:3576,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:2791,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5333,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3265,hsa:369,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:27113,hsa:598,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:2914,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4804,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4804,hsa:91807,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:369,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:5600,hsa:9261,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:10000,hsa:572,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7039,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5609,hsa:23683,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7332,hsa:6514,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2556,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:285,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26279,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:9965,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8517,hsa:4792,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:1942,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00547,hsa:1813,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7424,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8326,hsa:1855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:25865,hsa:3683,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4902,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6714,hsa:5295,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:9945,hsa:2821,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:2255,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1459,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:3456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:1499,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7124,hsa:7132,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:1571,hsa:8681,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:468,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:4718,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:23439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:54567,hsa:4853,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:1950,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:23710,hsa:2559,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:7852,hsa:2782,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4261,hsa:3113,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:2784,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:388585,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10000,hsa:2308,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:107,cpd:C00575,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:208,hsa:3164,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3265,hsa:5290,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51378,hsa:1813,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4878,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:28227,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4909,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:7048,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:1909,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1499,hsa:999,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00547,hsa:10327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11069,hsa:5906,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51764,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:5173,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:2673,path:hsa00010,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:810,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:330,hsa:842,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:8074,hsa:23533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2324,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3099,hsa:5207,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:6794,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7332,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:23683,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5336,hsa:808,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4233,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3665,hsa:3444,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:94235,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3082,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9945,hsa:2645,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,cpd:C01245,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:6885,hsa:5601,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
cpd:C00584,hsa:5732,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5156,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:952,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:207,hsa:90993,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00780,hsa:7189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:255189,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5582,hsa:10488,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:65018,hsa:4707,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5609,hsa:5599,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:92579,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5208,hsa:5213,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2475,hsa:2556,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:3799,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:26281,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:5142,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5534,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:4804,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1234,hsa:2773,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C00334,hsa:200959,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:6300,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3909,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:208,hsa:4790,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2770,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6196,hsa:1813,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7099,hsa:353376,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1942,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00547,hsa:154,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5571,hsa:32,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:7424,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:25,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:490,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6776,hsa:2100,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:55970,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3661,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:115,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3716,hsa:5293,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1457,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:3659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:4893,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:7424,hsa:2775,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00250,hsa:483,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374,hsa:2561,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4716,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8471,hsa:5296,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
cpd:C05981,hsa:207,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:9568,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5331,cpd:C01245,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:8517,hsa:4793,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:2990,hsa:79799,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:9048,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00547,hsa:3360,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8503,hsa:482,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:6772,hsa:3354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2247,hsa:22877,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:7297,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1907,hsa:1813,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:25865,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54567,hsa:4854,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:2695,hsa:4158,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1944,hsa:983,no_relation,no_relation,no_relation,no_relation,0.0
hsa:317,hsa:842,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:805,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5524,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:7171,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:64764,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5507,hsa:2998,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:3845,hsa:5507,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55626,hsa:8678,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5534,hsa:4775,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:59345,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:627,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3449,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:81029,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1576,hsa:151056,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:3480,hsa:8503,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:4625,hsa:4633,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:26291,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5604,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3454,hsa:7297,PPrel,binding/association,path:hsa05164 Influenza A,1,0.5
hsa:2249,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:815,hsa:5139,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:100137049,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:1945,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:4773,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2247,hsa:3133,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5330,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C11310,hsa:4717,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2247,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:6945,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1544,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7040,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:2790,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:208,hsa:5565,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05164 Influenza A,1,0.8
hsa:10000,hsa:2932,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2247,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:54575,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C15231,hsa:7381,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:231,hsa:3354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:23130,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3446,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:8822,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4914,hsa:53358,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1558,hsa:9456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2308,hsa:847,GErel,expression,path:hsa04213 Longevity regulating pathway - multiple species,1,0.5
hsa:197259,hsa:192111,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5154,hsa:9455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:113,cpd:C00575,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:3630,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C11310,cpd:C00219,no_relation,no_relation,no_relation,no_relation,0.0
hsa:185,cpd:C02135,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:9965,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5228,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2564,hsa:7417,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23683,hsa:3991,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5563,hsa:32,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5506,hsa:2997,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
cpd:C00584,hsa:3126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2917,hsa:2786,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:810,hsa:115,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6655,hsa:3265,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:102723407,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2913,hsa:94235,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1386,hsa:596,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:1946,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00788,hsa:3352,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6199,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2264,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8074,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5140,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:10846,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3716,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9223,hsa:5728,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8772,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C00020,hsa:5562,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1559,hsa:391013,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:9246,hsa:6233,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:2770,hsa:5294,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:91807,hsa:140465,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2668,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6794,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5563,hsa:6517,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:208,hsa:92579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112,cpd:C00575,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6752,hsa:5834,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3033,hsa:486,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:81579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2668,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2778,hsa:100137049,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:2668,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5228,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5506,hsa:5836,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:1946,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:27121,hsa:7482,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5599,hsa:7157,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00076,hsa:5153,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:2309,hsa:486,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27330,hsa:1756,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,hsa:2002,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5535,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5925,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6775,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:4638,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3908,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:673,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00788,hsa:2740,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3439,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:7423,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:5211,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:89953,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:340156,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1943,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5499,hsa:1388,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:2782,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:841,hsa:836,PPrel,activation,path:hsa05164 Influenza A,1,0.8
cpd:C07593,hsa:5567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:146850,hsa:1027,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5028,hsa:2776,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:810,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2695,hsa:5732,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1943,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3443,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2770,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:8792,hsa:4790,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:3716,hsa:324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:4893,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5970,path:map00960,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:5571,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5602,hsa:1432,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:90673,hsa:2997,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:2668,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5241,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:111,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
path:hsa00010,hsa:229,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:4908,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8517,hsa:3667,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:6750,hsa:10243,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:113,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2252,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7422,hsa:6655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5564,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7157,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5499,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:5970,hsa:10243,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1398,hsa:2889,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3082,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:26281,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:2252,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:27006,hsa:1027,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2069,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:53632,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1385,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:842,hsa:840,PPrel,activation,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:2792,hsa:3659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:6300,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2775,hsa:116444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7137,hsa:70,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:1557,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2251,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:57506,hsa:10018,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5534,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2913,hsa:2782,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1128,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5908,hsa:51196,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1557,hsa:5058,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:25759,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:163688,hsa:815,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1944,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3242,hsa:3362,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:5144,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51806,hsa:57172,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:7134,hsa:7139,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:5595,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2913,hsa:2786,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:92421,hsa:197259,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:814,hsa:5141,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5567,hsa:387,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3845,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5563,hsa:32,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:7532,hsa:2309,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6774,hsa:894,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5970,hsa:3592,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:55970,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
cpd:C00575,hsa:5568,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:4893,hsa:369,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2788,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:207,hsa:572,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5332,cpd:C01245,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3265,hsa:5290,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00584,hsa:5997,no_relation,no_relation,no_relation,no_relation,0.0
hsa:598,hsa:581,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:1544,hsa:54979,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5605,hsa:5501,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:2099,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1392,hsa:10297,no_relation,no_relation,no_relation,no_relation,0.0
hsa:196883,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:673,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6776,hsa:8737,GErel,expression,path:hsa04217 Necroptosis,1,0.5
hsa:6622,hsa:4698,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6885,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3440,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:4915,hsa:10603,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5747,hsa:5290,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1857,hsa:2932,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:808,hsa:114,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1459,hsa:3800,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7252,hsa:117,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2773,hsa:146850,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2253,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5604,hsa:5509,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:151056,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5598,hsa:6195,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2264,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4803,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3716,hsa:5296,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1857,hsa:10023,PPrel,binding/association,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:246,hsa:8605,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:30837,hsa:6774,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1558,hsa:123745,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:207,hsa:1026,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:3064,hsa:3708,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5595,hsa:3760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3098,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5562,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5521,hsa:55276,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00044,hsa:5906,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
hsa:7317,hsa:2354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4804,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00788,hsa:5021,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C05981,hsa:207,PCrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:5293,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:84335,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5290,hsa:3265,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6196,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8797,hsa:3759,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2247,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2247,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5567,hsa:10488,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5578,hsa:6531,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:3791,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3551,hsa:4792,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:92579,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:55072,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4728,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2791,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C00212,hsa:1812,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3643,hsa:3667,PPrel,activation,path:hsa04931 Insulin resistance,3,0.8
hsa:2253,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1573,hsa:1557,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:94235,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3242,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:148327,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:801,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4916,hsa:4855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1958,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:224,hsa:339896,ECrel,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:7423,hsa:26007,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1374,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1234,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2673,hsa:2821,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:1943,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9451,hsa:8517,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:7422,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5332,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283106,hsa:64837,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1375,hsa:2181,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:7855,hsa:1855,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:10000,hsa:10488,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:56034,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5533,hsa:4772,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2253,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5209,path:hsa00010,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5295,hsa:208,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5336,cpd:C01245,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1956,hsa:5296,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:207,hsa:53632,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:113,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5211,hsa:229,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:22943,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3242,hsa:5580,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1154,hsa:5618,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:4915,hsa:25759,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:91860,hsa:816,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
path:hsa00640,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:492,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1544,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:572,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1234,hsa:2788,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:387,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:5579,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:815,hsa:196883,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1950,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6750,hsa:134,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3101,hsa:5208,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2323,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7852,hsa:3688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5602,hsa:2353,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:7852,hsa:3397,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:54979,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2913,hsa:2788,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2720,hsa:2683,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:9568,hsa:2788,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:4852,hsa:3355,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7976,hsa:1857,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:1386,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5521,hsa:805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,cpd:C00076,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:814,hsa:5142,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3480,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3101,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:1432,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:3309,hsa:9451,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5579,hsa:148327,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:1956,hsa:6464,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2069,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5331,hsa:1956,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3717,hsa:6777,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:27102,hsa:1965,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:7039,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8822,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2775,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:468,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:246,hsa:54979,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:1944,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1392,hsa:153,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5579,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4726,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:11035,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3624,hsa:4790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:572,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:4854,hsa:5139,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:153,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:11069,hsa:5601,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:207,hsa:1026,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C07593,hsa:4709,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:627,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:329,hsa:840,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:5594,hsa:10891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5499,hsa:2538,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3441,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1436,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1559,hsa:1816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107,hsa:4137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5595,hsa:6772,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
cpd:C05981,hsa:10000,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2778,hsa:112,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5058,hsa:6416,PPrel,phosphorylation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:814,hsa:196883,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8823,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9020,hsa:5970,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2770,hsa:329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:116,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:808,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5587,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5563,hsa:32,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:2775,hsa:3593,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:7318,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1906,hsa:3350,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3458,hsa:3460,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:1234,hsa:7124,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:60673,hsa:9821,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1946,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5499,hsa:5837,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:5293,hsa:476,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5567,hsa:6548,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05224 Breast cancer,3,0.8
hsa:207,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:477,no_relation,no_relation,no_relation,no_relation,0.0
hsa:356,hsa:355,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:109,cpd:C00575,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:80310,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5295,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:2805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:64600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:5173,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:3445,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1392,hsa:79602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1536,hsa:1958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:490,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1557,hsa:100137049,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:8074,hsa:5836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5335,hsa:805,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:283106,hsa:64837,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:5594,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:5608,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:7157,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5568,hsa:1588,GErel,expression,path:hsa04913 Ovarian steroidogenesis,2,0.5
hsa:4916,hsa:399694,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1962,hsa:38,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:5602,hsa:8471,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:4790,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10379,hsa:6772,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:3480,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2821,hsa:2645,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:8823,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2773,hsa:11035,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:108,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9021,hsa:8471,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:51806,hsa:5532,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
cpd:C00575,hsa:283748,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:1946,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4215,hsa:5607,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2255,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:7137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7852,hsa:2784,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1945,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1435,hsa:1128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:2793,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:627,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9021,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:55970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2254,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26291,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00165,hsa:5578,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5154,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2893,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:83700,hsa:7082,PPrel,binding/association,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:5781,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:116444,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:51806,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2744,hsa:2746,ECrel,compound,path:hsa04964 Proximal tubule bicarbonate reclamation,1,0.5
hsa:4909,hsa:847,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:815,hsa:111,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2069,hsa:10891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:596,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:5143,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,cpd:C05981,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:207,hsa:5894,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55970,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10681,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C00788,hsa:3350,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8817,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1942,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5894,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5732,hsa:2778,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5594,hsa:4088,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:2778,hsa:111,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
path:hsa00010,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:482,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
cpd:C00076,hsa:5582,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:4254,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8823,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3551,hsa:4793,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:27006,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2778,hsa:113,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10645,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:4792,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:5567,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2554,hsa:135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5535,hsa:4773,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3551,hsa:4792,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:207,hsa:4846,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1950,hsa:2793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:814,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1944,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:374,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3481,hsa:2904,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4707,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4261,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6652,hsa:983,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2308,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2990,hsa:54657,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:22800,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:7479,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1459,hsa:64837,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4780,hsa:3162,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:2323,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2065,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2771,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:65018,hsa:4716,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:27123,hsa:7475,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:51806,hsa:57118,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:26229,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:208,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7124,hsa:7132,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:113,cpd:C00575,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:80310,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8074,hsa:1812,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6772,PPrel,phosphorylation,path:hsa05164 Influenza A,1,0.8
hsa:5155,hsa:80326,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2891,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5595,hsa:801,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:1742,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:1943,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:221,hsa:4129,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:5568,hsa:5144,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5210,hsa:5211,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:57144,hsa:3459,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:3845,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5567,hsa:3292,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:5781,hsa:5296,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:207,hsa:57521,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:5535,hsa:4776,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5532,hsa:4775,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:285,hsa:116444,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00640,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:91860,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:113,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:115,hsa:5501,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8651,hsa:3717,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:817,hsa:5142,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:208,hsa:107,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2770,hsa:5294,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5587,hsa:5908,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5567,hsa:6770,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:8823,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2247,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6750,hsa:1128,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5879,hsa:5291,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:11035,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4695,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7186,hsa:1147,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:284217,hsa:1605,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:5598,hsa:6197,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1813,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2673,hsa:3099,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:818,hsa:5144,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2308,hsa:6464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5331,hsa:3351,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5906,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,cpd:C05981,PCrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:9451,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:9261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00533,hsa:3101,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:10243,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,cpd:C05981,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8651,hsa:3716,PPrel,inhibition,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5567,hsa:2892,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:1457,hsa:147700,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2277,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:2906,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:4916,hsa:5336,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:51806,hsa:196883,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:65018,hsa:56901,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1576,hsa:30814,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5443,hsa:139760,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C01996,hsa:7137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5581,hsa:5599,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:3717,hsa:6772,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
cpd:C01996,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:5295,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1081,hsa:3360,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
cpd:C00025,hsa:2902,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:8823,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:79660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3984,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5443,hsa:5582,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91807,hsa:4637,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:23236,cpd:C00165,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1558,hsa:54979,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:51806,hsa:5530,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1558,hsa:100137049,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2248,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5906,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:399694,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:5610,GErel,expression,path:hsa04217 Necroptosis,1,0.5
hsa:2775,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:5021,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:815,hsa:10846,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1111,hsa:995,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8737,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5332,hsa:5908,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64764,hsa:2673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:197259,no_relation,no_relation,no_relation,no_relation,0.0
hsa:182,hsa:4854,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:54331,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26508,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:23678,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:1129,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27006,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4878,hsa:4881,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:208,hsa:2475,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
cpd:C11310,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:57172,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00788,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:57506,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:10327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11211,hsa:1856,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
cpd:C07593,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2918,hsa:2786,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3135,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:5580,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:5568,hsa:572,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2668,hsa:84335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2903,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:56616,hsa:332,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:3479,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5207,hsa:8681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:441282,hsa:2717,ECrel,compound,path:hsa00052 Galactose metabolism,4,0.5
hsa:2788,hsa:8704,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7317,hsa:7311,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:5568,hsa:356,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:51807,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:207,hsa:29904,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23130,hsa:55062,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:801,hsa:3460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2889,hsa:197259,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1907,hsa:1129,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:207,hsa:5894,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1536,hsa:817,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:10000,hsa:317,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:90993,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:1460,hsa:89953,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3265,hsa:5894,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:5599,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:89953,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3665,hsa:55967,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:8660,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5336,hsa:808,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5908,hsa:5900,PPrel,inhibition,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2784,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:5173,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:5501,hsa:5834,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:3845,hsa:4886,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:356,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:3126,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5623,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:84617,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5568,hsa:5465,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3479,hsa:3480,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:7133,hsa:1616,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00780,hsa:9568,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1946,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00780,hsa:6752,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3082,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5601,hsa:8471,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:3481,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:814,hsa:5139,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5291,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:8503,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:284,hsa:3098,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:7474,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:51806,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:60673,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6196,hsa:3845,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4804,hsa:5296,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2255,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1571,hsa:255189,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:1943,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:52,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:6775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2776,hsa:5335,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5336,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5028,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:109,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10000,hsa:2309,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:6622,hsa:4706,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5228,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:3667,PPrel,inhibition,path:hsa04931 Insulin resistance,2,0.8
hsa:5293,hsa:208,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5894,hsa:5604,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:4882,cpd:C00942,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:56034,hsa:23683,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5587,hsa:1147,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:230,hsa:2997,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5607,hsa:5598,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2918,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:2495,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:3030,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:5144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2890,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3452,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:805,hsa:818,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5970,hsa:6352,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:7167,hsa:26007,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:598,hsa:9021,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4287,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:818,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:8325,hsa:1855,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:7297,hsa:6774,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:1559,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5535,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:627,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2913,hsa:5562,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5518,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5587,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7139,hsa:7169,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:4909,hsa:4915,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:65018,hsa:1557,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:1026,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:4137,hsa:347688,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4780,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:3350,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2053,hsa:8644,ECrel,compound,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:7097,hsa:2203,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C00076,hsa:805,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,2,0.8
hsa:7253,hsa:2776,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5618,hsa:3717,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:6197,hsa:4089,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3326,hsa:197259,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:9965,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:208,hsa:1386,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:3551,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6196,hsa:5500,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5564,hsa:2203,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:1816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2260,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3973,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:207,hsa:90993,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3665,hsa:3451,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:5170,hsa:6446,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3099,hsa:5236,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:2322,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2252,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:2180,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5534,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:7533,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:6654,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00334,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:5499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:2053,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:123745,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:4916,hsa:25,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5290,hsa:10846,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:3360,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5595,hsa:6195,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:196883,cpd:C00575,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:2246,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00584,hsa:1813,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:11035,hsa:815,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:51806,hsa:5535,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:246,hsa:5320,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
cpd:C00025,hsa:2915,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2250,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3445,hsa:3455,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:1943,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5522,hsa:55276,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2892,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8326,hsa:1856,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4916,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5465,hsa:8310,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:8823,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2771,hsa:5330,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6804,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10411,hsa:5602,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4893,hsa:369,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2247,hsa:4794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:387,hsa:6093,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3479,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51764,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2254,hsa:920,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1586,GErel,expression,path:hsa04913 Ovarian steroidogenesis,2,0.5
hsa:6622,hsa:4539,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5970,hsa:7124,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:5291,hsa:481,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1571,hsa:7097,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1544,hsa:5321,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5500,hsa:5139,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5535,hsa:3800,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5533,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:810,hsa:7042,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:814,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:6195,hsa:5499,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:3064,hsa:5602,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4254,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:5606,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:4726,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2932,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:10000,hsa:1958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6237,hsa:2737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:4137,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5330,cpd:C01245,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2255,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:11035,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00025,hsa:2902,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
path:hsa00640,hsa:51380,maplink,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:27429,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00083,hsa:1374,PCrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:8517,hsa:4792,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:51135,hsa:3551,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:2771,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
cpd:C00076,hsa:5535,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5296,hsa:3265,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4909,hsa:7311,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:5834,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:51196,cpd:C00165,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:255189,cpd:C00219,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:207,hsa:2475,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:2538,cpd:C00031,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:3718,hsa:5295,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5900,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4772,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9568,hsa:3354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6934,path:hsa00400,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:163688,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:3362,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2790,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:26281,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6776,hsa:8600,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:2782,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2784,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5154,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2251,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5499,hsa:10398,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5602,hsa:3118,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4261,hsa:3109,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:4916,hsa:10603,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2081,hsa:7494,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2914,hsa:5338,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3098,hsa:5208,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5414,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3442,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:8817,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6655,hsa:3845,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3643,hsa:8399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:3799,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4878,hsa:1812,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:85366,hsa:6464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8743,hsa:8795,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:808,hsa:815,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5526,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22798,hsa:3688,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:7529,hsa:673,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:5156,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1460,hsa:147700,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2052,hsa:1646,ECrel,compound,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:9223,hsa:3444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5770,hsa:3643,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:102723407,hsa:9103,PPrel,binding/association,path:hsa05140 Leishmaniasis,1,0.5
hsa:2778,hsa:111,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:79660,hsa:197259,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5535,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1395,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4852,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5506,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3624,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4793,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
cpd:C00334,hsa:55276,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:5290,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:80310,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:55879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:842,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5568,hsa:4886,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:116443,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:2786,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:673,hsa:5605,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:388585,hsa:3683,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:5770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:3135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3443,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:10488,hsa:5173,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:148022,hsa:5208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7046,hsa:4087,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:3082,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:3710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:5507,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:5564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5414,hsa:332,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:3551,hsa:4792,PPrel,phosphorylation,path:hsa05164 Influenza A,2,0.8
hsa:5906,hsa:5296,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6750,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:10681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:116,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:10891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:4794,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:51806,hsa:5533,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:25780,hsa:5908,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1942,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2917,hsa:2771,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:5524,hsa:4137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:4170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5566,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9568,hsa:4794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:2946,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:5535,hsa:572,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5499,hsa:64764,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1946,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:26281,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:284,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
path:hsa00051,hsa:80201,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,3,0.5
hsa:2717,hsa:2717,ECrel,compound,path:hsa00052 Galactose metabolism,2,0.5
hsa:59345,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:8517,hsa:5970,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9456,hsa:3709,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:51806,hsa:107,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1576,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:673,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
cpd:C00212,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:57172,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1950,hsa:1398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5563,hsa:6513,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5330,cpd:C00165,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:8817,hsa:3655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2695,hsa:139760,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1857,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5733,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9965,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8503,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:4715,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:54539,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:207,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:11035,hsa:5834,PPrel,phosphorylation,path:hsa04217 Necroptosis,1,0.8
hsa:673,hsa:5605,PPrel,phosphorylation,path:hsa05216 Thyroid cancer,3,0.8
hsa:5908,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4804,hsa:398,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2253,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00533,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5566,hsa:572,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2912,hsa:3355,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7040,hsa:4843,PPrel,inhibition,path:hsa05140 Leishmaniasis,1,0.8
hsa:3351,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2246,hsa:5509,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9456,hsa:3710,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
cpd:C22381,hsa:5337,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C00575,hsa:255189,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:154,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1908,hsa:134,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:57818,cpd:C00031,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:208,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:64764,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C01996,hsa:331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:114,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7010,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:284,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3717,hsa:6773,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:7317,hsa:90673,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:55970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79660,hsa:2998,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:1944,hsa:6464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5155,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:27006,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2717,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6531,hsa:6804,PPrel,binding/association,path:hsa05031 Amphetamine addiction,2,0.5
cpd:C00780,hsa:3352,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4780,hsa:119391,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:5563,hsa:57521,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:1634,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:1398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5594,hsa:90993,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1559,hsa:8605,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:9021,hsa:8660,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:64764,hsa:5173,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:5535,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:163688,hsa:112,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7048,hsa:5519,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:1558,hsa:255189,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5582,hsa:5894,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2214,hsa:5579,ECrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:3716,hsa:6772,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5582,hsa:8737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:9103,hsa:5579,ECrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:801,hsa:5532,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:26291,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5568,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:2277,hsa:103,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:8644,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:10000,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:54331,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C11310,hsa:4540,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:91860,hsa:5535,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:10000,hsa:572,PPrel,phosphorylation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:6898,hsa:54205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:5595,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:3303,hsa:7097,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:3661,hsa:3448,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:3665,hsa:3443,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:56034,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4254,hsa:1958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79602,hsa:5465,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:7852,hsa:3442,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4915,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3665,hsa:3442,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:2069,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3665,hsa:3444,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:2778,hsa:4707,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5533,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:56034,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6197,hsa:7222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2550,hsa:2782,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:54518,hsa:5140,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5509,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2913,hsa:1558,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11345,hsa:2562,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:3845,hsa:5290,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:7422,hsa:5105,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2918,hsa:10681,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5562,hsa:32,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:2917,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:64764,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:7531,hsa:673,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:10000,hsa:1386,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9246,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:805,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,cpd:C00575,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7419,hsa:54205,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3134,hsa:567,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:8074,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4915,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3451,hsa:5908,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:196883,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2915,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:27330,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4886,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5608,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26508,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3449,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:596,hsa:578,PPrel,inhibition,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:5366,hsa:5609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:268,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:801,hsa:111,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2770,hsa:146850,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00547,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64764,hsa:4170,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:5663,hsa:6263,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4908,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8323,hsa:1856,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:25759,hsa:2549,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
cpd:C00788,hsa:1394,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1432,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3441,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:5335,hsa:5580,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5579,hsa:6531,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
cpd:C00076,hsa:5532,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1499,hsa:6932,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:3064,hsa:6392,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2771,hsa:5290,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2277,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:6775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5571,hsa:6513,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
cpd:C15231,hsa:29796,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1756,hsa:60,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:2720,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5140,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:208,hsa:8517,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7852,hsa:2790,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:27123,hsa:54361,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:805,hsa:5534,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5595,hsa:478,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5908,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:3448,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1234,hsa:55276,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:8737,GErel,expression,path:hsa04217 Necroptosis,1,0.5
hsa:440275,hsa:3551,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:816,hsa:113,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:65018,hsa:4535,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:11211,hsa:1855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:11035,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8074,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4294,hsa:5609,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1459,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4916,hsa:2885,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:3661,hsa:3441,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:801,hsa:5535,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:100506742,hsa:836,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3265,hsa:5293,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:3479,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9945,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:4846,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:5623,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9564,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6932,hsa:4609,GErel,expression,path:hsa05216 Thyroid cancer,1,0.5
cpd:C00575,hsa:5568,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2770,hsa:5295,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:117145,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:284,hsa:2790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2785,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:4893,hsa:5894,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3845,hsa:673,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:818,hsa:196883,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00212,hsa:1129,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2309,hsa:1027,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:117,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:801,hsa:814,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:9252,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00575,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,cpd:C05981,PCrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5532,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8823,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:388585,hsa:2064,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:5516,hsa:3765,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2784,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5582,hsa:2002,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2246,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:5602,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:221,hsa:314,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:5595,hsa:7040,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:64764,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:4254,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7186,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5608,hsa:5603,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4254,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2913,hsa:5567,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01996,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:3352,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3455,hsa:2905,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:2569,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:116,hsa:153,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C11310,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:26007,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:53358,path:hsa00400,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:4843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2069,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5594,hsa:148327,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:8313,hsa:324,PPrel,binding/association,path:hsa05224 Breast cancer,1,0.5
hsa:4609,hsa:1030,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:2475,hsa:6198,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1908,hsa:2920,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2668,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5900,hsa:5880,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6197,hsa:3460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5533,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5333,hsa:3800,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:23236,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5566,hsa:2309,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:3455,hsa:3716,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:10488,hsa:4170,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:10681,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C00547,hsa:3112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:815,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3718,hsa:6774,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1945,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4803,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1969,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:59345,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3099,hsa:5211,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5295,hsa:5590,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5894,hsa:2793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:1147,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6774,hsa:5443,GErel,expression,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:92552,hsa:3709,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8660,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2185,hsa:1399,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:3479,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7424,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3551,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:595,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:6667,hsa:7709,PPrel,binding/association,path:hsa05202 Transcriptional misregulation in cancer,1,0.5
hsa:10971,hsa:5894,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:207,hsa:10488,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1460,hsa:3831,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:10681,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1460,hsa:147700,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:2277,hsa:94235,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:5143,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00334,hsa:2561,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:1945,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00410,hsa:5241,PCrel,binding/association,path:hsa05224 Breast cancer,1,0.5
hsa:58494,hsa:7082,PPrel,binding/association,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:7252,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:2746,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1839,hsa:1956,PPrel,activation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:5894,hsa:4637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:5579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3098,hsa:5236,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
hsa:8503,hsa:10000,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:657,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:208,hsa:5571,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5155,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:4193,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:8823,hsa:1813,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5562,hsa:7311,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,cpd:C05981,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:6772,hsa:5880,no_relation,no_relation,no_relation,no_relation,0.0
hsa:111,cpd:C00575,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:7424,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:57506,hsa:3551,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:3101,hsa:55276,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
hsa:4301,hsa:5144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:1816,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
hsa:7358,hsa:7360,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:2932,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:3448,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:4637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1399,hsa:2889,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6197,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:4637,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2775,hsa:8503,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:94235,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2912,hsa:157,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:94235,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:148022,hsa:7187,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2885,hsa:6655,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:51378,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51176,hsa:595,GErel,expression,path:hsa05216 Thyroid cancer,1,0.5
hsa:8835,hsa:6776,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1908,hsa:3352,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1131,hsa:2776,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5600,hsa:2920,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:59345,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:7046,hsa:4088,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:2775,hsa:5330,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1571,hsa:5322,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5295,hsa:23439,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1950,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2250,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:102723407,hsa:5208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57506,hsa:1147,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:6195,hsa:126328,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01312,hsa:2905,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:598,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:10000,hsa:2309,PPrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C00584,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5515,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4780,hsa:2948,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:5509,hsa:5834,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:10018,hsa:596,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:818,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1906,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6195,hsa:3265,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2914,hsa:2790,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C05981,hsa:208,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1756,hsa:71,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:5578,hsa:1386,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:2912,hsa:51764,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7424,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2069,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:818,hsa:5141,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:392255,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:10327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5465,hsa:1375,GErel,expression,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:5601,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:2949,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9945,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1499,hsa:2548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:8536,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5568,hsa:116443,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:841,hsa:637,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:80310,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:116443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:486,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2903,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:11035,hsa:5601,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:29904,hsa:1938,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4908,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2064,hsa:8681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2668,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51176,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4914,hsa:5335,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:11345,hsa:2568,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
cpd:C00584,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4854,hsa:23493,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:5058,hsa:3984,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4301,hsa:5210,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2695,hsa:3973,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2641,hsa:139760,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5601,hsa:8471,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:55844,hsa:10645,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:1386,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5499,hsa:148327,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:26291,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4709,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2783,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:163688,hsa:57118,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4878,hsa:6794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5925,hsa:4886,no_relation,no_relation,no_relation,no_relation,0.0
hsa:958,hsa:3593,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
cpd:C00212,hsa:1395,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1544,hsa:8398,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:107,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5515,hsa:6198,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5154,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3456,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:3665,hsa:3442,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:5567,hsa:2737,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5567,hsa:490,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2914,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:2782,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84335,hsa:6198,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:130589,hsa:2717,ECrel,compound,path:hsa00052 Galactose metabolism,4,0.5
cpd:C00780,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5599,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1460,hsa:3799,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:2475,hsa:6198,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:4804,hsa:92579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7074,hsa:2906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:222,hsa:314,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:2255,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:11345,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:8503,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2249,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:246,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:123745,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6776,hsa:595,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:2805,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8817,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3690,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23493,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4914,hsa:10818,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1950,hsa:5322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:112,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1457,hsa:89953,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:4301,hsa:6494,PPrel,inhibition,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9568,hsa:2784,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:55012,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8517,hsa:4792,PPrel,phosphorylation,path:hsa05164 Influenza A,1,0.8
hsa:5567,hsa:776,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5155,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:64208,hsa:3776,PPrel,binding/association,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:5332,hsa:126328,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:572,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
cpd:C00025,hsa:2903,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:650,hsa:805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:285,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3693,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:8681,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:6093,hsa:5500,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5601,hsa:2558,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:1398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23683,hsa:2906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:108,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5501,hsa:84699,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5595,hsa:57818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5567,hsa:2903,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:10000,hsa:112,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:9568,hsa:6194,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C07593,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:90993,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:1435,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3569,hsa:6774,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:6300,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:4772,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5594,hsa:2002,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:84152,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7157,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:5506,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:8399,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2249,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6774,hsa:6514,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
cpd:C15231,hsa:440567,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5579,hsa:5594,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:3479,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8503,hsa:483,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:8321,hsa:116444,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:5170,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:6777,hsa:8737,GErel,expression,path:hsa04217 Necroptosis,1,0.5
hsa:90,hsa:659,PPrel,binding/association,path:hsa04350 TGF-beta signaling pathway,2,0.5
hsa:3480,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,cpd:C05981,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2791,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7332,hsa:7311,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:51422,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7533,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:8644,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:5568,hsa:57818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1234,hsa:2787,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:7297,hsa:6772,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5567,hsa:2905,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5595,hsa:9568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5610,hsa:8517,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2252,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2250,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5533,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8321,hsa:1857,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3953,hsa:11035,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3693,hsa:9821,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5598,hsa:6197,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2323,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:3627,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
cpd:C15231,hsa:10975,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5290,hsa:208,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3716,hsa:6772,PPrel,activation,path:hsa05164 Influenza A,2,0.8
hsa:56034,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6093,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:637,hsa:2893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5331,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:2773,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5295,hsa:486,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3717,hsa:53358,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:51764,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5604,hsa:5594,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:1946,hsa:5173,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7253,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:958,hsa:155,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:5970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3630,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:841,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2932,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:801,hsa:5532,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:52,hsa:5747,PPrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:56034,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4254,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1946,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2261,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7046,hsa:4088,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:3265,hsa:4705,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5608,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:8644,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:6776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2932,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5294,cpd:C05981,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:56034,hsa:920,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:3362,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:25805,hsa:658,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5594,hsa:1816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10411,hsa:5906,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C05981,hsa:207,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3305,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:116,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7533,hsa:2309,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1946,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6772,hsa:3442,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7976,hsa:1857,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:1649,hsa:596,PPrel,inhibition,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:208,hsa:567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4792,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:26281,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5071,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:6548,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
cpd:C04549,hsa:5210,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2773,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa04917 Prolactin signaling pathway,1,0.8
cpd:C01245,hsa:3708,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:285,hsa:779,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2212,hsa:5579,ECrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:1943,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:810,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3627,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:5598,hsa:595,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:3082,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:5140,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5602,hsa:3684,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11069,hsa:5599,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2254,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:107,cpd:C00575,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:8503,hsa:10000,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8717,hsa:7186,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2783,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:10645,hsa:8536,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2914,hsa:2771,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:2254,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4804,hsa:5291,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:54331,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:958,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2775,hsa:6714,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6750,hsa:3352,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:810,hsa:5533,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7133,hsa:7186,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:2252,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26281,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:627,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:7040,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2668,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:5142,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:5291,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
cpd:C00076,hsa:801,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2775,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5296,hsa:5170,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:107,cpd:C00575,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:3460,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:5580,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51764,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:91860,hsa:816,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8471,hsa:8503,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5595,hsa:486,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
cpd:C00165,hsa:6352,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5228,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1268,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:3441,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3310,hsa:7097,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
cpd:C11310,hsa:4711,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5293,cpd:C05981,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:231,hsa:2919,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5414,hsa:331,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:5579,hsa:3444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1080,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4261,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:5599,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:2773,hsa:114,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1457,hsa:3799,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:5566,hsa:3294,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:3915,hsa:3655,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:7252,hsa:154,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8326,hsa:1857,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2790,hsa:2982,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10488,hsa:7040,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:192111,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:1432,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2917,hsa:2783,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2885,hsa:6655,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3643,hsa:8660,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:1942,hsa:2550,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9451,hsa:3551,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:7422,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:650,hsa:90,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,2,0.8
cpd:C01245,hsa:3710,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:3815,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:207,hsa:8517,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:4793,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8074,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5500,hsa:84699,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2784,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:1375,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7039,hsa:4731,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5144,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9246,hsa:7311,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:10000,hsa:4846,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3626,hsa:4537,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:476,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:23411,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5623,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8823,hsa:7476,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:1388,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:816,hsa:3446,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5606,hsa:1432,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:374,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2773,hsa:8399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1906,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1544,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5563,hsa:32,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5567,hsa:1544,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:4893,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
cpd:C00584,hsa:5734,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:126129,hsa:2181,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:1962,hsa:5144,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00052,hsa:57016,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:3690,hsa:60,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:2773,hsa:5330,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00025,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:1499,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5468,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:5836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5602,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2668,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:111,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:2255,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8324,hsa:1857,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:801,hsa:2560,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4717,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5595,hsa:8681,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:10062,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:3350,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3479,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2250,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1571,hsa:54979,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:1944,hsa:840,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1557,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:2215,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:50487,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:4137,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2786,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5908,hsa:2791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:70,hsa:7168,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:112,cpd:C00575,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1962,hsa:2639,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:7317,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:50487,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9965,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4893,hsa:5290,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5906,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:468,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5499,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2913,hsa:2790,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C03758,hsa:1812,PCrel,activation,path:hsa05031 Amphetamine addiction,3,0.8
hsa:4803,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:163688,hsa:114,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00076,hsa:163688,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,2,0.8
hsa:5293,hsa:5170,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4790,hsa:3451,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5568,hsa:4772,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7318,hsa:7314,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:2254,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8517,hsa:4792,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:2771,hsa:3763,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1388,hsa:5173,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:9455,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:818,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3661,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:817,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5781,hsa:6714,PPrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2788,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:11273,hsa:3709,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:27123,hsa:7476,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2246,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2252,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51378,hsa:117,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6778,hsa:8737,GErel,expression,path:hsa04217 Necroptosis,1,0.5
hsa:3667,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1379,hsa:5743,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:3447,hsa:3454,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:7252,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9568,hsa:2791,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:5523,hsa:1586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:317,hsa:842,PPrel,binding/association,path:hsa05160 Hepatitis C,1,0.5
hsa:91860,hsa:324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:627,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:64764,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:137362,path:hsa00400,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:2695,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:9252,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6196,hsa:5506,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:285,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8817,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2212,hsa:6300,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:146850,cpd:C05981,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5608,hsa:5600,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:112,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3441,hsa:3454,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5563,hsa:2538,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5563,hsa:90673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2261,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2254,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4878,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2695,hsa:1816,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51764,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2323,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5295,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5534,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
cpd:C01312,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4282,hsa:259307,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
cpd:C00076,hsa:5578,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:208,hsa:2308,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:7423,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2323,hsa:1909,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:5585,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2250,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7422,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:64600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2203,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:4717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5534,hsa:4772,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5623,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5578,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4638,hsa:6237,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1649,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7409,hsa:5881,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:3284,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:578,hsa:823,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:137362,hsa:5053,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:5588,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:113,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4725,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8660,hsa:894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:1386,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:7010,hsa:2568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:1394,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:79444,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5608,hsa:5603,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:80310,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:3655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2904,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6750,hsa:1129,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:56034,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7852,hsa:2783,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:51806,hsa:816,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5908,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:5908,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1909,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5295,hsa:481,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5567,hsa:116444,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:207,hsa:2309,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:7423,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2069,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5594,hsa:90993,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:1573,hsa:100137049,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:6772,hsa:3126,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:208,hsa:7388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:5595,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5500,hsa:10488,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1081,hsa:1394,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
hsa:5293,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:135,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1234,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2892,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3845,hsa:5894,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:10000,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4193,hsa:7157,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5598,hsa:30814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:111,cpd:C00575,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:51806,hsa:5534,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:810,hsa:5534,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5568,hsa:776,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:3914,hsa:3655,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:2784,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5567,hsa:2892,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2805,path:map00960,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:10818,hsa:1399,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2792,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C00334,hsa:2567,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:2793,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:4893,hsa:5894,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:57121,hsa:6262,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7529,hsa:5894,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:6197,hsa:5506,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:26281,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:284,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1234,hsa:2773,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:9965,hsa:2917,no_relation,no_relation,no_relation,no_relation,0.0
hsa:834,hsa:3553,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:163688,hsa:111,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5608,hsa:5565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C15231,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:3265,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:23236,cpd:C00165,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4804,hsa:51135,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2791,hsa:4217,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:5499,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2215,hsa:1432,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:90,hsa:4087,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:2641,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:5290,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5532,hsa:4772,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:64764,hsa:1958,GErel,expression,path:hsa05020 Prion disease,1,0.5
hsa:1435,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:810,hsa:3354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:5578,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9021,hsa:6774,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:3973,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:3725,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3082,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:387,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:116443,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:4881,hsa:330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:2203,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:53358,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:8817,hsa:7494,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57172,hsa:3383,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:391013,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:146850,hsa:231,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:54361,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5608,hsa:6300,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2775,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5566,hsa:3360,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1459,hsa:64837,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:5728,cpd:C05981,PCrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5608,hsa:5600,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5595,hsa:64764,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:71,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:85366,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:224,path:hsa00640,maplink,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:51378,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1436,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6652,hsa:3099,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:208,hsa:1388,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:2309,PPrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:208,hsa:4846,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:493,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:801,hsa:818,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8823,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C22381,hsa:52,PCrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5599,hsa:3725,PPrel,activation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:2793,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:23236,hsa:53358,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:3725,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:51806,hsa:815,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2277,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1386,hsa:2353,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:2885,hsa:6654,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:1544,hsa:55970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:4638,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4803,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:842,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2806,path:hsa00400,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:6932,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:3708,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
path:hsa00520,hsa:3098,maplink,compound,path:hsa00051 Fructose and mannose metabolism,2,0.5
hsa:2773,hsa:53358,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:196883,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:56034,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7423,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5530,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:480,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:818,hsa:5143,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:11035,hsa:2747,PPrel,phosphorylation,path:hsa04217 Necroptosis,1,0.8
hsa:815,hsa:5139,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1558,hsa:84647,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
cpd:C01312,hsa:6714,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9455,hsa:146850,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3456,hsa:55062,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:8503,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:51764,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:1944,hsa:5834,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4698,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5523,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5565,hsa:2475,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:9456,hsa:9454,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,2,0.5
hsa:1909,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10000,hsa:111,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2778,hsa:113,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:2893,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:55626,hsa:8678,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00165,hsa:5579,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:285,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00951,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2997,cpd:C00369,PCrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:5568,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7494,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5336,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:4698,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55740,hsa:60,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2248,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4915,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:2564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10818,hsa:1398,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:84699,hsa:3725,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:6195,hsa:53358,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:4254,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5568,hsa:2903,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1392,hsa:135,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3082,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3310,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:10000,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5579,hsa:5595,PPrel,phosphorylation,path:hsa05140 Leishmaniasis,1,0.8
hsa:92579,hsa:6531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2260,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:2787,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:3717,hsa:8503,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1944,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:284,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:7297,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:230,no_relation,no_relation,no_relation,no_relation,0.0
hsa:134,hsa:2770,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:208,hsa:9586,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5293,hsa:3845,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5732,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2321,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4794,hsa:1616,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:84647,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:8322,hsa:1857,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:246,hsa:3362,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:8503,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:65018,hsa:4715,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:387,hsa:60,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5293,hsa:478,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3480,hsa:5290,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:5021,hsa:775,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:9021,hsa:5837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4853,hsa:2064,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:808,hsa:5530,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:51806,hsa:259307,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4254,hsa:3690,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3625,hsa:92,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:817,hsa:5139,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:80310,hsa:7381,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:1385,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51806,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:2081,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4878,hsa:3352,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:107,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2773,hsa:5331,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:94235,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2247,hsa:1812,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:115,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C22381,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2914,hsa:2770,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:7039,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00547,hsa:3684,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1499,hsa:83439,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:80201,hsa:2720,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:1386,hsa:5173,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:30837,hsa:3717,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5578,hsa:6548,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:10000,hsa:57521,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:2805,hsa:7484,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3448,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:7360,path:hsa00040,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:94235,hsa:153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3725,hsa:7124,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:3098,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10319,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:5021,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5335,cpd:C00076,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5293,hsa:486,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:4803,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2251,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5228,hsa:3456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:154,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5535,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:122809,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:30837,hsa:6776,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:55970,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5291,hsa:578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:817,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
cpd:C05981,hsa:208,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:5210,hsa:2203,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5335,hsa:3101,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:135,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4190,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:90993,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
cpd:C00780,hsa:3440,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:7054,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5021,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:11069,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:182,hsa:4855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
cpd:C00165,hsa:5578,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2251,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1558,hsa:5320,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:27006,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5578,hsa:23683,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8324,hsa:1855,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:208,hsa:2475,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:90993,hsa:3725,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:1459,hsa:89953,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:4794,hsa:6446,no_relation,no_relation,no_relation,no_relation,0.0
hsa:995,hsa:5139,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:483,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:6622,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3552,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:5209,hsa:5213,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:208,hsa:572,PPrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:8503,hsa:478,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5291,hsa:3265,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5567,hsa:2890,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3440,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6776,hsa:2645,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5571,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10411,hsa:6237,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7010,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3440,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:3665,hsa:3447,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:26291,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4851,hsa:23462,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:4851,hsa:388585,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:1557,hsa:54979,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:4893,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:4088,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:71,hsa:10398,PPrel,binding/association,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:54331,hsa:54331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1907,hsa:2565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:111,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4916,hsa:53358,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5207,hsa:5214,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:1950,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5594,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5565,hsa:2538,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
cpd:C00212,hsa:7253,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2770,hsa:3765,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5568,hsa:3362,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:5564,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
cpd:C05981,hsa:5170,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5535,hsa:2932,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5208,hsa:2203,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5291,hsa:10000,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2534,hsa:1394,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5599,hsa:3725,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:834,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C00788,hsa:3360,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6772,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1906,hsa:3351,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10000,hsa:2932,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:7157,hsa:581,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5594,hsa:84699,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00547,hsa:5836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:330,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9455,hsa:2911,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:1908,hsa:4886,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7855,hsa:1855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:22798,hsa:51380,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2915,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:999,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55879,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:27006,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6750,hsa:4886,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5881,hsa:5058,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5595,hsa:3350,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2309,hsa:3312,GErel,expression,path:hsa04213 Longevity regulating pathway - multiple species,1,0.5
hsa:2792,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:27006,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6622,hsa:4701,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:80201,hsa:4790,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4704,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3630,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2787,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2773,hsa:9817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:27006,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:84335,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:11069,hsa:22800,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5565,hsa:5105,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:8322,hsa:1855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5296,hsa:208,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2778,hsa:111,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:6688,hsa:2209,GErel,expression,path:hsa05202 Transcriptional misregulation in cancer,1,0.5
hsa:2323,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2254,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2771,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:91860,hsa:57172,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:83593,hsa:3689,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:26281,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5021,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2791,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C00334,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:8517,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:4909,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2641,hsa:7253,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5500,hsa:10488,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:8835,hsa:6772,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:3443,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6198,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2668,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1946,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:808,hsa:5532,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:3630,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7186,hsa:3551,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5566,hsa:2902,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:27006,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:222,hsa:4129,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:4916,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1459,hsa:89953,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:54518,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:7137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9021,hsa:3667,PPrel,inhibition,path:hsa04931 Insulin resistance,2,0.8
hsa:7039,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5604,hsa:5594,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:2778,hsa:111,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:3718,hsa:6775,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:284,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5568,hsa:5139,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1081,hsa:3362,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
hsa:5970,hsa:659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:26281,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:207,hsa:2932,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:805,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:246,hsa:255189,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5566,hsa:4843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4728,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:572,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4087,hsa:8772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:8605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:492,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:109,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8517,hsa:1559,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:8503,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:57818,hsa:5236,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:3099,hsa:3352,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4804,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9455,hsa:3709,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:598,hsa:578,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,2,0.8
hsa:1559,hsa:100137049,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:7422,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3973,hsa:2778,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:2253,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00051,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:3351,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5567,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:4886,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3082,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8323,hsa:1855,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2776,hsa:3845,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1559,hsa:30814,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2250,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9945,path:hsa00010,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:8822,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9306,hsa:3717,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5330,cpd:C00076,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5623,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1909,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:5908,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:5501,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:9978,hsa:920,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3551,hsa:1111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5291,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6622,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6622,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5522,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3452,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2912,hsa:2786,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C01312,hsa:153,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7317,hsa:1129,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9246,hsa:7316,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:4908,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:5465,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:22800,hsa:5338,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5610,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2892,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:387,hsa:9475,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:27113,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5588,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2308,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:4780,hsa:2940,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:9456,hsa:9456,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,2,0.5
hsa:3630,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1950,hsa:6262,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11337,hsa:2567,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:3654,hsa:7189,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:815,hsa:6714,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7046,hsa:4087,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5595,hsa:9586,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8817,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2775,hsa:91860,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:39,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5481,hsa:10105,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:23566,hsa:2776,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1392,hsa:3360,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2932,hsa:3800,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00788,hsa:3351,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2918,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:5350,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:23683,hsa:5906,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5623,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:284,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4915,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:6262,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:1385,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:3918,hsa:3655,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:2252,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1576,hsa:391013,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5595,hsa:84699,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1956,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:1728,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5506,hsa:5837,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:8835,hsa:6774,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:3480,hsa:5295,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:805,hsa:5141,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1902,hsa:4193,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:8517,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2906,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:1950,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5608,hsa:6300,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2790,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2250,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2788,hsa:126328,no_relation,no_relation,no_relation,no_relation,0.0
hsa:102723407,hsa:2212,PPrel,binding/association,path:hsa05140 Leishmaniasis,1,0.5
hsa:5154,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:595,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:27330,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5598,hsa:6196,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4780,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51094,hsa:5465,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:3481,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:196883,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7534,hsa:2309,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4254,hsa:483,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:572,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6712,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:5170,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2534,hsa:3798,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:5834,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5533,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:91860,hsa:8536,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6197,hsa:4893,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1457,hsa:56924,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5580,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:5881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:817,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6622,hsa:54539,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6195,hsa:5500,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:163688,hsa:3553,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9655,hsa:3717,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2785,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2252,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2784,hsa:4794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5142,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7124,hsa:7132,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:805,hsa:5533,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:673,hsa:774,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:207,PCrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:9451,hsa:1965,PPrel,phosphorylation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
path:map00960,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3449,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:3480,hsa:5293,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
cpd:C00334,hsa:9568,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00780,hsa:139760,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1234,hsa:2771,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:6885,hsa:5594,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5228,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6772,hsa:6514,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:2885,hsa:6655,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2792,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7318,hsa:6233,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:51806,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9586,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:1816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:818,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:834,hsa:3553,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:2773,hsa:113,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4790,hsa:4843,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:7124,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:116,hsa:154,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:107,cpd:C00575,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3326,hsa:7157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:1385,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:51764,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:217,hsa:51733,ECrel,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:5566,hsa:776,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:26291,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4217,hsa:2563,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00165,hsa:5581,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:2791,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2550,hsa:3627,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:6772,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5606,hsa:5600,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:6093,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2913,hsa:2773,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:79660,hsa:2997,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:5533,hsa:27089,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2308,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:816,hsa:5139,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3452,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:246,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:627,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1945,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5610,hsa:1147,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2917,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4233,hsa:810,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:3459,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:595,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:5154,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:54205,hsa:1813,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:9882,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5468,hsa:6258,PPrel,binding/association,path:hsa05216 Thyroid cancer,1,0.5
hsa:5443,hsa:25865,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4855,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2668,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2786,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:801,hsa:5532,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8503,cpd:C05981,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51806,hsa:818,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3082,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1392,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:115,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:163688,hsa:816,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5170,hsa:3973,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:153,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7852,hsa:2791,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:10000,hsa:5970,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5211,path:hsa00010,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
cpd:C00547,hsa:3351,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27121,hsa:7473,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3098,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:84699,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6196,hsa:5507,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:4254,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2249,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1857,hsa:2932,PPrel,inhibition,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5159,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:163688,PCrel,binding/association,path:hsa05031 Amphetamine addiction,2,0.5
hsa:3439,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5601,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:9475,hsa:91807,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:116,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:5296,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5564,hsa:2475,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:4233,hsa:2885,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:2773,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:207,hsa:2932,PPrel,phosphorylation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5879,hsa:5290,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2250,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55526,hsa:1743,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:10488,hsa:2353,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:1460,hsa:147700,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:6774,hsa:2645,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5533,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5970,hsa:596,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:340061,hsa:29110,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:65018,hsa:4713,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:80310,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4087,hsa:4089,PPrel,binding/association,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:27006,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:11035,hsa:5836,PPrel,phosphorylation,path:hsa04217 Necroptosis,1,0.8
hsa:4790,hsa:55970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1129,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2534,hsa:5296,PPrel,activation,path:hsa05020 Prion disease,1,0.8
cpd:C00584,hsa:1395,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27006,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:776,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
cpd:C00334,hsa:2893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83439,hsa:595,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:1907,hsa:3350,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2786,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2793,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5295,hsa:5879,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:8651,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2673,hsa:3098,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:3551,hsa:4793,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:8817,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:468,hsa:2353,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:2783,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:596,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:3265,hsa:369,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:2770,hsa:109,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5291,hsa:208,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1644,hsa:8639,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:578,hsa:824,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:91860,hsa:114,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C03758,hsa:139760,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8325,hsa:1857,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5604,hsa:126328,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:89953,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:51806,hsa:818,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2668,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5506,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:29904,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:1435,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:116443,hsa:5587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:834,hsa:5142,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:481,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1459,hsa:89953,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:6416,hsa:5601,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2912,hsa:54331,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5601,hsa:6300,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1946,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1557,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3626,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:596,GErel,expression,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:6093,hsa:5499,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2253,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1956,hsa:5295,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:3064,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,cpd:C00165,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4852,hsa:3351,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2983,cpd:C00942,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2247,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3451,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5599,hsa:64837,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7039,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5564,hsa:57818,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:718,hsa:3689,PPrel,binding/association,path:hsa05140 Leishmaniasis,1,0.5
hsa:5170,hsa:6513,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:4638,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2778,hsa:113,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5566,hsa:2906,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5606,hsa:1432,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:3630,hsa:3106,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8326,hsa:1856,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:8823,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1942,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5594,hsa:27330,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3665,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:658,hsa:4086,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,3,0.8
path:map00960,path:hsa00400,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:2246,hsa:57118,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6794,hsa:53632,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:2254,hsa:3655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4902,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1557,hsa:246,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2792,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5335,hsa:805,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:3551,hsa:3667,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:805,hsa:817,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00212,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:1645,GErel,expression,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:70,hsa:4625,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:229,hsa:8789,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:90993,hsa:5173,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:8651,hsa:7316,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8324,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:817,hsa:148327,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5594,hsa:8681,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:842,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9021,hsa:3717,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2246,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10681,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:801,hsa:817,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:4190,hsa:5105,ECrel,compound,path:hsa04964 Proximal tubule bicarbonate reclamation,1,0.5
hsa:7039,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10319,hsa:23401,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27330,hsa:79660,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5567,hsa:6720,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1457,hsa:147700,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:3691,hsa:60,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:5599,hsa:4539,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4878,hsa:2740,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4254,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5155,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1544,hsa:5322,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:80310,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:808,hsa:808,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:3265,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:2793,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5516,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2717,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,cpd:C01245,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:581,hsa:54205,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:7423,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:801,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C00076,hsa:91860,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:11035,hsa:818,PPrel,phosphorylation,path:hsa04217 Necroptosis,1,0.8
hsa:5599,hsa:2353,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:7533,hsa:5894,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:4780,hsa:4258,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:91860,hsa:339896,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:94235,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5567,hsa:116444,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
cpd:C00547,hsa:4940,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:10000,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5291,hsa:482,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1573,hsa:246,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:208,hsa:2932,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:53632,hsa:2905,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5293,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5894,hsa:26100,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:2353,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5208,hsa:8789,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5599,hsa:2353,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4851,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:4233,PPrel,activation,path:hsa05144 Malaria,1,0.8
hsa:1945,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2254,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5568,hsa:1586,GErel,expression,path:hsa04913 Ovarian steroidogenesis,2,0.5
cpd:C04549,hsa:53349,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4624,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6009,hsa:2475,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:207,hsa:148327,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1907,hsa:134,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2776,hsa:5330,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4803,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:810,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
hsa:2247,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51733,hsa:339896,ECrel,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:56034,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6237,hsa:51196,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4261,hsa:3123,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:7423,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2771,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:5337,hsa:23683,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3625,hsa:7042,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:3099,path:hsa00010,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5236,hsa:7360,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:658,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3643,hsa:8660,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:1576,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4881,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2917,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124454,cpd:C00031,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5728,cpd:C05981,PCrel,inhibition,path:hsa05224 Breast cancer,3,0.8
hsa:805,hsa:5535,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4803,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:4137,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:1129,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:4214,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:3725,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5582,hsa:283748,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4853,hsa:26508,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:2354,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:53632,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11345,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:9586,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:7132,hsa:8717,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5518,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:136,hsa:2776,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2250,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5155,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:23683,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:60,hsa:10398,PPrel,binding/association,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:4878,hsa:117,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2771,hsa:4794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5293,cpd:C05981,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:1813,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2254,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6195,hsa:90673,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:6772,hsa:3659,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5335,hsa:808,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C01245,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5908,hsa:7409,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1544,hsa:100137049,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:9370,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:578,hsa:54205,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:5296,hsa:5170,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8823,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:4793,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5605,hsa:3553,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2247,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:59283,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00076,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3643,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8503,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:6752,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3973,hsa:1586,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
cpd:C01996,hsa:1813,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:801,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:3845,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5608,hsa:5600,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2246,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3551,hsa:4790,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:22943,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11345,hsa:2561,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:3082,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:2254,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6237,hsa:5337,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00076,hsa:51806,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,2,0.8
hsa:11035,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107,cpd:C00575,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8651,hsa:4790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5588,hsa:3667,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:1234,hsa:2771,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5154,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9451,hsa:1147,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:7043,hsa:4843,PPrel,inhibition,path:hsa05140 Leishmaniasis,1,0.8
hsa:26291,hsa:139760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8322,hsa:1855,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:222,hsa:4128,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:814,hsa:111,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2247,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1234,hsa:2782,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8325,hsa:2997,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:3162,GErel,expression,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:2792,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5568,hsa:1871,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4852,hsa:1909,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2771,hsa:107,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5594,hsa:3265,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1956,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8326,hsa:1855,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4893,cpd:C00031,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8321,hsa:4843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2790,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2250,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:9564,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:369,hsa:5604,PPrel,phosphorylation,path:hsa05224 Breast cancer,3,0.8
hsa:2778,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4792,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5595,hsa:3798,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5534,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:6622,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11285,hsa:3107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:5610,GErel,expression,path:hsa04217 Necroptosis,1,0.5
hsa:5602,hsa:5600,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:9306,hsa:6777,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5236,path:hsa00010,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:4803,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4803,hsa:54518,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2990,hsa:7367,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:5595,hsa:6197,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5567,hsa:2182,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:657,hsa:4086,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:4909,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2914,hsa:2775,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:5566,hsa:491,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:92579,hsa:5236,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:4790,hsa:4846,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5519,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3667,hsa:8503,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:5566,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7465,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5894,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
cpd:C00076,hsa:801,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,2,0.8
hsa:2914,hsa:146850,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:5320,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2254,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3661,hsa:7124,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:5291,hsa:10000,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:148022,hsa:8517,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:805,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5568,hsa:1385,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:2550,hsa:2792,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:1943,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:102723407,hsa:6850,PPrel,binding/association,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:2249,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:122809,hsa:6772,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:27,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6196,hsa:5501,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5603,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2081,hsa:7186,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5606,hsa:5603,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6197,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:816,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:8651,hsa:3717,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2254,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:353500,hsa:659,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
cpd:C01245,hsa:3710,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5567,hsa:2309,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:3479,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2787,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:283106,hsa:3798,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:3481,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2773,hsa:3592,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:6622,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5535,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5579,hsa:4214,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5623,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:7360,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2254,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3446,hsa:4540,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:112,PPrel,inhibition,path:hsa04924 Renin secretion,1,0.8
hsa:8789,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:5139,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:356,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3683,hsa:3383,PPrel,binding/association,path:hsa05144 Malaria,2,0.5
hsa:1432,hsa:54205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8312,hsa:324,PPrel,binding/association,path:hsa05224 Breast cancer,1,0.5
hsa:2069,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3689,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:391013,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3098,path:hsa00051,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5568,hsa:5144,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1943,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4790,hsa:2919,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:134,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3458,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3309,hsa:9451,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:3352,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5906,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:85366,hsa:140465,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2787,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:1398,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5336,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4792,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:2778,hsa:114,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5609,hsa:5733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1392,hsa:3798,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3456,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:1644,hsa:259307,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:8817,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9965,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4793,hsa:847,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5533,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3665,hsa:3446,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:1946,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C11310,hsa:4728,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:801,hsa:115,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:208,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:126129,hsa:51703,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:3586,hsa:4843,PPrel,inhibition,path:hsa05140 Leishmaniasis,1,0.8
cpd:C11310,hsa:4719,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:114,cpd:C00575,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5579,hsa:6548,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:917,hsa:356,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C03758,hsa:134,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3082,hsa:140465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:5170,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:208,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
path:hsa00520,hsa:3101,maplink,compound,path:hsa00051 Fructose and mannose metabolism,2,0.5
hsa:5566,hsa:5144,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4790,hsa:7222,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:3667,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5609,hsa:5601,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2252,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3440,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:2913,hsa:2770,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
cpd:C05981,hsa:10000,PCrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:1234,hsa:3763,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9048,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5970,hsa:3444,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:2250,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:399694,hsa:6714,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
cpd:C00165,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23710,hsa:2556,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:5516,hsa:6263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2932,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C01996,hsa:1131,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00165,hsa:5578,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2790,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
path:hsa00052,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:7169,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:8471,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:6772,hsa:5610,GErel,expression,path:hsa04217 Necroptosis,1,0.5
hsa:5228,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2792,hsa:200959,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6257,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:4794,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:627,hsa:11035,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6750,hsa:808,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5582,hsa:5587,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5021,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:3799,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6197,hsa:3265,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3630,hsa:3643,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:9965,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:91807,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:23533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9655,hsa:6776,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2251,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5530,hsa:100137049,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:2203,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5535,hsa:4776,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:25759,hsa:5571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:3354,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C07593,hsa:7137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:137362,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:3109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6197,hsa:79660,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:7039,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:5563,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:207,hsa:2475,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:56034,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1856,hsa:23401,PPrel,binding/association,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:657,hsa:4086,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,3,0.8
cpd:C00076,hsa:5582,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8817,hsa:3303,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:53358,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1573,hsa:84647,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:3480,hsa:5296,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5567,hsa:2893,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:805,hsa:815,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3717,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:79660,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3101,hsa:5214,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
cpd:C01996,hsa:154,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:112,cpd:C00575,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5908,hsa:25865,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:25,hsa:23683,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C00575,hsa:5567,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5595,hsa:8681,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:116444,hsa:5609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8737,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2915,hsa:478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5623,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:114,cpd:C00575,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2251,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00076,hsa:5532,PCrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:818,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:5879,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:9945,hsa:3099,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:2790,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:8074,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:285,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:369,hsa:5605,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:51378,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:801,hsa:5535,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:57172,hsa:4846,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2787,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:4852,hsa:1813,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:283106,hsa:89953,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3716,hsa:6773,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:2770,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:27123,hsa:1395,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1133,hsa:2776,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2717,hsa:2720,ECrel,compound,path:hsa00052 Galactose metabolism,4,0.5
hsa:3630,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3845,hsa:2904,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6197,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3444,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5335,hsa:91860,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2668,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00780,hsa:7253,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:369,hsa:7849,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:595,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5602,hsa:8660,PPrel,inhibition,path:hsa04931 Insulin resistance,2,0.8
hsa:6093,hsa:4660,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6714,hsa:5291,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:2277,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:51806,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3098,hsa:5210,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:387,hsa:9475,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3101,hsa:2203,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:815,hsa:4790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:109,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:51422,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6776,hsa:2099,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:26281,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C01245,cpd:C00076,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:11337,hsa:2560,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:9048,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9965,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:815,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:5337,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:9048,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7043,hsa:7048,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5296,cpd:C05981,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2793,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:4909,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3911,hsa:4846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2784,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5443,hsa:153,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5607,hsa:5598,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5609,hsa:8681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:4301,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:55276,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:2953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5481,hsa:83447,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5214,hsa:2720,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83439,hsa:595,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:9021,hsa:6773,PPrel,inhibition,path:hsa05164 Influenza A,1,0.8
hsa:3815,hsa:51380,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5562,hsa:32,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:1742,hsa:2904,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:208,hsa:4846,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:65018,hsa:7043,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:140465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1129,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:7534,hsa:369,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:3717,hsa:5296,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:163688,hsa:85366,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00334,hsa:2558,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:130589,hsa:57016,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:3101,path:hsa00010,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2100,hsa:4609,GErel,expression,path:hsa05224 Breast cancer,2,0.5
hsa:2645,hsa:3447,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2770,hsa:108,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3630,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C03758,hsa:2550,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2778,hsa:112,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:8823,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4851,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:3991,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:208,hsa:2308,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:375189,hsa:71,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5595,hsa:3725,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:5610,hsa:23439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:627,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:163688,hsa:5534,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5567,hsa:10846,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3452,hsa:6714,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124454,path:hsa00250,maplink,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:2790,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:57818,hsa:6464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7422,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1576,hsa:134,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:10891,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:8660,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:4208,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:3630,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:776,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:246,hsa:50487,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:11035,hsa:197259,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:627,hsa:4804,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1499,hsa:9223,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:26281,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:122809,hsa:1816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:57521,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:1435,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4909,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5535,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5170,hsa:207,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5338,hsa:5587,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:163688,hsa:113,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5566,hsa:493,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10683,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3033,hsa:38,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:1944,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00212,hsa:3973,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4254,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8326,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:6199,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:91860,hsa:314,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2773,hsa:111,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:27006,hsa:3101,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:108,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5599,hsa:5603,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2770,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:2253,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:5579,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1909,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5594,hsa:100137049,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5567,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5604,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:9965,hsa:329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3442,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2990,hsa:54579,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
path:hsa00250,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5515,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5170,hsa:5585,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8651,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5468,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:1576,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:627,hsa:7040,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11345,hsa:2564,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:355,hsa:23533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1605,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4773,hsa:5743,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:5568,hsa:2512,no_relation,no_relation,no_relation,no_relation,0.0
hsa:116,hsa:5732,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3444,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3799,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6774,hsa:8600,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:1892,hsa:2639,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:637,hsa:581,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:7048,hsa:5139,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2538,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5595,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1544,hsa:11145,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:285,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4804,hsa:3355,no_relation,no_relation,no_relation,no_relation,0.0
hsa:388585,hsa:4609,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:2550,hsa:2786,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:658,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:818,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1457,hsa:3798,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5566,hsa:3991,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4804,hsa:5290,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5571,hsa:32,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:284,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5021,hsa:782,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4772,hsa:5997,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:2568,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:1946,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:779,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:810,cpd:C20640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:55012,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2247,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:27330,hsa:90673,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5529,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2248,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23493,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2917,hsa:10681,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:808,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:5599,PPrel,activation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:6774,hsa:2100,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5565,hsa:598,no_relation,no_relation,no_relation,no_relation,0.0
hsa:134,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10000,hsa:3441,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23710,hsa:2560,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:57521,hsa:6198,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:3350,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1969,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:80201,hsa:774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2247,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7424,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:317,no_relation,no_relation,no_relation,no_relation,0.0
hsa:79444,hsa:840,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:5291,hsa:1128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7360,path:hsa00053,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
cpd:C00334,hsa:3362,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:4886,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8503,hsa:476,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2246,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:4659,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2893,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2254,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2550,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4914,hsa:53358,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4893,hsa:5293,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:808,hsa:108,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5291,hsa:207,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:8503,hsa:1586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:9586,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5595,hsa:9586,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:4902,hsa:2790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2770,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:51135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:1558,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:4790,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11069,hsa:5906,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3626,hsa:3683,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1557,hsa:54331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:4846,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:7423,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:637,hsa:578,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:4803,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:4792,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:207,hsa:2932,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
cpd:C22381,hsa:1128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:196883,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00704,hsa:9817,PCrel,inhibition,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:6093,hsa:64600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3798,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:810,hsa:815,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:91860,hsa:4638,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5530,hsa:572,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:2918,hsa:2771,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:1457,hsa:3798,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:5605,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1457,hsa:64837,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:208,hsa:3551,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:572,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:4217,hsa:5606,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5571,hsa:84335,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2770,hsa:3125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:388585,hsa:1026,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:1459,hsa:3799,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C01996,hsa:2550,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:11345,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:673,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2914,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:6548,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5209,hsa:2203,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:208,hsa:2308,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2784,hsa:805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6898,hsa:4282,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:1385,hsa:3725,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:8503,cpd:C05981,PCrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:5170,hsa:10000,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C00575,hsa:11069,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4804,hsa:6272,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:8326,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7132,hsa:8717,PPrel,binding/association,path:hsa05160 Hepatitis C,1,0.5
hsa:91860,hsa:5532,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C05981,hsa:10000,PCrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:59345,hsa:163688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:117145,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:80201,hsa:5213,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:3448,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:6772,hsa:5747,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10131,hsa:54205,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00788,hsa:1812,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5582,hsa:999,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3030,hsa:1962,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:51806,hsa:107,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4659,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8324,hsa:578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5595,hsa:283748,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
path:hsa00520,hsa:3033,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:54979,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5155,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3480,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5481,hsa:7419,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5208,hsa:5214,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2788,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:80310,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3716,hsa:6772,PPrel,phosphorylation,path:hsa05140 Leishmaniasis,1,0.8
hsa:57506,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2212,hsa:5603,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:3661,hsa:4087,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:3551,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:2535,hsa:1856,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:163688,hsa:5534,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5879,hsa:5296,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:810,hsa:5530,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5595,hsa:3845,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:51733,hsa:51380,ECrel,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:51806,hsa:817,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4780,hsa:5879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:30001,hsa:9601,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:27123,hsa:7473,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
path:hsa00010,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:815,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2788,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1944,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C21013,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:5291,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8817,cpd:C00219,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:1385,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2792,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:998,hsa:71,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:11069,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:7475,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:84335,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2247,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:26291,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:9568,hsa:5610,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2773,hsa:5332,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:8074,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2264,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10681,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5603,hsa:2353,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5106,cpd:C00031,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:8681,hsa:10381,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3452,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:374,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2787,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5605,hsa:94235,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2977,hsa:840,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2247,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00165,hsa:5578,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2915,hsa:5743,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3445,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3800,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:2916,hsa:2770,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3551,hsa:4793,PPrel,activation,path:hsa05164 Influenza A,2,0.8
hsa:374,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7423,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3791,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:139760,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51378,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:3991,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4909,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5579,hsa:3667,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:5595,hsa:5562,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:163688,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4893,hsa:5894,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:5594,hsa:595,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:116,hsa:4843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:1813,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,cpd:C00704,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:374291,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:9568,hsa:2787,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:1435,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:123745,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3350,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:207,hsa:1027,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4893,hsa:5602,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:196883,cpd:C00575,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3480,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1460,hsa:5499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:3845,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2770,hsa:113,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1460,hsa:3799,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:8822,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3065,hsa:23411,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2791,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:6416,hsa:3351,no_relation,no_relation,no_relation,no_relation,0.0
hsa:28227,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3362,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26508,hsa:4791,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:355,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:91860,hsa:818,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:207,hsa:84335,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2250,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,cpd:C00044,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
hsa:3265,hsa:369,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3717,hsa:6776,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
cpd:C00533,hsa:3667,PCrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:80201,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2263,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:816,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2081,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3446,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:5291,hsa:1827,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3912,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:5602,PPrel,phosphorylation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:3667,hsa:5295,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:6777,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2737,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5623,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:11035,hsa:6609,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:51378,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7094,hsa:3674,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3446,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:815,hsa:10846,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6196,hsa:1394,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5293,hsa:5836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3800,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:26281,hsa:391013,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2354,hsa:23411,PPrel,binding/association,path:hsa05031 Amphetamine addiction,1,0.5
hsa:4261,hsa:3111,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5530,hsa:4776,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4893,hsa:8503,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5608,hsa:5600,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:7039,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3451,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2918,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7529,hsa:4694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5563,hsa:57818,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5568,hsa:2891,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6776,hsa:23439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:196883,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5594,hsa:23439,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3661,hsa:5294,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3099,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2904,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:56034,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:11211,hsa:1856,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00575,hsa:5568,PCrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:810,hsa:3684,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7157,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6196,hsa:5506,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:54518,hsa:7094,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:163688,hsa:815,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:8822,hsa:54979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:116444,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:3630,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2821,hsa:3127,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:134,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27123,hsa:89780,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2788,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:329,hsa:842,PPrel,inhibition,path:hsa05145 Toxoplasmosis,1,0.8
hsa:22943,hsa:7476,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1956,hsa:25759,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5295,hsa:480,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3098,hsa:5209,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:995,hsa:983,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8471,hsa:5290,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:6777,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5058,hsa:3985,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
path:hsa00520,hsa:6652,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:4790,hsa:2904,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:207,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C01312,hsa:117,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3626,hsa:93,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5293,cpd:C05981,PCrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:2209,hsa:5743,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:91860,hsa:57118,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:255189,hsa:3973,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3460,hsa:3718,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5293,cpd:C05981,PCrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:998,hsa:4217,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:654,hsa:658,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:26291,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:919,hsa:356,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2214,hsa:292,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:5743,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:5595,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5566,hsa:329,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:4790,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10681,hsa:5609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2911,hsa:116443,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4914,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4852,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3714,hsa:4851,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:6195,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:1147,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5332,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:468,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1909,hsa:51384,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:10000,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5159,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:801,hsa:112,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4615,hsa:51135,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:2066,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1557,hsa:30814,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:673,hsa:5605,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2475,hsa:6199,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:285,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00547,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:229,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2550,hsa:2790,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:816,hsa:5139,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:810,hsa:51806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5141,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:25759,hsa:4659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,hsa:5058,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:2308,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:65018,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2770,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:5603,hsa:2920,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:824,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2254,hsa:3351,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:481,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2793,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:810,hsa:815,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:8503,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:39,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:652,hsa:657,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,2,0.8
hsa:2252,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:673,hsa:5605,PPrel,phosphorylation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:3030,hsa:3033,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:2778,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:5565,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5610,hsa:3449,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:139760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:4090,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:3479,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1081,hsa:1812,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
hsa:6195,hsa:5509,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:207,hsa:2475,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1460,hsa:2911,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:8517,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4233,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5595,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2247,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3481,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3481,hsa:4794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3355,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:136,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1459,hsa:7097,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23462,hsa:7474,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4731,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2641,hsa:1394,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5601,hsa:8660,PPrel,phosphorylation,path:hsa04931 Insulin resistance,2,0.8
hsa:207,hsa:5208,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:91860,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:3303,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:5606,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:283106,hsa:147700,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3480,hsa:2791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29904,hsa:1938,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5567,hsa:6262,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4217,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
cpd:C00076,hsa:808,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2792,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:115,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,hsa:2752,PPrel,phosphorylation,path:hsa04217 Necroptosis,1,0.8
hsa:27330,hsa:468,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00025,hsa:5732,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1909,hsa:3759,PPrel,inhibition,path:hsa04924 Renin secretion,1,0.8
hsa:10379,hsa:4938,GErel,expression,path:hsa05164 Influenza A,1,0.5
cpd:C07593,hsa:4698,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2771,hsa:146850,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5582,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55970,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2251,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4852,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:255189,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:8822,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:6548,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5970,hsa:4843,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:6794,hsa:5563,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00165,hsa:5321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5663,hsa:6262,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4851,hsa:5565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2247,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6776,hsa:6514,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:8717,hsa:7186,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:208,hsa:5208,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:207,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8471,hsa:5295,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:4261,hsa:3108,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:51378,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1147,hsa:25759,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:8681,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:8681,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:64764,hsa:10891,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5566,hsa:778,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6197,hsa:3984,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:1743,no_relation,no_relation,no_relation,no_relation,0.0
hsa:124454,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:163688,hsa:818,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5533,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3443,GErel,expression,path:hsa05164 Influenza A,1,0.5
cpd:C00025,hsa:2906,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2246,hsa:5294,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1634,hsa:7040,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:11035,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3449,hsa:4794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:3759,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5970,hsa:3627,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:1908,hsa:1813,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:124454,hsa:10603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:55967,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C01245,hsa:3709,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:6195,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4915,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3459,hsa:3717,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:3911,hsa:5747,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2889,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283106,hsa:6262,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:1909,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5834,cpd:C00031,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:3630,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2308,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
cpd:C00575,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2902,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5518,hsa:2002,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,hsa:2891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83729,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:200186,hsa:5579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3439,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:6654,hsa:3265,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:816,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3714,hsa:4853,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5568,hsa:2903,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5336,hsa:292,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5580,hsa:5579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:10846,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2792,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:56034,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2248,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6714,hsa:5290,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2249,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1576,hsa:1573,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:283106,hsa:147700,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:2911,hsa:9454,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:5154,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2255,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:11035,hsa:5599,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:7852,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1813,hsa:2773,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8835,hsa:6777,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1946,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51378,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4804,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3440,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:1457,hsa:3798,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1950,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:387,hsa:8600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4909,hsa:4637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5579,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:5143,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2793,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:8737,hsa:293,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:2771,hsa:114548,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:3362,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5155,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00584,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2215,hsa:5743,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:7010,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2911,hsa:2904,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:23493,hsa:1026,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:2249,hsa:54205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:3265,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3791,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83729,hsa:7040,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:8817,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2246,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:115,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:229,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5509,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2641,hsa:1816,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1908,hsa:1909,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5337,hsa:25865,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C00076,hsa:111,PCrel,inhibition,path:hsa04924 Renin secretion,2,0.8
hsa:246,hsa:100137049,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:1942,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5566,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2889,hsa:5906,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8074,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:5058,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:3443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:1385,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:2253,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:11145,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5609,hsa:9451,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2793,hsa:7381,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:83447,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5623,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:80201,hsa:5214,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5582,hsa:84699,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5500,hsa:2997,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:2778,hsa:115,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3717,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:26279,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:3109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4852,hsa:1128,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00547,hsa:3800,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8313,hsa:10297,PPrel,binding/association,path:hsa05224 Breast cancer,1,0.5
hsa:5567,hsa:123745,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4535,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3845,hsa:5291,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5578,hsa:255189,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C00334,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:2919,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
cpd:C00334,hsa:4886,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:823,hsa:8851,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1557,hsa:1573,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:207,hsa:572,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5295,hsa:207,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2917,hsa:2792,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2791,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:5335,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:126792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1943,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6196,hsa:5507,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:673,hsa:1586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23533,hsa:5170,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5594,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6197,hsa:50487,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2214,hsa:5579,ECrel,compound,path:hsa05140 Leishmaniasis,1,0.5
hsa:2785,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:3265,hsa:9103,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5443,hsa:1395,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9965,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1395,hsa:6352,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:1375,GErel,expression,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:5908,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11273,hsa:4137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9568,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7124,hsa:7133,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:805,hsa:5319,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:2247,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:51196,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5880,hsa:57144,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5155,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4902,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6774,hsa:3630,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:1943,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2549,hsa:5290,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5156,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:673,hsa:5605,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:5582,hsa:123745,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C00165,hsa:5582,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1945,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:109,cpd:C00575,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:374,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5894,hsa:5605,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5609,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5610,hsa:1965,PPrel,phosphorylation,path:hsa05164 Influenza A,1,0.8
hsa:6794,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:2250,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10000,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3630,hsa:6197,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:26291,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5770,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:5894,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5207,path:hsa00010,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:1839,hsa:6548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:4707,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:6352,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:818,hsa:148022,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4908,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00788,hsa:153,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:1962,hsa:39,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:5535,hsa:3117,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5214,hsa:226,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2783,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
cpd:C07593,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7099,hsa:4615,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:55970,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6750,hsa:3354,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1942,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:23236,hsa:8795,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5330,cpd:C01245,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5582,hsa:148327,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5908,hsa:7410,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27243,hsa:197259,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:6774,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:5139,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5970,hsa:1435,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:10379,hsa:4599,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:4878,hsa:2983,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5216,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:818,hsa:5140,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5567,hsa:3351,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:3667,PPrel,phosphorylation,path:hsa04931 Insulin resistance,2,0.8
hsa:7097,hsa:4615,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:8503,hsa:208,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:148327,hsa:7220,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:5295,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:11337,hsa:2555,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:5567,hsa:2891,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2784,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2214,hsa:5603,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:2771,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3265,hsa:5599,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:10683,hsa:4851,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:8074,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2255,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:818,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6196,hsa:3135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:134,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2918,hsa:2770,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:5747,hsa:8503,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3718,hsa:6773,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2261,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5565,hsa:57818,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5520,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:111,cpd:C00575,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:2783,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1943,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7976,hsa:1855,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:208,hsa:2475,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
cpd:C00575,hsa:5568,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:9586,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:10645,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3101,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27102,hsa:1147,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:91860,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:28227,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1644,hsa:314,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:27006,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3099,hsa:486,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3445,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:3458,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5781,hsa:2550,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:2353,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:7422,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5154,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:572,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:2251,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5228,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:353500,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:472,hsa:1128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:163688,hsa:814,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5571,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:139760,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:23710,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1816,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:801,hsa:112,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3439,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:7424,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5894,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:7482,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7422,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1892,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:6347,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4909,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5906,hsa:4301,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1956,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9370,hsa:51094,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:163688,hsa:5533,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1435,hsa:2906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:3113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:894,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5733,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51378,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00788,hsa:4881,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1544,hsa:5319,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5564,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:224,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:208,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:3661,hsa:5972,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:7042,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:3800,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1392,hsa:1812,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4803,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:154,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5900,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2309,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5228,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2773,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:4261,hsa:3115,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:10645,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00083,hsa:10846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5535,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5970,hsa:3552,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:9103,hsa:2558,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3446,hsa:3454,PPrel,activation,path:hsa05164 Influenza A,1,0.8
cpd:C00584,hsa:2891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5105,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:2570,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:2277,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5208,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:27330,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:4790,hsa:3593,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:5601,hsa:3667,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:6652,hsa:3101,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:200186,hsa:5021,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1544,hsa:1573,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5568,hsa:7849,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:3480,hsa:5293,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:8817,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:2595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:5142,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1457,hsa:4698,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7532,hsa:483,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9455,hsa:2775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:94235,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5587,hsa:3688,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:818,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3098,hsa:2673,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:805,hsa:5534,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:182,hsa:4853,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:6773,hsa:10379,PPrel,binding/association,path:hsa05164 Influenza A,1,0.5
hsa:148327,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8536,hsa:4846,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4804,hsa:6714,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7010,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5154,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51422,hsa:32,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5159,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:26281,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:27006,hsa:56901,no_relation,no_relation,no_relation,no_relation,0.0
hsa:657,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4914,hsa:6464,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:637,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5588,hsa:1147,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:1436,hsa:2893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3440,hsa:3454,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:1945,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1906,hsa:6256,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5598,hsa:27330,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2323,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5970,hsa:598,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5579,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83729,hsa:7042,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:2785,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5566,hsa:6262,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5155,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4902,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2776,hsa:5330,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4916,hsa:6464,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6773,hsa:5610,GErel,expression,path:hsa04217 Necroptosis,1,0.5
hsa:163688,hsa:814,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1573,hsa:1559,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:23462,hsa:4170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:4914,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:7252,hsa:139760,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00942,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4615,hsa:51135,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5568,hsa:2892,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5155,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5606,hsa:5603,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6885,hsa:1147,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5567,hsa:5604,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2253,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3479,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6197,hsa:5501,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:2778,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3459,hsa:3717,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1571,hsa:8789,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5295,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:4804,hsa:2180,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83660,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5580,hsa:5604,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2805,hsa:4282,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:27330,hsa:5500,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:2793,hsa:4625,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2323,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5579,hsa:7849,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:4915,hsa:3351,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55276,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2309,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5521,hsa:197259,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:196883,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:816,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C22381,hsa:9817,PCrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2214,hsa:5743,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:4908,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2277,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1435,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3265,hsa:1432,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3913,hsa:3655,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5566,hsa:491,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:1573,no_relation,no_relation,no_relation,no_relation,0.0
hsa:126129,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5532,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:91807,hsa:4637,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:9048,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5579,hsa:7222,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3717,hsa:6772,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:1943,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5894,hsa:1019,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:4539,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:4843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:2775,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:7423,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4851,hsa:3280,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:5595,hsa:84699,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00076,hsa:91860,PCrel,binding/association,path:hsa05031 Amphetamine addiction,2,0.5
hsa:1435,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2915,hsa:2905,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:26007,hsa:226,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:3952,hsa:3953,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:3630,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:208,hsa:1026,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:841,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:136,hsa:2778,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2787,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:38,hsa:5211,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:6772,PPrel,phosphorylation,path:hsa05164 Influenza A,2,0.8
hsa:4287,hsa:3709,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:90673,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:116,hsa:139760,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5571,hsa:50487,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5443,hsa:3973,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3667,hsa:8503,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00780,hsa:5837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:8681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,hsa:7170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:200186,hsa:8471,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:340156,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:51806,hsa:5533,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2246,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5571,hsa:92579,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:468,hsa:2354,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:5594,hsa:468,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:6714,hsa:5293,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5602,hsa:3725,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3667,hsa:5291,PPrel,activation,path:hsa04931 Insulin resistance,3,0.8
hsa:2914,hsa:2784,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5594,hsa:57818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:113,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:80201,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:3122,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3106,hsa:567,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:1649,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:1812,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:113,cpd:C00575,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51806,hsa:814,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4137,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4233,hsa:2885,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:7423,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:23710,hsa:2568,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:117,hsa:2778,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:7852,hsa:2770,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:7855,hsa:1856,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2248,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27113,hsa:596,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
path:hsa00010,hsa:26007,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
cpd:C00025,hsa:2915,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
cpd:C21011,hsa:177,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:208,hsa:2475,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5567,hsa:775,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:3565,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5443,hsa:154,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3439,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5601,hsa:147700,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2785,hsa:3655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:4916,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2253,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2185,hsa:5829,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:2782,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:1946,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5970,hsa:3451,GErel,expression,path:hsa05164 Influenza A,2,0.5
cpd:C03758,hsa:1128,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2792,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2475,hsa:83593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:1645,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6198,hsa:3667,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:4790,hsa:3441,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:8517,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:148327,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5332,cpd:C00165,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:11035,hsa:1398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:3725,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:23401,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:6196,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3718,hsa:5296,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:284,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5587,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:478,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3481,hsa:3480,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:3845,hsa:5894,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3442,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5605,hsa:5594,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:1544,hsa:81579,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:10379,hsa:6773,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:5524,hsa:6945,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:6772,hsa:2782,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22926,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:6446,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7139,hsa:7168,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:9475,hsa:4637,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:1394,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4853,hsa:3280,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:2792,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2788,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2788,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2255,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1946,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2775,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:51176,hsa:595,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:1943,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:56034,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:148022,hsa:1558,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:4792,PPrel,activation,path:hsa05160 Hepatitis C,2,0.8
cpd:C01312,hsa:135,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3551,hsa:4792,PPrel,activation,path:hsa05160 Hepatitis C,2,0.8
cpd:C00076,hsa:801,PCrel,binding/association,path:hsa05031 Amphetamine addiction,2,0.5
hsa:627,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3625,hsa:4838,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:815,hsa:113,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9568,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:7849,hsa:6256,PPrel,binding/association,path:hsa05216 Thyroid cancer,1,0.5
hsa:1558,hsa:30814,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2215,hsa:5337,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:5519,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:10645,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:8605,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:2913,hsa:55970,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:51422,hsa:32,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:2248,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9568,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:29110,hsa:3661,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:90673,hsa:5836,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:163688,hsa:57172,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2775,hsa:3973,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6750,hsa:51764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:196883,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2778,hsa:3444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9817,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1812,hsa:2778,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:10000,hsa:572,PPrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2932,hsa:3798,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2246,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:801,hsa:5530,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:208,hsa:3164,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10891,hsa:5465,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5770,hsa:5587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:91860,hsa:22877,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:3973,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:2251,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:163688,hsa:107,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5295,hsa:483,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:8823,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5566,hsa:151056,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148022,hsa:11035,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:11337,hsa:2558,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:6311,hsa:3709,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1559,hsa:6775,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2890,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:1234,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:4707,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00942,hsa:5139,PCrel,inhibition,path:hsa04924 Renin secretion,1,0.8
hsa:8822,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:572,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:207,hsa:2309,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3481,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:5143,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:91860,hsa:5530,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:1902,hsa:2778,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1392,hsa:2783,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:2997,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5571,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:203068,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8817,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,cpd:C05981,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2247,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5290,cpd:C05981,PCrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:5291,cpd:C05981,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:3661,hsa:90673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:5603,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:2776,hsa:23401,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3447,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:51806,hsa:815,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C11310,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5443,hsa:4158,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7010,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:5296,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3717,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3569,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:3845,hsa:5293,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5330,cpd:C01245,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5071,hsa:23236,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C07593,hsa:4536,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa05216 Thyroid cancer,2,0.8
hsa:2771,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83439,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5535,hsa:4772,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:207,hsa:2309,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
cpd:C00027,hsa:9817,PCrel,inhibition,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:55970,hsa:7170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:83593,hsa:3683,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2775,hsa:3383,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:135,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8822,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51733,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:5618,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:51806,hsa:816,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6300,hsa:9261,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1644,hsa:4129,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:5564,hsa:32,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:3479,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:810,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:1576,hsa:64600,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5170,hsa:208,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3442,hsa:480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:7132,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:3973,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:5533,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2775,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:3265,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:805,hsa:108,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:177,hsa:3845,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5970,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:9586,hsa:2354,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:4914,hsa:5336,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2771,hsa:23533,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:814,hsa:5144,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:84152,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5579,hsa:4843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1907,hsa:2550,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5154,hsa:3448,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4908,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5214,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3355,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2263,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2775,hsa:3763,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3915,hsa:3630,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:776,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
path:hsa00510,path:hsa00053,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5582,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5519,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:3265,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2253,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:80201,hsa:5208,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:80201,hsa:9945,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:440275,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:7480,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7855,hsa:1857,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:259307,path:map00960,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
cpd:C00076,hsa:5535,PCrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:10235,hsa:5908,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7852,hsa:2788,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:808,hsa:111,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5293,hsa:482,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:27123,hsa:5465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:5501,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3913,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4718,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5594,hsa:6196,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3630,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00076,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3551,hsa:5747,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4607,hsa:4624,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:8503,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5336,hsa:51806,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:51806,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26291,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C07593,hsa:374291,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1559,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3625,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5530,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8321,hsa:1857,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:6885,hsa:5602,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:7186,hsa:9568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:4294,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4790,hsa:1435,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:207,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2668,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:815,hsa:493,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:26281,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:11069,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2773,hsa:3593,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:6885,hsa:5599,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:581,hsa:54205,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
path:hsa00250,hsa:5338,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:3725,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:1945,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5294,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C11310,hsa:4731,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2913,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2323,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1544,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:5603,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:10000,hsa:1026,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2475,hsa:6199,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:51806,hsa:2891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:81579,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:1942,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2790,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3717,hsa:5291,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:84335,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:6655,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:3442,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:572,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9965,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:2309,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3815,hsa:5293,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:815,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2821,hsa:3115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5535,hsa:4775,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2784,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:4893,hsa:673,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:816,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6198,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:2475,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:5566,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10379,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:5894,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00575,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5580,hsa:23683,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5207,hsa:8789,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:1942,hsa:10965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3593,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:2778,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90,hsa:5582,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9306,hsa:3101,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:1385,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:817,hsa:9586,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5565,hsa:32,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:65018,hsa:4722,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6622,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:842,hsa:836,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1557,hsa:123745,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:673,hsa:5605,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5332,cpd:C00165,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:6772,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5331,cpd:C01245,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:27,hsa:5587,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:7132,hsa:3444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3625,path:hsa00400,no_relation,no_relation,no_relation,no_relation,0.0
hsa:658,hsa:659,PPrel,binding/association,path:hsa04350 TGF-beta signaling pathway,2,0.5
hsa:11069,hsa:5602,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2932,hsa:2998,PPrel,phosphorylation,path:hsa04931 Insulin resistance,3,0.8
hsa:5154,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3791,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4909,hsa:1398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:5747,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5500,path:hsa00250,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:3667,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:9306,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2550,hsa:2771,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:4915,hsa:5336,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:207,hsa:112,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5608,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5515,hsa:6773,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:51135,hsa:7189,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:374,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5533,hsa:4773,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:10000,hsa:53632,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2246,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:1813,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1576,hsa:2821,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:5879,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00250,hsa:339896,maplink,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:5291,cpd:C05981,PCrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5894,hsa:5604,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:27006,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:477,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:7423,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7040,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:151056,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:55879,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3691,hsa:71,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:2778,hsa:4843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2203,path:hsa00010,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:283106,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:4717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2998,cpd:C00369,PCrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:5566,hsa:6770,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:51806,hsa:6652,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:283748,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:6772,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5063,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:1385,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:3064,hsa:27089,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3630,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:285,hsa:6548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:483,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91,hsa:4087,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,2,0.8
hsa:5170,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3553,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:5594,hsa:100137049,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2252,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3643,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1459,hsa:3798,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5524,hsa:7189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6196,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:810,hsa:5530,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:805,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5154,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:22926,hsa:7494,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:2252,hsa:5208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:2783,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3440,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:4254,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:207,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2064,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4700,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:85366,hsa:1154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5516,hsa:4725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:1129,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:1017,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6416,hsa:3460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:113,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2251,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:815,hsa:5144,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3630,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00165,hsa:347733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3440,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2917,hsa:94235,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5567,hsa:1385,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:6622,hsa:4535,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2253,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:823,hsa:100506742,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:2737,hsa:2735,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
cpd:C03758,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1907,hsa:2920,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2641,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:2353,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5894,hsa:25759,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2309,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5566,hsa:3283,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:30837,hsa:6772,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:7529,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:3265,hsa:673,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:3082,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:11035,hsa:5837,PPrel,phosphorylation,path:hsa04217 Necroptosis,1,0.8
hsa:5582,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:657,hsa:824,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5155,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:1027,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2475,hsa:6198,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6198,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:2560,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:7476,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5582,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5970,hsa:3440,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:2247,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5781,hsa:5293,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:1559,hsa:151056,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:4803,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5566,hsa:598,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:151056,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:3716,hsa:6774,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:11345,hsa:55879,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
cpd:C00165,hsa:4701,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2475,hsa:3667,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:3309,hsa:22926,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:815,hsa:5321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5228,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1956,hsa:3292,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2538,path:hsa00010,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5021,hsa:2778,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1081,hsa:3973,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
cpd:C11310,hsa:4708,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5566,hsa:10846,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1956,hsa:481,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:572,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:801,hsa:814,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:810,hsa:114,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:55844,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9475,hsa:5499,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1559,hsa:5106,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2790,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:1943,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:90673,hsa:5837,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:11345,hsa:2557,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:6257,hsa:5468,PPrel,binding/association,path:hsa05202 Transcriptional misregulation in cancer,1,0.5
hsa:673,hsa:5604,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5906,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3449,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2309,PPrel,phosphorylation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2251,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5605,PPrel,phosphorylation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:3845,hsa:5600,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:109,hsa:1573,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:6772,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:51764,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6197,hsa:79660,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5881,hsa:57144,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:817,hsa:4137,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5566,hsa:5142,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5601,hsa:3667,PPrel,inhibition,path:hsa04931 Insulin resistance,2,0.8
hsa:65018,hsa:4536,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:51806,hsa:399694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:107,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:91860,hsa:814,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1392,hsa:1394,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2788,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:84699,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5605,hsa:5594,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2775,hsa:5290,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5879,hsa:5062,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3661,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:94235,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:810,hsa:5535,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2563,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:148327,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:808,hsa:816,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:1234,hsa:2791,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5563,hsa:4843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3444,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:115,cpd:C00575,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:207,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:482,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:808,hsa:6196,no_relation,no_relation,no_relation,no_relation,0.0
hsa:841,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3101,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5571,hsa:6517,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5228,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6300,hsa:3725,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2785,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:6774,hsa:8737,GErel,expression,path:hsa04217 Necroptosis,1,0.5
hsa:2277,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3479,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2246,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3265,hsa:5295,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2932,hsa:8312,PPrel,binding/association,path:hsa05224 Breast cancer,1,0.5
hsa:7976,hsa:1856,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:2053,hsa:1646,ECrel,compound,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:2770,hsa:3763,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3716,hsa:6773,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:2064,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2914,hsa:2787,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1544,hsa:151056,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5908,hsa:673,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4902,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5582,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:109,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:805,hsa:113,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C22381,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27330,hsa:5507,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa05164 Influenza A,1,0.8
hsa:11211,hsa:1857,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:3479,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5564,hsa:84335,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:10000,hsa:9882,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:6654,hsa:4893,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:51176,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4088,hsa:6197,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:7709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2695,hsa:2740,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5601,hsa:3799,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:818,hsa:90993,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:8074,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:163688,hsa:140465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4909,hsa:85366,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:116443,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C11310,hsa:4725,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:153,hsa:2778,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:6794,hsa:5565,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:6804,hsa:774,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6654,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9455,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3455,hsa:7297,PPrel,binding/association,path:hsa05164 Influenza A,1,0.5
hsa:808,hsa:818,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2251,hsa:3716,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:7384,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:5295,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5563,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:51764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:572,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:7423,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:5331,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:9568,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3845,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9103,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:3265,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2786,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:657,hsa:4090,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:6622,hsa:7849,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:4772,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:94235,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5562,hsa:5106,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:2250,hsa:5747,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10379,hsa:5610,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:246,hsa:123745,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:207,hsa:2309,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
cpd:C11310,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2914,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01996,hsa:4886,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3320,hsa:8737,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:6622,hsa:774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2475,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:208,hsa:842,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5414,hsa:329,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:10488,hsa:2353,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:65018,hsa:4729,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5605,hsa:5595,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5604,hsa:5594,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5335,hsa:3446,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4902,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00788,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C01245,hsa:3708,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:22926,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:6233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8837,hsa:841,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:814,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4854,hsa:9882,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:10379,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7132,hsa:3551,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:25865,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1545,hsa:2052,ECrel,compound,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:70,hsa:7171,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:26279,hsa:1388,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5781,hsa:1395,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:3577,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:7124,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:91860,hsa:112,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1956,hsa:5291,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2821,hsa:3099,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:5879,hsa:10298,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:111,cpd:C00575,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:163688,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2264,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:108,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:26281,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4535,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:64091,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:23305,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:9882,no_relation,no_relation,no_relation,no_relation,0.0
hsa:657,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:6198,hsa:6194,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2790,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:814,hsa:4846,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6774,hsa:2550,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
cpd:C00780,hsa:153,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10000,hsa:9586,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5609,hsa:5599,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5879,hsa:5058,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:356,hsa:355,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5906,hsa:7409,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2250,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:9586,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
cpd:C03758,hsa:4158,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10683,hsa:3447,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6776,hsa:123745,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:817,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:369,hsa:5604,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1946,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4914,hsa:3667,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1950,hsa:197259,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5595,hsa:5321,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1557,hsa:51764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:28514,hsa:4854,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:673,hsa:5604,PPrel,phosphorylation,path:hsa05224 Breast cancer,3,0.8
hsa:4908,hsa:7278,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54518,hsa:83660,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:163688,hsa:5535,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5599,hsa:3667,PPrel,phosphorylation,path:hsa04931 Insulin resistance,2,0.8
hsa:54331,hsa:5211,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:3456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2990,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1385,hsa:5173,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:8817,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1557,hsa:5321,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:6776,hsa:3659,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5908,hsa:5293,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4909,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1081,hsa:1395,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
hsa:3665,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2260,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1432,hsa:2353,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5506,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6196,hsa:468,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3170,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:6194,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:140465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:5290,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:2185,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:8398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57521,hsa:6199,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
cpd:C00584,hsa:1128,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00575,hsa:5566,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7048,hsa:5518,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:2261,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:1544,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:2915,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:116443,hsa:1742,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:5602,hsa:3798,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5747,hsa:5295,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4780,hsa:2939,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:340061,hsa:5320,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1915,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5602,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4254,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:255189,hsa:2921,no_relation,no_relation,no_relation,no_relation,0.0
hsa:345456,hsa:60,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5335,hsa:51806,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:9568,hsa:1559,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:255189,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5562,hsa:2538,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:2695,hsa:135,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3551,hsa:3667,PPrel,inhibition,path:hsa04931 Insulin resistance,2,0.8
hsa:3444,hsa:116443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:90,hsa:4093,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:8789,path:hsa00010,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:1128,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2261,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4914,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:107,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:116,hsa:117,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C03758,hsa:117,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2791,hsa:3798,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5173,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5530,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:51422,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
cpd:C00575,hsa:5568,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1394,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:65018,hsa:7367,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2215,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:1394,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8325,hsa:1855,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2787,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:1386,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:815,hsa:5142,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2912,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:805,hsa:817,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:32,hsa:1374,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:2064,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:340156,hsa:4637,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1945,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:2309,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:3442,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5566,hsa:1386,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:9246,hsa:7314,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:5606,hsa:5603,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9451,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:808,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:55967,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5336,hsa:163688,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2099,hsa:779,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:7384,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5663,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3689,hsa:80201,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:5106,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:4137,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7253,hsa:5336,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4695,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1946,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2791,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1457,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:123745,PCrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:8517,hsa:23533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283106,hsa:89953,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:9048,hsa:7494,no_relation,no_relation,no_relation,no_relation,0.0
hsa:637,hsa:578,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6714,hsa:5296,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:10645,hsa:116443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:92579,path:hsa00010,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:7097,hsa:4615,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:107,hsa:8681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:2885,PPrel,binding/association,path:hsa05160 Hepatitis C,1,0.5
hsa:5663,hsa:2932,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:207,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5528,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9965,hsa:2775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1392,hsa:1816,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2773,hsa:107,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3718,hsa:8503,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5970,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:135,hsa:5336,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5465,hsa:126129,GErel,expression,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:637,hsa:578,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:116,hsa:1816,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2885,hsa:6654,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:808,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:4893,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3984,hsa:1072,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6774,hsa:3973,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:3099,hsa:55276,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
hsa:5331,cpd:C00076,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:388585,hsa:595,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:3082,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C01996,hsa:3354,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:91860,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3845,hsa:8503,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2776,hsa:5331,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:1559,hsa:8399,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5522,hsa:6773,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:91807,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:3355,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5894,hsa:5290,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2932,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:135,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00195,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23683,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5524,hsa:207,PPrel,inhibition,path:hsa04931 Insulin resistance,2,0.8
hsa:5522,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:815,hsa:1388,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5568,hsa:5143,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5925,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23710,hsa:355,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4854,hsa:2064,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:51422,hsa:5837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4853,hsa:388585,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:55970,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:26281,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2776,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:4886,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5564,hsa:5106,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:2255,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6195,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:3592,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:3479,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9002,hsa:2776,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1943,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10000,hsa:114,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
cpd:C00575,hsa:10411,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1944,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5519,hsa:6772,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:4803,hsa:4914,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3480,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2212,hsa:5579,ECrel,compound,path:hsa05140 Leishmaniasis,1,0.5
hsa:6688,hsa:929,GErel,expression,path:hsa05202 Transcriptional misregulation in cancer,1,0.5
hsa:5208,path:hsa00010,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5595,hsa:483,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
cpd:C00076,hsa:100137049,PCrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:59345,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:23439,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2354,hsa:3065,PPrel,binding/association,path:hsa05031 Amphetamine addiction,1,0.5
hsa:9451,hsa:3551,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2248,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2770,hsa:246,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8660,hsa:5291,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2064,hsa:5293,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:2787,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6622,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:399694,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:80310,hsa:4728,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23130,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:3798,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:9586,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5568,hsa:5143,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:64764,hsa:658,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3456,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5290,hsa:11035,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1026,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:7852,hsa:5337,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90,hsa:4086,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,3,0.8
cpd:C00212,hsa:134,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4803,hsa:4804,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:10000,hsa:572,PPrel,inhibition,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:5501,hsa:3459,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:2921,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:163688,hsa:5535,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:9965,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:801,hsa:59285,no_relation,no_relation,no_relation,no_relation,0.0
hsa:50507,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8323,hsa:1856,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2308,hsa:2538,GErel,expression,path:hsa04931 Insulin resistance,1,0.5
hsa:207,hsa:113,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:8817,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6655,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5507,hsa:5834,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:1234,hsa:2770,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5526,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:55012,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1375,hsa:23205,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:1573,hsa:3661,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3445,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:5156,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4855,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:10891,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:1111,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8324,hsa:1856,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
cpd:C00025,hsa:2904,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:10000,hsa:6446,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8322,hsa:1856,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5500,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:7074,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1459,hsa:7384,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5604,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:1435,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2806,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:9261,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5568,hsa:572,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00025,hsa:3444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:3553,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9568,hsa:2785,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:5530,hsa:4776,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3265,hsa:5894,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:494551,hsa:983,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1950,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:801,hsa:5534,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3265,hsa:5291,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2773,hsa:196883,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C03758,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5894,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00575,hsa:5567,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9454,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:3688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2904,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4909,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:23683,hsa:3689,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2932,hsa:1499,PPrel,phosphorylation,path:hsa05224 Breast cancer,1,0.8
hsa:2323,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7976,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:4697,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3309,hsa:2002,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283106,hsa:3798,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4254,hsa:5211,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5604,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:80310,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C22381,hsa:8517,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5571,hsa:5106,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:6195,hsa:4893,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:207,hsa:9586,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2917,hsa:55970,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5527,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:23683,hsa:3551,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2771,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5594,hsa:84699,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00025,hsa:2906,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:4902,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1457,hsa:3831,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:1557,hsa:81579,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:8660,hsa:5293,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5599,hsa:2495,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:9945,hsa:80201,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:2788,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3106,hsa:808,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8503,hsa:486,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1902,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:9252,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:26291,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5295,cpd:C05981,PCrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:5331,cpd:C00165,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C07593,hsa:4726,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8325,hsa:1857,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3624,hsa:7042,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:9048,hsa:53358,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:595,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:79444,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5330,cpd:C01245,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8074,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2247,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7039,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5210,hsa:5214,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5296,hsa:207,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:3845,hsa:6352,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2550,hsa:2791,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:6868,hsa:1839,PPrel,activation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:581,hsa:54205,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:10000,hsa:2475,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:2209,hsa:5603,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:208,hsa:572,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51806,hsa:5530,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:27123,hsa:5970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5663,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4775,hsa:5997,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:111,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:22800,hsa:51196,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:815,hsa:3683,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:7137,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00575,hsa:1646,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:808,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,path:hsa00053,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2792,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:9965,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4893,hsa:5291,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4909,hsa:2775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10379,hsa:5371,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:2770,hsa:6714,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:801,hsa:5535,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8817,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1906,hsa:3352,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8322,hsa:581,no_relation,no_relation,no_relation,no_relation,0.0
hsa:115,cpd:C00575,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:84335,hsa:6198,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:3661,hsa:4853,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,cpd:C00704,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5293,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2770,hsa:3762,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5908,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2323,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3684,hsa:5743,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:3665,hsa:3445,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:7332,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:130589,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3101,hsa:2821,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:65018,hsa:4541,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:9455,hsa:9455,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,2,0.5
hsa:10000,hsa:355,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:5595,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:4803,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3439,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4720,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3280,hsa:4709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80201,hsa:5236,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:1969,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3718,hsa:6777,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:7852,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112,cpd:C00575,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6750,hsa:6752,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7297,hsa:6774,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
cpd:C00165,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:596,hsa:5321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:58494,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4881,hsa:2567,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5598,path:hsa00051,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4878,hsa:1395,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:130399,hsa:4087,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:2255,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4915,hsa:399694,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:805,hsa:107,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2309,hsa:3303,GErel,expression,path:hsa04213 Longevity regulating pathway - multiple species,1,0.5
hsa:3912,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6945,hsa:32,GErel,expression,path:hsa04931 Insulin resistance,1,0.5
hsa:5608,hsa:6300,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4893,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:5322,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
cpd:C00547,hsa:4158,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2787,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5535,hsa:572,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:5566,hsa:5465,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2254,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:317,PPrel,activation,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:5595,hsa:1385,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:2069,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26281,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5333,cpd:C01245,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3099,path:hsa00051,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:814,hsa:10846,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1945,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:207,hsa:2475,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:7132,hsa:1616,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00547,hsa:135,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1459,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:28514,hsa:4855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:810,hsa:5535,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6300,hsa:3593,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:5053,hsa:259307,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:5587,hsa:4851,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5335,cpd:C00165,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:673,hsa:5604,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:65018,hsa:2203,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:53632,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:6885,hsa:5336,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1943,hsa:1080,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:374291,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6622,hsa:4536,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:810,hsa:818,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:113,cpd:C00575,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:5533,hsa:2915,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:8817,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2932,hsa:64837,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3459,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:814,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:55012,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1908,hsa:6752,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2776,hsa:5335,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:51378,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:4804,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:53632,hsa:5106,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
cpd:C05981,hsa:208,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26291,hsa:3309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7976,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:340156,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:200186,hsa:207,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2784,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1234,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00195,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5564,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:28227,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:115,cpd:C00575,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3456,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1943,hsa:5582,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8325,hsa:1856,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:7422,hsa:3354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:2099,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:10488,hsa:2354,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:4780,hsa:221357,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:10379,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1268,hsa:2773,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C01996,hsa:6752,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2785,hsa:4540,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5894,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3107,hsa:5501,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5336,hsa:91860,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:83660,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5568,hsa:1386,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:4088,hsa:4089,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:4780,hsa:2952,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:5600,hsa:4843,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:818,hsa:2776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10683,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2246,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2912,hsa:156,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:54518,hsa:7054,no_relation,no_relation,no_relation,no_relation,0.0
hsa:114,cpd:C00575,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:2784,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:3630,hsa:5970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:6772,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:10645,hsa:53632,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:7424,hsa:5140,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2890,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2770,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:6237,hsa:5338,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7408,hsa:71,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2069,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1906,hsa:9568,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:801,hsa:4718,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5170,hsa:10000,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2255,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5595,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9693,hsa:5908,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:283106,hsa:3798,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2550,hsa:2785,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:2778,hsa:112,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:27121,hsa:80326,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:999,hsa:2889,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1945,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4214,hsa:5609,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4886,hsa:2770,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27102,hsa:1147,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2770,hsa:2002,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00547,hsa:3350,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:11149,hsa:3776,PPrel,binding/association,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:815,hsa:109,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4790,hsa:268,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:5481,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4914,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6776,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2253,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2475,hsa:6198,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2786,hsa:54579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:4713,no_relation,no_relation,no_relation,no_relation,0.0
hsa:332,hsa:842,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:2557,hsa:3451,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:4886,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:8660,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:7297,hsa:6772,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5296,hsa:207,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3714,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:109,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00334,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83729,hsa:4838,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:80310,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2771,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:1457,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25865,hsa:1147,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3098,hsa:55276,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
hsa:1388,hsa:1649,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:1375,hsa:2180,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:817,hsa:5142,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1857,hsa:23401,PPrel,binding/association,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:4855,hsa:3280,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:2913,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2263,hsa:1109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5605,PPrel,activation,path:hsa05216 Thyroid cancer,3,0.8
cpd:C00788,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4233,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2252,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9965,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51806,hsa:5530,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5906,hsa:673,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3693,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5894,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1906,hsa:1128,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4909,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5501,hsa:10488,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3661,hsa:3449,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:91860,hsa:107,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5602,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:112,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7409,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:3725,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2793,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2773,hsa:112,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6622,hsa:4715,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:163688,hsa:196883,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9451,hsa:4780,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:5970,hsa:3576,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:808,hsa:5532,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:468,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64764,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27330,hsa:3265,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:54106,hsa:5143,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283106,hsa:57172,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:116444,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5499,hsa:490,no_relation,no_relation,no_relation,no_relation,0.0
hsa:192111,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:230,hsa:8789,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:55626,hsa:441925,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5566,hsa:25,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8322,hsa:1857,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:208,hsa:842,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7423,hsa:3360,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7043,hsa:7220,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:4843,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:4909,hsa:81029,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4793,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:3667,hsa:5295,PPrel,activation,path:hsa04931 Insulin resistance,3,0.8
hsa:808,hsa:817,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:113,hsa:5532,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:115,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4893,hsa:5293,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:818,hsa:1386,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:1944,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2248,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:472,hsa:1111,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3845,hsa:673,PPrel,activation,path:hsa05216 Thyroid cancer,2,0.8
hsa:2771,hsa:114,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:57506,hsa:1147,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:4790,hsa:3592,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:5207,hsa:5211,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2773,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5155,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10451,hsa:5880,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5610,hsa:3551,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2309,hsa:3310,GErel,expression,path:hsa04213 Longevity regulating pathway - multiple species,1,0.5
hsa:6195,hsa:4728,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:79444,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:65018,hsa:4714,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4851,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5527,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:3800,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
cpd:C11310,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2932,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:10488,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2248,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1576,hsa:246,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:207,hsa:572,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5970,hsa:3383,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:5335,cpd:C00165,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5564,hsa:32,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:65018,hsa:1394,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5836,cpd:C00031,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:23493,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:64764,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6885,hsa:5595,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:116,hsa:1394,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:91860,hsa:196883,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1942,hsa:3099,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5533,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5293,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6311,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:140465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5293,PPrel,activation,path:hsa04931 Insulin resistance,3,0.8
hsa:1573,hsa:23462,no_relation,no_relation,no_relation,no_relation,0.0
hsa:330,hsa:836,PPrel,inhibition,path:hsa05145 Toxoplasmosis,1,0.8
hsa:4137,hsa:7277,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1742,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5601,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1147,hsa:5143,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:3643,PPrel,activation,path:hsa04931 Insulin resistance,3,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa05164 Influenza A,1,0.8
cpd:C05981,hsa:208,PCrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:54331,hsa:39,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:83593,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7852,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,hsa:5500,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:6446,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3064,hsa:7381,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5535,hsa:5499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:6263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:4893,hsa:5296,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5600,hsa:3593,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:8835,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25,hsa:25865,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:4780,hsa:653689,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:5609,hsa:5602,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6776,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5582,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8326,hsa:1855,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5322,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5568,hsa:51380,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:7124,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:2212,hsa:5743,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:2782,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4804,hsa:8767,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:6197,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:5294,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4915,hsa:10603,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6885,hsa:841,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4694,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2252,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3845,hsa:5894,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2783,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2773,hsa:3763,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1557,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3643,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7124,hsa:3125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:108,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5595,hsa:482,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5602,hsa:3831,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3082,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:23710,hsa:2555,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:8823,hsa:1742,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1378,hsa:5743,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:2246,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:163688,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54518,hsa:5216,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5170,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:51806,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2354,hsa:3066,PPrel,binding/association,path:hsa05031 Amphetamine addiction,1,0.5
hsa:2773,hsa:5290,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C22381,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:3630,hsa:6195,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:246,hsa:84647,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
cpd:C03758,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:915,hsa:356,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6772,hsa:5141,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2641,hsa:2740,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5595,hsa:1385,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1906,hsa:1129,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2778,hsa:115,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:23566,hsa:2778,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C01996,hsa:91807,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3444,hsa:3455,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:2771,hsa:6548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6199,hsa:3170,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:1907,hsa:10846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:486,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:4087,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:4886,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6772,hsa:3118,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:5335,hsa:2354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,hsa:2752,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:3098,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5509,hsa:5143,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2645,hsa:5236,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5532,hsa:2932,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:284,hsa:117,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:5141,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1081,hsa:153,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
hsa:5562,hsa:57521,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:5331,cpd:C00165,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2538,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51176,hsa:4609,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
cpd:C15231,hsa:2538,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:5837,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:3351,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6197,hsa:5500,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:1147,hsa:8471,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:1398,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3452,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:7852,hsa:54331,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5532,hsa:4776,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5021,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9103,path:hsa00051,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:5338,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8312,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1978,hsa:253314,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8517,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:285,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:810,hsa:3688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25,hsa:23683,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:23710,hsa:2562,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:4902,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51085,hsa:32,GErel,expression,path:hsa04931 Insulin resistance,1,0.5
hsa:5595,hsa:477,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5608,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:5599,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:2246,hsa:23411,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:91807,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:51764,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5293,hsa:5294,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6652,hsa:80201,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:80201,path:hsa00010,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5568,hsa:3459,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2912,hsa:5144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2323,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:25865,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2247,hsa:659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1544,hsa:50487,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5443,hsa:11145,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3448,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25865,hsa:3689,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4780,hsa:83447,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:10000,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:801,hsa:5533,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5970,hsa:3446,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:1856,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2932,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5337,hsa:79861,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:1386,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5970,hsa:3593,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:5228,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3451,hsa:153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:217,hsa:339896,ECrel,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:7360,hsa:5499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:330,hsa:836,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:5970,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00780,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5534,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:2770,hsa:3593,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:805,hsa:153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2249,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:3449,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:2778,hsa:107,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3985,hsa:1072,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2917,hsa:2793,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:9048,hsa:774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:53632,hsa:32,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:2562,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:192111,hsa:10059,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:6622,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1906,hsa:5021,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1544,hsa:54331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2550,hsa:5208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4915,hsa:5335,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8503,hsa:208,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:3665,hsa:3445,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:3098,hsa:3133,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5781,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6776,hsa:3630,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:9454,hsa:3708,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:8503,hsa:481,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2784,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5501,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2914,hsa:2792,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:8817,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:808,hsa:5533,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3460,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:673,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2913,hsa:59345,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5599,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:775,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:116443,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:2309,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:4915,hsa:53358,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:59345,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7048,hsa:387,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:817,hsa:10488,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2560,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:113,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4804,hsa:3354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:84812,cpd:C00165,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2475,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:2893,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1457,hsa:147700,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:25,hsa:25865,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:578,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:9586,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4852,hsa:6752,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5509,hsa:5837,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:4233,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7252,hsa:7253,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5534,hsa:572,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:56034,hsa:2793,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:10411,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27102,hsa:1111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:5208,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:10681,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,hsa:3125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3135,hsa:9817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:3659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:22943,hsa:7474,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:208,hsa:55970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3101,hsa:2673,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:5792,hsa:3667,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:4878,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5567,hsa:1588,GErel,expression,path:hsa04913 Ovarian steroidogenesis,2,0.5
hsa:91860,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:6752,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5290,hsa:480,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:6714,hsa:25,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:1435,hsa:805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5601,hsa:2353,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1129,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3717,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4261,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:776,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:23586,hsa:57506,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5509,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:5747,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2309,hsa:3689,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4878,hsa:1394,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:775,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:8074,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:387,hsa:71,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2247,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:23462,hsa:4791,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:2246,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5500,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:57118,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:1909,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3445,hsa:1573,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3458,hsa:3459,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:7424,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5568,hsa:5140,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5170,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7976,hsa:1856,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2771,hsa:5320,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5609,hsa:5602,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:637,hsa:581,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:3643,hsa:5290,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5291,hsa:5747,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5563,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5335,hsa:163688,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5506,hsa:2998,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:4902,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C22381,hsa:4217,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2915,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5119,hsa:197259,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:5598,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5210,hsa:8789,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5566,hsa:779,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:54205,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:107,cpd:C00575,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2251,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5879,hsa:5295,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2783,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2977,cpd:C00942,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:7042,hsa:7048,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:810,hsa:816,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3661,hsa:3447,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:4790,hsa:3447,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:4893,hsa:5894,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8822,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1950,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:10681,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8717,hsa:8737,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:4790,hsa:3439,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:5601,hsa:3760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:3091,GErel,expression,path:hsa04919 Thyroid hormone signaling pathway,1,0.5
hsa:92552,hsa:5579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:5733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2805,path:hsa00400,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:2324,hsa:4716,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:4843,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:801,hsa:114,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1943,hsa:5294,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1459,hsa:5142,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:7137,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8823,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2215,hsa:54205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2309,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2902,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:207,hsa:2308,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5568,hsa:123745,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7039,hsa:4129,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:4780,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:6750,hsa:5021,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51422,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:285,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3643,hsa:8471,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:163688,hsa:817,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4261,hsa:3123,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
cpd:C00334,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:1432,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:10645,hsa:5562,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:627,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:4780,hsa:1728,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:4893,hsa:5290,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:627,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1544,hsa:255189,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
cpd:C00076,hsa:283748,PCrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5021,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:27006,hsa:3362,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:818,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:80310,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1375,hsa:51703,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:10645,hsa:80201,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:2353,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:4908,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4137,hsa:10382,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:27006,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00780,hsa:3973,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5571,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5663,hsa:3710,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2773,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:5350,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5293,hsa:51135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:6804,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3845,hsa:5894,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2538,hsa:5236,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5519,hsa:2549,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:64764,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4909,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4261,hsa:3118,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:2277,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6197,hsa:5509,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:3460,hsa:3716,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:2249,hsa:163688,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:815,hsa:5140,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1944,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2246,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3480,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:1109,GErel,expression,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:116,hsa:3973,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5595,hsa:1026,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:5154,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51378,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:805,hsa:814,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:331,hsa:842,PPrel,inhibition,path:hsa05145 Toxoplasmosis,1,0.8
hsa:55970,hsa:4087,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:4215,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:9586,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:637,hsa:578,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:340156,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:51384,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1147,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4217,hsa:5608,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2475,hsa:6198,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:1944,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7533,hsa:572,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:140465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:9568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84647,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:51806,hsa:111,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5170,hsa:23678,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C07593,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:207,hsa:5563,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:27035,cpd:C00704,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:51806,hsa:134,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:3354,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00575,hsa:8681,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:9693,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26281,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C03758,hsa:5021,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4790,hsa:3441,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:4790,hsa:330,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5291,hsa:483,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1436,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5524,hsa:5507,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5565,hsa:3460,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:7484,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2720,hsa:2538,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5335,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57016,hsa:2720,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5606,hsa:6300,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5605,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2324,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:177,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:126328,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00584,hsa:1812,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:59345,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:285,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:494551,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6196,hsa:23683,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5881,hsa:5062,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2767,hsa:5336,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2775,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:8503,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5594,hsa:8681,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4851,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2773,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:64764,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5578,hsa:84699,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:10000,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:5834,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3350,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2321,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4261,hsa:3127,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:111,cpd:C00575,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5535,hsa:2788,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2905,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:55970,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:23462,hsa:51422,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5582,hsa:1388,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
cpd:C01245,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:1388,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3661,hsa:3456,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:115,hsa:5564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5468,hsa:6256,PPrel,binding/association,path:hsa05216 Thyroid cancer,1,0.5
hsa:27006,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2564,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:1906,hsa:1909,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:2918,hsa:2792,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6885,hsa:5602,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:2209,hsa:808,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1908,hsa:5153,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1544,hsa:283748,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:111,cpd:C00575,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5594,hsa:1573,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5338,hsa:4258,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:468,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5595,hsa:59283,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2099,hsa:595,GErel,expression,path:hsa05224 Breast cancer,2,0.5
hsa:10681,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:2740,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:817,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1956,hsa:6464,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:10451,hsa:5879,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5623,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:5894,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8326,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4193,hsa:7157,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1435,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148022,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:5743,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:9568,hsa:94235,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:11337,hsa:2568,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:1956,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C05981,hsa:207,PCrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:1945,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1457,hsa:3659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:207,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4893,hsa:5296,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1128,hsa:2740,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2892,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5170,hsa:23678,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:2891,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2641,hsa:4881,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2990,hsa:54658,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:1436,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3101,hsa:5213,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5605,hsa:5594,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:801,hsa:196883,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:818,hsa:5141,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5601,hsa:1432,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5021,hsa:784,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C05981,hsa:6655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:2538,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:2253,hsa:4093,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:8503,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:285,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7297,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2064,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8323,hsa:1857,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
cpd:C07593,hsa:4714,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1644,hsa:5563,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5894,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5563,hsa:1816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:1435,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:5211,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6655,hsa:3845,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2771,hsa:23236,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2475,hsa:6198,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:2905,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:80201,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:2891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7849,hsa:6257,PPrel,binding/association,path:hsa05216 Thyroid cancer,1,0.5
hsa:5595,hsa:80201,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54518,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7249,hsa:6009,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:8471,hsa:3283,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22926,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:123745,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3448,hsa:134,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4916,hsa:5881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5564,hsa:7297,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C13050,hsa:6261,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6655,hsa:3265,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:810,hsa:57118,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5535,hsa:2911,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C00547,hsa:153,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:3082,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5524,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5528,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2668,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2253,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5021,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5598,hsa:3725,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:10000,hsa:842,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5500,hsa:84699,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:810,hsa:113,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4914,hsa:25759,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:22877,hsa:32,GErel,expression,path:hsa04931 Insulin resistance,1,0.5
hsa:5210,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:108,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:7424,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:84335,hsa:6199,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:22877,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5563,hsa:92579,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:1459,hsa:3800,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:3099,hsa:2720,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:4790,hsa:3593,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:2248,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:90993,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:1906,hsa:5733,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2250,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:815,hsa:4846,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5568,hsa:3101,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3082,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:284,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:810,hsa:1129,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:81579,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5599,hsa:3718,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:627,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6932,hsa:3164,no_relation,no_relation,no_relation,no_relation,0.0
hsa:59345,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C21011,hsa:1645,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2915,hsa:116444,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6772,hsa:3117,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:5606,hsa:6300,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
path:hsa00052,hsa:231,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:284,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5595,hsa:2353,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5154,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:51764,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5063,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2100,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2932,hsa:3798,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:340156,hsa:140465,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5522,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:51806,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
hsa:1956,hsa:5290,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:718,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:218,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:51378,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6655,hsa:3845,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:4790,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10379,hsa:9451,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:3479,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1385,hsa:2353,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:5601,hsa:5216,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3099,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6416,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3101,hsa:5211,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:51378,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:387,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:10023,hsa:84335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:2308,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:64764,hsa:2354,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:2783,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4233,hsa:5291,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3624,hsa:92,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:6654,hsa:3265,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2771,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:810,hsa:814,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6195,hsa:2720,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7039,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:22943,hsa:2475,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3064,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148022,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25805,hsa:90,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,2,0.8
hsa:1944,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:10488,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:7010,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:226,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4881,hsa:2893,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4726,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2254,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6750,hsa:1813,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2323,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3459,hsa:7297,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:26508,hsa:5880,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2913,hsa:156,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5296,hsa:482,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:283106,hsa:89953,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:5578,hsa:9586,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:1944,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5578,hsa:1388,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:8074,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:25865,hsa:3551,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:27165,hsa:2747,ECrel,compound,path:hsa04964 Proximal tubule bicarbonate reclamation,1,0.5
hsa:2783,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8326,hsa:10382,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5588,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:163688,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
cpd:C00788,hsa:9568,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2786,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5567,hsa:116443,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3107,hsa:10243,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5525,hsa:4916,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5623,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5294,hsa:1956,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6093,hsa:5499,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3265,hsa:5894,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5605,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5623,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2771,hsa:773,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10681,hsa:4625,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5509,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C04549,hsa:26100,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4878,hsa:7253,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3134,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2905,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2248,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2783,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:369,hsa:5605,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:3164,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51764,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3845,hsa:2775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3133,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:572,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2251,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5501,hsa:5142,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:4792,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
cpd:C01245,hsa:3135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:111,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2253,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:673,hsa:5605,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5579,hsa:5587,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:11337,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:6300,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:1432,hsa:9261,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2720,hsa:8704,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:27006,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3643,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:7384,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2717,hsa:93432,ECrel,compound,path:hsa00052 Galactose metabolism,3,0.5
hsa:805,hsa:814,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5295,cpd:C05981,PCrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
cpd:C01312,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2915,hsa:9454,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:5330,cpd:C01245,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:3630,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1544,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10488,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3446,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:1943,hsa:5836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6850,hsa:930,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5601,hsa:4838,no_relation,no_relation,no_relation,no_relation,0.0
hsa:53632,hsa:57818,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:84152,hsa:5500,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:3280,hsa:595,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:4804,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3624,hsa:93,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:1906,hsa:4090,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5350,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51764,hsa:8678,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3446,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:6714,hsa:5295,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:7465,hsa:983,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2787,hsa:5063,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,cpd:C05981,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4790,hsa:2921,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:51806,hsa:196883,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6804,hsa:778,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5908,hsa:54518,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51806,hsa:815,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5595,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:283106,hsa:3800,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:8660,hsa:5291,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5156,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2775,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:3626,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:5143,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C01996,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8660,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1459,hsa:59284,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:673,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:10971,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4804,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:627,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:3458,hsa:3459,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:4254,hsa:11035,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,hsa:8503,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3066,hsa:23411,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2775,cpd:C00704,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:399694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3445,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:6934,hsa:595,GErel,expression,path:hsa05216 Thyroid cancer,1,0.5
hsa:2784,hsa:8737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2917,hsa:59345,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6655,hsa:4893,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:5535,hsa:84152,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:7364,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:57818,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5565,hsa:6513,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:26281,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:123745,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:3643,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3815,hsa:8503,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:55072,hsa:329,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:2783,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:6197,hsa:90673,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:1544,hsa:26279,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5908,hsa:5291,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:657,hsa:5499,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3455,hsa:7409,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2784,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:1392,hsa:3973,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5605,hsa:1129,no_relation,no_relation,no_relation,no_relation,0.0
hsa:222,hsa:8639,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:1576,hsa:1544,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:54205,hsa:255189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:112,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8323,hsa:1855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
cpd:C00020,hsa:5563,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10488,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4538,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:90673,hsa:1742,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:808,hsa:3655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27429,hsa:331,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:2248,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6777,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5617,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5296,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:221,hsa:4128,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:3717,hsa:6778,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:207,hsa:572,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:10000,hsa:4193,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5595,hsa:3099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:115,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6622,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
path:hsa00052,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3447,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:814,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00025,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:1432,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2534,hsa:25865,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4794,hsa:2786,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:53358,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:6652,hsa:3098,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2251,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00788,hsa:5733,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9564,hsa:314,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5532,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2778,hsa:8605,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:5228,hsa:3655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5058,hsa:9020,PPrel,activation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:51806,hsa:109,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2770,hsa:112,PPrel,inhibition,path:hsa04924 Renin secretion,1,0.8
hsa:2792,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5213,hsa:226,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:10681,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2790,hsa:3451,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:2921,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:4659,hsa:140465,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:26281,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:196883,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3480,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3449,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5908,hsa:5291,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9451,hsa:1649,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80201,hsa:5210,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5566,hsa:1375,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3845,hsa:5291,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1399,hsa:2889,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:3452,hsa:3454,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:2246,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8743,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:441925,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:5732,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4852,hsa:154,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C11310,hsa:4698,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2535,hsa:1855,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:7252,hsa:4881,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2782,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7849,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2263,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:54331,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2932,hsa:1499,PPrel,inhibition,path:hsa05224 Breast cancer,1,0.8
hsa:5602,hsa:3799,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5021,hsa:776,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5588,hsa:5599,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5332,hsa:1111,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55012,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:4893,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:39,path:hsa00020,maplink,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:2309,hsa:5106,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:142,cpd:C00076,PCrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1644,hsa:2806,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:2783,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2323,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2911,hsa:2776,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6772,hsa:345611,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:1956,hsa:5290,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:5481,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:4086,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5159,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:134,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54205,hsa:842,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1392,hsa:5732,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4902,hsa:8398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:8503,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:841,hsa:8737,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:2247,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3443,hsa:3455,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:1906,hsa:4886,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8651,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:5834,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2058,path:hsa00250,maplink,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:817,hsa:7476,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:11285,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9454,hsa:2911,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:5970,hsa:3445,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:4775,hsa:5743,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:1544,hsa:3383,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:3688,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:10000,PCrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:8074,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:90993,hsa:1958,GErel,expression,path:hsa05020 Prion disease,1,0.5
hsa:654,hsa:659,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:7423,hsa:5142,no_relation,no_relation,no_relation,no_relation,0.0
hsa:30814,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:2915,hsa:5881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:5506,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:56034,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6197,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1558,hsa:8399,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2550,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5880,hsa:56924,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8743,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2069,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5533,hsa:4776,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1571,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:818,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5290,hsa:3800,no_relation,no_relation,no_relation,no_relation,0.0
hsa:841,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9021,hsa:3667,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:9965,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1436,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2885,hsa:5781,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2792,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C00195,hsa:5588,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5970,hsa:4846,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:9965,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:5594,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:4261,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:952,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:8503,hsa:5021,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5663,hsa:6261,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:91860,hsa:5535,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:4915,hsa:340156,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:10000,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7424,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10681,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4792,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:23533,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:8817,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2250,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1558,hsa:5322,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:3098,path:hsa00010,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:2913,hsa:157,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2251,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:2906,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:6655,hsa:3845,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:2792,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C00334,hsa:3355,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1950,hsa:5142,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5894,hsa:5605,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:7852,hsa:59345,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:331,hsa:836,PPrel,inhibition,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5601,hsa:89953,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6885,hsa:3551,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5609,hsa:5602,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:4878,hsa:153,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9586,hsa:627,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:1147,hsa:8660,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:1147,hsa:3667,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:2323,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:246,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5781,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7039,hsa:4724,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:801,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:163688,hsa:111,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6622,hsa:4697,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4855,hsa:23462,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:6622,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4217,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:208,PCrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:810,hsa:5532,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5908,hsa:3397,PPrel,inhibition,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:163688,hsa:115,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2565,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:80201,hsa:2203,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
cpd:C00788,hsa:1129,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5582,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:91807,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:226,hsa:8789,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:26291,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:801,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64764,hsa:598,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C22381,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10000,hsa:1147,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5021,hsa:2673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:115,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1956,hsa:5336,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:4902,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C07593,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2782,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:90,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,path:hsa00400,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:4794,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2247,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6300,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:10000,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2253,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3443,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5579,hsa:3667,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:2308,hsa:5105,GErel,expression,path:hsa04931 Insulin resistance,1,0.5
hsa:2249,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4217,hsa:5609,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:10000,hsa:2932,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:7855,hsa:1856,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:3667,hsa:5296,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:3630,hsa:10062,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:8817,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5571,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2911,hsa:116444,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3443,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3624,hsa:7043,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5499,hsa:5564,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9246,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:6622,hsa:4090,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:6775,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:7852,hsa:2786,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3551,hsa:4792,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:6197,hsa:5507,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5562,hsa:32,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:5579,hsa:8605,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:859,hsa:4842,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:5605,hsa:5594,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:91860,hsa:5530,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:55970,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5568,hsa:51478,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:51806,hsa:115,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5291,hsa:207,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3915,hsa:3688,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
cpd:C00575,hsa:3112,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00010,hsa:3099,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
hsa:2776,hsa:5332,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1558,hsa:26279,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:3082,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:2911,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4697,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:815,hsa:6531,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:4893,hsa:51196,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5331,cpd:C00165,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1544,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00095,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2308,hsa:5106,GErel,expression,path:hsa04931 Insulin resistance,1,0.5
hsa:1956,hsa:53358,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:27121,hsa:7484,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:816,hsa:5141,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:80310,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5155,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7048,hsa:5515,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:3661,hsa:3448,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:3481,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1644,hsa:137362,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:2069,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,hsa:5058,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5594,hsa:6195,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4790,hsa:3440,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:5567,hsa:778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4914,hsa:6464,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5290,cpd:C05981,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C00212,hsa:117,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2784,hsa:5140,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1902,hsa:2776,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51764,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:6622,hsa:4540,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2064,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:3362,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00584,hsa:2550,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5291,hsa:3845,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5603,hsa:3593,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
cpd:C03758,hsa:3354,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2785,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5516,hsa:4843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5837,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5336,hsa:5580,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1942,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:285,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8074,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2784,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4790,hsa:7124,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:6772,hsa:3119,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:4217,hsa:91807,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:3763,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7252,hsa:1395,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10681,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:2913,hsa:2771,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:2069,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2249,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4893,hsa:1432,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5894,hsa:5604,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:2990,hsa:54490,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:4804,hsa:5296,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:808,hsa:818,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:2641,hsa:3360,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:5210,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:208,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
path:hsa00010,hsa:3098,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
hsa:5587,hsa:3684,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:207,hsa:7249,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:51378,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5021,hsa:2771,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2912,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2915,hsa:2776,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:654,hsa:90,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5500,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10411,hsa:5908,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7128,hsa:11035,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:1386,hsa:11035,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:57506,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:2002,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2932,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:2790,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1459,hsa:2565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4233,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:341208,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2309,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5228,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00165,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2771,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C07593,hsa:4539,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00076,hsa:91860,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,2,0.8
cpd:C00195,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:841,hsa:637,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2354,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:805,hsa:81616,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8321,hsa:1855,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:51806,hsa:815,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5582,hsa:90993,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:7039,hsa:627,no_relation,no_relation,no_relation,no_relation,0.0
hsa:331,hsa:10298,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:7297,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:1080,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:134,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9655,hsa:5880,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5533,hsa:4775,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5606,hsa:6300,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2308,hsa:9474,GErel,expression,path:hsa04213 Longevity regulating pathway - multiple species,1,0.5
hsa:5241,hsa:7471,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:2770,hsa:114,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:268,hsa:659,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:1969,hsa:23236,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4217,hsa:5609,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:27121,hsa:60,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2052,hsa:10327,ECrel,compound,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:2253,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3082,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5293,hsa:5879,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:56034,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4804,hsa:8503,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3791,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25865,hsa:1962,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:1386,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:1129,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1499,hsa:6932,PPrel,activation,path:hsa05216 Thyroid cancer,1,0.8
hsa:4804,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:5335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:10369,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C01245,hsa:3709,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3101,path:hsa00051,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:9568,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5216,hsa:71,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7423,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1435,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2252,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:207,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1946,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7252,hsa:2740,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4233,hsa:5296,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:22943,hsa:840,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2069,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5481,hsa:292,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2214,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3451,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:6934,hsa:4609,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:2932,hsa:147700,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:5296,hsa:208,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2053,hsa:1109,ECrel,compound,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:2911,hsa:2905,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3099,hsa:5105,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4909,hsa:151056,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:90993,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:4914,hsa:399694,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5609,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3447,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:27330,hsa:5501,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:163688,hsa:5535,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4254,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4780,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C22381,hsa:2790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:148327,hsa:10891,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:2771,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:2915,hsa:116443,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5291,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3099,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5879,hsa:5582,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:7157,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:3101,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2260,hsa:7278,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5290,hsa:5058,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8326,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:10379,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:801,hsa:4638,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2052,hsa:1109,ECrel,compound,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:163688,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3451,hsa:3683,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5443,hsa:3360,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3459,hsa:3718,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2247,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:11337,hsa:2564,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:4893,hsa:673,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C00025,hsa:2903,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5582,hsa:6352,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4261,hsa:4780,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:3122,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:11337,hsa:2556,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:2771,hsa:111,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4893,hsa:4794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2064,hsa:5291,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:3030,hsa:5834,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:84152,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1435,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3350,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:208,hsa:2889,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:55970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5535,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:2911,hsa:4893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:5295,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:4217,hsa:1812,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:10000,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:10681,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:1081,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9945,hsa:5881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2064,hsa:25759,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:51764,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:4794,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:5021,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:801,hsa:5533,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:284,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5154,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2783,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:91860,hsa:111,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1459,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:116,hsa:3362,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5610,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1499,hsa:83439,PPrel,activation,path:hsa05216 Thyroid cancer,1,0.8
hsa:5294,hsa:5170,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:4853,hsa:5880,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5598,hsa:26279,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:9882,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:10681,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1375,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3452,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2785,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:208,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:3576,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:3082,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5414,hsa:330,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:834,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3908,hsa:3655,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:6195,hsa:3845,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00025,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51733,hsa:1938,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:23439,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5063,hsa:3985,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:51764,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:26291,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8503,hsa:4893,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1459,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3445,hsa:3454,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:8074,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3815,hsa:5295,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:23710,hsa:6197,no_relation,no_relation,no_relation,no_relation,0.0
hsa:53632,hsa:84335,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5521,hsa:6773,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
cpd:C05981,hsa:207,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:7046,hsa:4170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3098,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:480,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1856,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:1147,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:2737,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5500,hsa:637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:3459,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2893,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5332,hsa:8517,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7189,hsa:5601,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3717,hsa:9020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3445,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:5500,hsa:148327,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4254,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:817,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1460,hsa:3800,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2251,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:208,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:11069,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00704,hsa:5970,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3441,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2932,hsa:4137,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,2,0.8
hsa:5603,hsa:3135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2212,hsa:1432,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:5777,hsa:5594,PPrel,inhibition,path:hsa05140 Leishmaniasis,1,0.8
hsa:208,hsa:5564,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:7423,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5217,hsa:60,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5501,hsa:9586,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C07593,hsa:56901,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5155,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1128,hsa:2776,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1457,hsa:64837,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:50487,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:4170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1460,hsa:3798,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3352,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2792,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2890,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:200186,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8399,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:2773,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:3845,hsa:5293,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:56616,hsa:331,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:8503,hsa:56901,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5155,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:658,hsa:4086,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:3098,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:2915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2253,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4881,cpd:C00942,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:285,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:5579,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:1956,hsa:8503,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2904,hsa:1742,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:80310,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:572,PPrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:6622,hsa:4538,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5605,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:10000,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:4852,hsa:2905,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:208,hsa:51422,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5599,hsa:8471,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:3265,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5291,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8074,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1544,hsa:5908,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:23439,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:8074,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2535,hsa:1857,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:3815,hsa:25759,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:1943,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2915,hsa:2903,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:246,hsa:11145,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5594,hsa:9586,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:5468,hsa:6257,PPrel,binding/association,path:hsa05216 Thyroid cancer,1,0.5
hsa:94235,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:3447,hsa:3455,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:200186,hsa:208,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8823,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4254,hsa:356,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6198,hsa:1975,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3845,hsa:5894,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8817,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:91807,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C01245,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:2561,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2902,hsa:1742,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:208,hsa:2309,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2255,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2773,hsa:108,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1388,hsa:596,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:5601,hsa:3800,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4852,hsa:5140,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:3551,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:3480,hsa:8503,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:4780,hsa:114112,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:1943,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2277,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5562,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:1154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:4886,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4902,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5296,cpd:C05981,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:122809,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7133,hsa:598,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:369,hsa:5604,PPrel,phosphorylation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:3106,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6868,hsa:3991,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5336,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:59345,hsa:3446,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:4193,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4893,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:4794,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2791,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6197,hsa:90673,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5568,hsa:387,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6622,hsa:3552,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:817,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2793,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5535,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11345,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:51703,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4909,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5296,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:3725,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3551,hsa:4793,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:2773,hsa:109,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6196,hsa:90673,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:805,hsa:5530,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:11069,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4773,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:25865,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4720,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5159,hsa:4208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5173,hsa:2904,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4908,hsa:4915,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:801,hsa:283748,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:6514,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3099,hsa:5208,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:6093,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10971,hsa:5732,no_relation,no_relation,no_relation,no_relation,0.0
hsa:111,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:6714,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5568,hsa:2892,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6199,hsa:1975,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00780,hsa:3355,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3458,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5173,hsa:2903,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2253,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8837,hsa:841,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:2246,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5595,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:111,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2788,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:4916,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2246,hsa:5208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6197,hsa:4536,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01312,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5443,hsa:1816,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6794,hsa:7481,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:6752,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6714,hsa:5295,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:5519,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:476,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1892,hsa:5587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2309,hsa:2550,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C21013,hsa:177,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2246,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:80310,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5021,hsa:10368,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5566,hsa:2903,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3265,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23401,hsa:1855,PPrel,binding/association,path:hsa05224 Breast cancer,1,0.5
hsa:2069,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5582,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1436,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4803,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:91860,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:22943,hsa:7478,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2791,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:952,cpd:C13050,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:50848,hsa:332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:8789,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3099,hsa:2891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5567,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:128866,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1813,hsa:8503,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2550,hsa:2770,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:2069,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4709,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2917,hsa:2790,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5509,hsa:2998,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:10379,hsa:440275,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:1375,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3309,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5979,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3690,hsa:71,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:8074,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2773,hsa:109,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4908,hsa:4915,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:26229,hsa:126792,ECrel,compound,path:hsa00532 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,1,0.5
hsa:3845,hsa:369,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7132,hsa:5599,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:5293,hsa:207,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4852,hsa:5733,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:113,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:5604,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2255,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1147,hsa:8660,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5609,hsa:29904,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:84699,hsa:2353,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
cpd:C00334,hsa:340061,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4261,hsa:3108,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:5526,hsa:92579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:55276,no_relation,no_relation,no_relation,no_relation,0.0
hsa:200186,hsa:4729,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3448,hsa:6196,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5599,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:27123,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:9568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:6772,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:10379,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1374,hsa:2182,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:637,hsa:596,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:8321,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:7478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9456,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8324,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5535,hsa:4694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51510,hsa:197259,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:84152,hsa:5501,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:283748,cpd:C00219,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2260,hsa:5291,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:8822,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4722,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:51806,hsa:113,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7424,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2914,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:4776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3910,hsa:3688,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:2771,hsa:108,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:91860,hsa:5533,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5522,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:2788,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2793,hsa:2565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:572,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:468,hsa:134,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1375,hsa:81616,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:285,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:572,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3443,hsa:3454,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5970,hsa:3448,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:1943,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3101,hsa:2720,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:3265,hsa:5600,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1544,hsa:84647,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2255,hsa:226,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10488,hsa:627,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:7852,hsa:7124,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5608,hsa:6300,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:1571,hsa:3108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:200186,hsa:64764,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:2250,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2277,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1855,hsa:23401,PPrel,binding/association,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:1559,hsa:8681,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:284217,hsa:3688,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:816,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:79660,hsa:5834,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
cpd:C00212,hsa:139760,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10000,hsa:468,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2255,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5568,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:492,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8074,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3098,hsa:5211,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5606,hsa:5603,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:9306,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4878,hsa:5732,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2786,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64132,hsa:11285,ECrel,compound,path:hsa00532 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,1,0.5
hsa:50487,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:94235,hsa:2903,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:1388,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5021,hsa:27091,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00547,hsa:1649,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5519,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00788,hsa:154,PCrel,activation,path:hsa04024 cAMP signaling pathway,2,0.8
hsa:345456,hsa:71,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:814,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:112,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1559,hsa:1573,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:10681,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5563,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:1388,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3661,hsa:3446,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:2775,hsa:111,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4261,hsa:3845,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:2099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:29110,hsa:3661,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3630,hsa:116443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,cpd:C00076,PCrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2253,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:823,PCrel,activation,path:hsa04217 Necroptosis,2,0.8
hsa:2770,hsa:5291,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2246,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5021,hsa:778,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1573,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:3592,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:2932,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:1649,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:4804,hsa:3117,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:4793,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:11337,hsa:2559,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:5566,hsa:116444,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5296,hsa:10000,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1557,hsa:64600,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:3481,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00547,hsa:5021,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4902,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C16844,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:196883,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:9455,hsa:9456,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,2,0.5
hsa:7422,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5599,hsa:3800,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00025,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4261,hsa:3119,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:27006,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5603,hsa:9261,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:4261,hsa:3112,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:207,hsa:2932,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:818,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:816,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2255,hsa:6464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2902,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:1945,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3627,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:4790,hsa:2920,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:27330,hsa:5509,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:2053,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:3162,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4902,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7139,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6196,hsa:64600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2776,hsa:4893,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:57506,hsa:7187,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5594,hsa:7157,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:230,hsa:26007,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:7099,hsa:4615,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2263,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1855,hsa:10023,PPrel,binding/association,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:2793,hsa:56924,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10023,hsa:2783,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6772,hsa:3593,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:1908,hsa:3354,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5210,hsa:5213,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2550,hsa:2784,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:8823,hsa:2793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:5291,hsa:208,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1942,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:817,hsa:4846,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6654,hsa:4893,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2550,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3265,hsa:5296,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5562,hsa:57818,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:3481,hsa:1728,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:1147,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:163688,hsa:5880,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2323,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4915,hsa:2939,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1435,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4638,hsa:4637,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:7039,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2263,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5170,hsa:208,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2214,hsa:5600,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:4137,hsa:112714,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8503,cpd:C05981,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:3845,hsa:1432,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5295,hsa:10000,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C11310,hsa:5209,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:57118,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:108,cpd:C00575,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5604,hsa:5594,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:3481,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7297,hsa:6772,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:7423,hsa:7187,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:5106,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8517,hsa:4793,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:501,hsa:51166,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:23683,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:1559,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
cpd:C11310,hsa:4704,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:818,hsa:5144,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:841,hsa:840,PPrel,activation,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:3479,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5499,hsa:64764,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
path:hsa00010,hsa:230,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:4793,hsa:4093,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9002,hsa:2778,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1950,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2792,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1573,hsa:1544,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:2982,cpd:C00942,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:2246,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4852,hsa:1129,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:80310,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa05224 Breast cancer,3,0.8
hsa:3845,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:5208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:84699,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:6794,hsa:5562,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:1946,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C07593,hsa:4708,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:51422,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:3778,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:3665,hsa:3452,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:4804,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:9586,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:9475,hsa:4659,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1943,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:4089,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4254,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00788,hsa:134,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7424,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:816,hsa:148327,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:4803,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3479,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5021,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:6655,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:2534,hsa:5293,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:2775,hsa:2775,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:134,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5568,hsa:2890,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:207,hsa:4193,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:4254,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5610,hsa:1965,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:11035,hsa:5836,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:8503,hsa:30814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1499,hsa:6934,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:163688,hsa:817,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:810,hsa:5533,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:7332,hsa:3717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8651,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9455,hsa:3710,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:1147,hsa:4792,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
cpd:C00334,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:658,hsa:92,PPrel,binding/association,path:hsa04350 TGF-beta signaling pathway,2,0.5
hsa:3082,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5770,hsa:3448,no_relation,no_relation,no_relation,no_relation,0.0
hsa:369,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:4793,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:650,hsa:134,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:196883,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2538,hsa:55276,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5579,hsa:10488,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:2771,hsa:196883,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:369,hsa:5605,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2260,hsa:2776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1738,hsa:1743,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:801,hsa:815,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1576,hsa:100137049,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:3908,hsa:3688,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:2846,hsa:2776,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51378,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2261,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00025,hsa:2737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:64764,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:59345,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:51806,hsa:109,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:283106,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:5594,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:3689,hsa:5743,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:2641,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:3354,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:5294,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2784,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:817,hsa:5141,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1432,hsa:2920,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:3441,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:51378,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5523,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1978,hsa:2737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2770,hsa:5332,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:801,hsa:818,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
cpd:C00780,hsa:1395,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2932,hsa:147700,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:2255,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2053,hsa:10327,ECrel,compound,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:8517,hsa:4792,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:38,path:hsa00020,maplink,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:808,hsa:113,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2932,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10023,hsa:1857,PPrel,binding/association,path:hsa05224 Breast cancer,1,0.5
hsa:2255,hsa:9693,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:27330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,cpd:C00165,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4893,hsa:5295,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:818,hsa:1019,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:207,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:283106,hsa:3799,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:2775,hsa:3455,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:5571,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5571,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2912,hsa:5581,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4792,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:7332,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1813,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2912,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:64764,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5295,cpd:C05981,PCrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:57506,hsa:7187,PPrel,binding/association,path:hsa05160 Hepatitis C,1,0.5
hsa:1807,hsa:1109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:3831,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:805,hsa:10645,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1812,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5567,hsa:5894,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:572,hsa:1129,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:4093,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5894,hsa:9456,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:6389,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2782,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:815,hsa:64764,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3098,hsa:5207,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:4803,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5595,hsa:5972,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:1072,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4908,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4914,hsa:3667,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1945,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5566,hsa:2892,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1559,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:112,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7010,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:1432,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5567,hsa:2904,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:3082,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3630,hsa:91860,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84152,hsa:5499,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5170,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:51079,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:9048,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00704,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5338,hsa:25865,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:8822,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5170,hsa:208,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:56034,hsa:2891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1969,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:57506,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:3569,GErel,expression,path:hsa04931 Insulin resistance,2,0.5
hsa:8823,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:91860,hsa:107,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5290,hsa:5580,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:468,hsa:1958,GErel,expression,path:hsa05020 Prion disease,1,0.5
hsa:55970,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2912,hsa:2792,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10000,hsa:9586,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3442,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:23236,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:65018,hsa:4537,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C03758,hsa:1816,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5894,hsa:5605,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:3912,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00780,hsa:2740,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5578,hsa:5141,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2917,hsa:2791,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5770,hsa:3667,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:4908,hsa:54578,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:3444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:1576,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
cpd:C00025,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:2997,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2215,hsa:5603,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:2786,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2309,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:23236,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5335,cpd:C00165,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1111,hsa:494551,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4908,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9771,hsa:5906,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:54331,hsa:5143,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3091,hsa:6513,GErel,expression,path:hsa04919 Thyroid hormone signaling pathway,1,0.5
hsa:5970,hsa:7124,GErel,expression,path:hsa04931 Insulin resistance,2,0.5
hsa:5293,cpd:C05981,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:2788,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2535,hsa:1857,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2793,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8822,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:4792,PPrel,phosphorylation,path:hsa05164 Influenza A,2,0.8
hsa:2323,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:468,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6237,hsa:5144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1268,hsa:5331,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00533,hsa:2983,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:4790,hsa:3552,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:1644,hsa:2805,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:5610,hsa:1965,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:3442,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:109,cpd:C00575,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:23566,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,cpd:C00575,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:5608,hsa:774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:4893,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:356,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4659,hsa:10398,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5213,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:5509,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:10243,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00083,hsa:1375,PCrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:5602,hsa:55276,no_relation,no_relation,no_relation,no_relation,0.0
hsa:330,hsa:840,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:1388,hsa:1958,GErel,expression,path:hsa05020 Prion disease,1,0.5
hsa:5071,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:2891,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:1950,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:2905,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00165,hsa:5582,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:51764,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:4893,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2308,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5970,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:2788,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:109,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5518,hsa:5139,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55844,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6300,hsa:3725,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:4261,hsa:3112,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:2260,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:113,hsa:5294,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2904,hsa:81579,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:208,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2773,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:5566,hsa:51478,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:2778,hsa:112,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:3845,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2932,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2914,hsa:2773,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:3305,hsa:7097,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5290,cpd:C05981,PCrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:10645,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:196883,cpd:C00575,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7408,hsa:60,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51422,hsa:5106,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
cpd:C01245,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3918,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:353376,hsa:148022,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1956,hsa:5293,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:6093,hsa:4659,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4893,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:805,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:126129,hsa:23205,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:7252,hsa:2903,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,hsa:226,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:6655,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:55012,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:7481,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7976,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6750,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1081,hsa:3973,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
hsa:6934,hsa:4609,GErel,expression,path:hsa05216 Thyroid cancer,1,0.5
hsa:27123,hsa:7481,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5908,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:3667,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:1457,hsa:3800,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:1950,hsa:4940,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:109,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2787,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2668,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:3122,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:8717,hsa:27089,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5564,hsa:2538,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5608,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:107,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2249,hsa:4843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5481,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:4539,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5521,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3625,hsa:93,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:207,hsa:2308,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:83593,hsa:3688,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5568,hsa:4772,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:5605,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:4878,hsa:574537,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:5465,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5568,hsa:468,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:7423,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:130589,hsa:25759,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3718,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56034,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5568,hsa:1385,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:7852,hsa:51764,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:572,hsa:596,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:154,hsa:4843,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8851,hsa:4137,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8517,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:89953,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6195,hsa:5501,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:108,cpd:C00575,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:5507,hsa:5837,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:3717,hsa:6776,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2277,hsa:3655,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2249,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5228,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2277,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3845,hsa:197259,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:5578,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:23236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1856,hsa:2932,PPrel,inhibition,path:hsa05224 Breast cancer,1,0.8
hsa:5335,hsa:5106,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:25865,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51378,hsa:7474,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,hsa:398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5588,hsa:8517,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5228,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C11310,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3101,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:200186,hsa:10000,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:80310,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:2555,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5601,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3815,hsa:5291,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5154,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3688,hsa:71,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:2277,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:197259,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5295,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1962,hsa:3033,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:817,hsa:10846,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1435,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1943,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:369,hsa:4634,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2892,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:208,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1385,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2784,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:810,hsa:814,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
cpd:C00076,hsa:112,PCrel,inhibition,path:hsa04924 Renin secretion,2,0.8
hsa:2932,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1907,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2645,hsa:5236,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
cpd:C00095,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:2181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:54659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2069,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2913,hsa:56924,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5208,hsa:3953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:595,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
cpd:C00533,hsa:9817,PCrel,inhibition,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:27330,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1942,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4254,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:482,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1385,hsa:2354,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:2790,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5604,hsa:5594,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3446,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10319,hsa:3688,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5295,cpd:C05981,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:7531,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:255189,PCrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2790,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3082,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2791,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5532,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:1544,hsa:246,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:3480,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7424,hsa:7186,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5207,hsa:1588,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:6773,PPrel,phosphorylation,path:hsa05164 Influenza A,1,0.8
hsa:2277,hsa:5732,no_relation,no_relation,no_relation,no_relation,0.0
hsa:440275,hsa:8517,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:3984,hsa:1073,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C04549,hsa:55062,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:816,hsa:5142,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1942,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:22943,hsa:7481,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:285,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:657,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5900,hsa:5836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:10000,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:11345,hsa:2567,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:51764,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:80201,hsa:4129,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3452,hsa:6233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:1942,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:3448,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5501,hsa:659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:26291,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5594,hsa:477,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:9048,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2912,hsa:10681,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10411,hsa:5601,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
path:hsa00010,hsa:7167,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:815,hsa:5587,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:481,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3480,hsa:5296,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:5578,hsa:2892,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4537,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5881,hsa:10298,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5295,hsa:637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:7137,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C01996,hsa:23439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2911,hsa:9456,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
cpd:C22381,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:5605,PPrel,phosphorylation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:27006,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:90993,hsa:4170,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:6197,hsa:468,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C01245,hsa:3709,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:3091,hsa:5211,GErel,expression,path:hsa04919 Thyroid hormone signaling pathway,1,0.5
hsa:5170,hsa:10110,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5295,hsa:4893,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1945,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:5534,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:59345,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:2786,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6197,hsa:5509,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
cpd:C01996,hsa:1128,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:23566,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:5338,no_relation,no_relation,no_relation,no_relation,0.0
hsa:399694,hsa:2549,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:3630,hsa:2939,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:64764,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:92579,cpd:C00031,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
cpd:C03758,hsa:5732,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C05981,hsa:207,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:1576,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:5320,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2914,hsa:2785,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2251,hsa:2903,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:10488,PPrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:10379,hsa:6774,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:3914,hsa:3688,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:163688,hsa:109,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5155,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2786,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10645,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4843,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:1460,hsa:3798,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:5499,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:1945,cpd:C00076,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2260,hsa:399694,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:1558,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:2556,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,cpd:C05981,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:65018,hsa:55062,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1388,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:627,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:959,hsa:958,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:4893,hsa:5600,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:26281,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4915,hsa:399694,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3265,hsa:3576,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9246,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:5321,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:51806,hsa:108,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5567,hsa:5144,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8660,hsa:4725,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2645,path:hsa00010,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:2550,hsa:10681,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:5564,hsa:92579,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:9693,hsa:5906,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3443,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:26281,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5609,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
cpd:C01471,hsa:9817,PCrel,inhibition,path:hsa05225 Hepatocellular carcinoma,1,0.8
cpd:C00076,hsa:4705,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10379,hsa:27102,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:2250,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9965,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2912,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2914,hsa:2793,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:6196,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:126129,hsa:1540,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9021,hsa:2893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:8503,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:91860,hsa:112,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1944,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:581,hsa:54205,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:10105,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:71,hsa:824,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3449,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:56616,hsa:330,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:2668,hsa:1573,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5534,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:650,path:hsa00010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4772,hsa:1827,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:137362,hsa:4282,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
cpd:C03758,hsa:153,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:572,hsa:4615,no_relation,no_relation,no_relation,no_relation,0.0
hsa:108,hsa:840,no_relation,no_relation,no_relation,no_relation,0.0
hsa:440275,hsa:1147,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:5578,hsa:100137049,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2917,hsa:2784,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:163688,hsa:114,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:805,hsa:5535,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:814,hsa:10846,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C11310,hsa:4701,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:11069,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4878,hsa:4881,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:374,hsa:4710,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10379,hsa:4600,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:2309,hsa:10018,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:10379,hsa:4090,no_relation,no_relation,no_relation,no_relation,0.0
hsa:137362,hsa:79660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:283106,hsa:64837,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5526,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6885,hsa:3350,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:107,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:6196,hsa:5500,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:2251,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2251,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:56034,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2251,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3459,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3242,hsa:5106,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5925,hsa:3352,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2906,hsa:1742,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:4261,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:2905,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:5293,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8326,hsa:1857,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:673,hsa:5605,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:9454,hsa:2915,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:4909,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3099,hsa:5213,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:163688,hsa:5532,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:3551,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84699,hsa:2977,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2918,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1436,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C01312,hsa:3442,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3908,hsa:1605,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:6772,hsa:3115,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:2885,hsa:6655,PPrel,binding/association,path:hsa05160 Hepatitis C,1,0.5
hsa:8323,hsa:1857,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1392,hsa:5580,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:5743,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:5606,hsa:53358,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27123,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:1388,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5507,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1558,hsa:81579,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5567,hsa:3294,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
hsa:5535,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:84699,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:572,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:10000,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:91860,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5567,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:2253,hsa:116444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6750,hsa:1909,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1944,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2549,hsa:5291,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5290,hsa:478,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:27330,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4261,hsa:3126,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:23401,hsa:1857,PPrel,binding/association,path:hsa05224 Breast cancer,1,0.5
hsa:2251,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5332,cpd:C01245,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:6932,hsa:595,GErel,expression,path:hsa05224 Breast cancer,1,0.5
cpd:C00575,hsa:641371,PCrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:7423,hsa:5880,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1956,hsa:5293,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:7097,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4909,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:142,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5535,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:1943,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C05981,hsa:100532726,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:7410,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:595,PPrel,phosphorylation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:627,hsa:4804,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:8517,hsa:8471,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:1436,hsa:7709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:23683,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2475,hsa:6198,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:1435,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3551,hsa:4794,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5331,cpd:C00165,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:545,hsa:1111,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8651,hsa:6776,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:8817,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6720,hsa:32,GErel,expression,path:hsa04931 Insulin resistance,1,0.5
hsa:1856,hsa:2932,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2247,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9223,hsa:9693,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2932,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:815,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5534,hsa:2911,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10683,hsa:4853,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:91860,hsa:818,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:208,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:115,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2771,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5520,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3098,hsa:3760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3105,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:7297,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6778,hsa:2181,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:2932,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:1385,hsa:627,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:111,hsa:4659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:11145,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5602,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:5140,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1432,hsa:2921,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
cpd:C00165,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:478,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5527,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4695,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5595,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:480,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1435,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2792,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C00788,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7128,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9568,hsa:2786,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:284,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4803,hsa:808,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9103,hsa:9568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:468,hsa:85366,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:1558,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:6196,hsa:5509,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:6655,hsa:3265,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:2784,hsa:1571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:10000,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:11145,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:3845,hsa:5603,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5291,hsa:480,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
cpd:C00334,hsa:55879,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:2695,hsa:5208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55844,cpd:C00584,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00195,hsa:5908,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00520,hsa:80201,maplink,compound,path:hsa00051 Fructose and mannose metabolism,2,0.5
hsa:94235,hsa:477,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:4790,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5879,hsa:5293,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7297,hsa:22800,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:7388,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6772,hsa:4843,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:284,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8321,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:10383,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:130399,hsa:157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3444,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:3098,hsa:7157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:94235,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:801,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4712,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3716,hsa:5295,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5515,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7097,hsa:3170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5524,hsa:5837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2792,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1436,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5336,hsa:810,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:207,hsa:51422,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2324,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:11345,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:154,PCrel,activation,path:hsa04024 cAMP signaling pathway,2,0.8
hsa:5582,hsa:100137049,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1944,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:116,hsa:2740,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5290,hsa:476,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5594,hsa:482,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:25865,hsa:51764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5335,hsa:140465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:9586,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:285,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5516,hsa:6772,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:27121,hsa:637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:111,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1021,hsa:5925,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:2081,hsa:7186,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:59345,hsa:1385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:4881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7186,hsa:776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2787,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
cpd:C00076,hsa:5530,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2253,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:155,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:5320,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
cpd:C00780,hsa:1909,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2792,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:83729,hsa:51806,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:3091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:2353,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5335,hsa:810,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5332,cpd:C00165,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5970,hsa:10379,no_relation,no_relation,no_relation,no_relation,0.0
hsa:182,hsa:4725,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01996,hsa:7385,no_relation,no_relation,no_relation,no_relation,0.0
hsa:71,hsa:3091,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:1128,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2918,hsa:3135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:4695,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:207,PCrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
path:hsa00640,hsa:339896,maplink,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
cpd:C00165,hsa:5579,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3626,hsa:7043,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:1559,hsa:3292,no_relation,no_relation,no_relation,no_relation,0.0
hsa:111,hsa:1435,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:57118,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1460,hsa:38,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:114,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:285,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1571,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2775,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:3845,hsa:5894,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3326,hsa:8737,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1557,hsa:8681,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2793,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3458,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3456,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:7010,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1906,hsa:1813,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3064,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:1816,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5214,hsa:230,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2775,hsa:113,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:9048,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:2737,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3479,hsa:5734,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:5139,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:440275,hsa:1147,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:208,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:6654,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5595,hsa:2002,PPrel,phosphorylation,path:hsa05140 Leishmaniasis,1,0.8
hsa:369,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:185,hsa:2776,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:1944,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7167,hsa:226,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,2,0.5
hsa:7423,hsa:3162,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2099,hsa:4609,GErel,expression,path:hsa05224 Breast cancer,2,0.5
hsa:5571,hsa:57818,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:3551,hsa:1728,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3845,hsa:6300,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2770,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64135,hsa:57506,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:7124,hsa:7132,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2914,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:5836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4916,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:1812,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:222,hsa:801,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4287,hsa:3708,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2770,hsa:112,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:545,hsa:1111,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2885,hsa:842,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2260,hsa:5293,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:1943,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C11310,hsa:4710,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1571,hsa:3445,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:814,hsa:5144,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4915,hsa:4086,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2912,hsa:2783,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:596,hsa:2740,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C01312,hsa:1812,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5879,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5119,hsa:2100,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5579,hsa:100137049,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1558,hsa:5294,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5500,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:8399,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:2203,hsa:5295,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2309,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:1956,hsa:71,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:91807,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6712,hsa:2911,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5908,hsa:55970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1946,hsa:627,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:153,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:83729,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2209,hsa:5579,ECrel,compound,path:hsa05140 Leishmaniasis,1,0.5
hsa:2775,hsa:5294,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:3101,hsa:5207,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:27006,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2254,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:65018,hsa:5236,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1950,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5295,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C03758,hsa:3763,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3440,GErel,expression,path:hsa05164 Influenza A,1,0.5
cpd:C05981,hsa:10000,PCrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:51378,hsa:5321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3397,hsa:5291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5211,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1026,hsa:1017,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:5336,hsa:5580,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:3440,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:4792,PPrel,activation,path:hsa05164 Influenza A,2,0.8
hsa:4790,hsa:3452,GErel,expression,path:hsa05164 Influenza A,2,0.5
cpd:C07593,hsa:4719,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4893,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3479,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2254,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:27330,hsa:122970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5336,hsa:805,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5170,hsa:5586,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:22943,hsa:7479,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1576,hsa:3654,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:4208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:70,hsa:7169,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
cpd:C00334,hsa:2563,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:4624,hsa:4634,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:6885,hsa:5606,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5213,path:hsa00010,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:816,hsa:10488,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:55276,hsa:7360,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
cpd:C00575,hsa:5567,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:3815,hsa:399694,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:2249,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5530,hsa:2932,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:65018,hsa:4705,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5170,hsa:6199,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:329,hsa:836,PPrel,inhibition,path:hsa05145 Toxoplasmosis,1,0.8
hsa:4093,hsa:4089,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
cpd:C22381,hsa:2891,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01996,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1457,hsa:64837,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:9843,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1576,hsa:26279,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:3630,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:54331,hsa:2776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5291,hsa:5590,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5600,hsa:2353,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:55526,hsa:1738,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:5170,hsa:207,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:1892,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5443,hsa:5732,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1021,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3569,GErel,expression,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:5603,hsa:2919,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:208,hsa:2475,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:627,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:596,hsa:7416,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2064,hsa:5296,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:5970,hsa:3569,GErel,expression,path:hsa04931 Insulin resistance,2,0.5
hsa:2246,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2775,hsa:5296,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1942,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00076,hsa:30,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7099,hsa:148022,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:2249,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1855,hsa:2932,PPrel,inhibition,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:8878,hsa:3125,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2770,hsa:4089,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:3352,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:91860,hsa:9020,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5290,PPrel,activation,path:hsa04931 Insulin resistance,3,0.8
hsa:9454,hsa:3709,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:207,hsa:4792,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:117145,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5532,hsa:2717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5525,hsa:207,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10683,hsa:782,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:108,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2885,hsa:6654,PPrel,binding/association,path:hsa05160 Hepatitis C,1,0.5
cpd:C01312,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:637,hsa:291,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:4881,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:200186,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5516,hsa:6199,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:1945,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2261,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1605,hsa:1605,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:2983,cpd:C00942,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:1892,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:5144,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
path:hsa00010,hsa:226,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:9456,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5154,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C11310,hsa:4541,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1962,hsa:1962,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:4780,hsa:4259,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:3265,hsa:5293,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1855,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:818,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:3630,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2932,hsa:2998,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1917,hsa:5777,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
cpd:C00334,hsa:1129,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5567,hsa:5140,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C03758,hsa:4881,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3456,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:3911,hsa:1072,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:51380,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:1399,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:22943,hsa:7483,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2254,hsa:25759,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:391013,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2913,hsa:1909,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:90993,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:6932,hsa:595,GErel,expression,path:hsa05216 Thyroid cancer,1,0.5
hsa:65018,hsa:4710,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3716,hsa:6774,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:1154,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9451,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1436,hsa:4233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2914,hsa:55970,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:808,hsa:5530,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:126129,hsa:2180,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:5602,hsa:89953,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5568,hsa:491,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4780,hsa:4780,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4723,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5336,hsa:801,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3099,hsa:8789,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2775,hsa:5331,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5155,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7010,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5610,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:5733,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:1812,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8325,hsa:7360,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2251,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:230,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10379,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,hsa:817,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5599,hsa:8660,PPrel,phosphorylation,path:hsa04931 Insulin resistance,2,0.8
hsa:65018,hsa:54539,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7423,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5734,hsa:3440,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:9103,hsa:51764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:4893,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2791,hsa:115,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:27121,hsa:7483,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2787,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:673,hsa:5604,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5331,hsa:3655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:5599,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7531,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:107,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:5834,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51733,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51422,hsa:32,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:4804,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4217,hsa:5600,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:1457,hsa:3799,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00334,hsa:2564,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:2254,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C07593,hsa:90,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5335,cpd:C01245,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
cpd:C00076,hsa:805,PCrel,binding/association,path:hsa05031 Amphetamine addiction,2,0.5
hsa:5154,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C01996,hsa:5733,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2784,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:6932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5564,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5533,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:4838,hsa:93,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5599,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:65018,hsa:784,no_relation,no_relation,no_relation,no_relation,0.0
hsa:56924,hsa:3984,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:7423,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2254,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:123745,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5499,hsa:134,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:1958,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2252,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3242,hsa:137362,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:2277,hsa:4851,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2914,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:5880,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8660,hsa:5571,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:23683,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4261,hsa:3125,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:4916,hsa:4731,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:30814,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:1857,hsa:2932,PPrel,inhibition,path:hsa05224 Breast cancer,1,0.8
hsa:8817,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00575,hsa:5566,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1969,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5170,hsa:207,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:7253,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C01312,hsa:1395,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00212,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:136,hsa:6531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:84699,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:5970,hsa:3442,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:208,hsa:572,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:65018,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:332,hsa:79861,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9021,hsa:6777,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5565,hsa:57521,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:65018,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4716,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7423,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1944,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:285,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:468,hsa:1649,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:673,hsa:140465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7852,hsa:2767,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C00584,hsa:2740,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:27006,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4790,hsa:3444,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5602,hsa:4170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5515,hsa:57118,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6093,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6774,hsa:126129,GErel,expression,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:8823,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3480,hsa:23411,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3098,hsa:5236,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:2249,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4660,hsa:10398,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2668,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6199,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:146850,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6750,hsa:3350,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3689,hsa:3383,PPrel,binding/association,path:hsa05144 Malaria,2,0.5
hsa:224,hsa:51733,ECrel,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:3815,hsa:5332,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5567,hsa:3991,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:11345,hsa:2558,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:8651,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:57144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2786,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:5144,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:818,hsa:148327,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:816,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2249,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:57121,hsa:2776,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1573,hsa:64600,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:81579,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:2277,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1457,hsa:3831,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:54979,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2247,hsa:84647,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4137,hsa:347733,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8822,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1950,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:79660,hsa:4729,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:818,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:1259,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2641,hsa:154,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2254,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1644,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00533,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:779,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64764,hsa:7296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:637,hsa:53358,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5565,cpd:C00416,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1234,hsa:51764,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4790,hsa:7124,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:2323,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2255,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,path:hsa00040,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:3445,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2783,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:8074,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3460,hsa:3717,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:834,hsa:3606,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:5210,path:hsa00010,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:3446,hsa:3455,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:1945,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2775,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2913,PCrel,activation,path:hsa04724 Glutamatergic synapse,3,0.8
hsa:23130,hsa:26100,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:5582,hsa:814,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4694,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:23493,hsa:4702,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2309,hsa:356,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:2821,hsa:55276,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:3460,hsa:7297,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5566,hsa:5141,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5879,hsa:106821730,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:51378,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5604,hsa:5595,PPrel,phosphorylation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:1375,hsa:3360,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4301,hsa:5880,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:7124,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:1435,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2255,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7494,hsa:1649,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:2932,hsa:2997,PPrel,phosphorylation,path:hsa04931 Insulin resistance,3,0.8
hsa:5606,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:340156,hsa:10398,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5443,hsa:3362,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2247,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51733,path:hsa00640,maplink,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:5604,hsa:5142,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:111,PPrel,inhibition,path:hsa04924 Renin secretion,1,0.8
hsa:27006,hsa:2560,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3718,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:818,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8503,hsa:3845,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:4780,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:5582,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5332,hsa:11145,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2990,hsa:7366,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:5733,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1557,hsa:4842,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:5600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:2773,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:8517,hsa:4792,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:596,hsa:581,PPrel,inhibition,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2775,hsa:4722,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:5291,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:51764,hsa:8660,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:5293,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2918,hsa:54331,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2782,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:5291,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:207,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2081,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:5140,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:468,hsa:4158,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:6774,hsa:9021,GErel,expression,path:hsa04931 Insulin resistance,2,0.5
hsa:2248,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00788,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:9021,GErel,expression,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:2913,hsa:2787,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2792,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:94235,hsa:5207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2990,hsa:54659,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:25759,hsa:2885,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:5594,hsa:6197,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5154,hsa:5618,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8324,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:4705,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5159,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10000,hsa:108,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:80310,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00547,hsa:1395,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2250,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:116,hsa:32,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:2788,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2903,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:4893,hsa:4704,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9945,hsa:4700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:59345,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01996,hsa:139760,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55844,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8074,hsa:5894,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:283748,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:2251,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:207,hsa:109,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
cpd:C00584,hsa:9568,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5595,hsa:481,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1571,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1605,hsa:1756,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:5970,hsa:2919,GErel,expression,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.5
hsa:27006,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5609,hsa:5602,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:8322,hsa:1855,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2247,hsa:4793,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1813,hsa:2770,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2771,hsa:113,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:231,hsa:2720,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:1385,hsa:4170,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:2250,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2805,hsa:3725,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5566,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:1573,hsa:8399,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:7422,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6794,hsa:5563,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5296,hsa:208,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1946,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:399694,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8324,hsa:482,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:11145,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:2254,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3456,hsa:3454,PPrel,activation,path:hsa05164 Influenza A,1,0.8
cpd:C11310,hsa:4713,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:815,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2149,hsa:2776,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5608,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5623,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:6773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:51196,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6300,hsa:2353,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1944,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4804,hsa:3099,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5530,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5604,hsa:5594,PPrel,phosphorylation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4914,hsa:4637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:1432,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3265,hsa:673,PPrel,activation,path:hsa05216 Thyroid cancer,2,0.8
hsa:2932,hsa:64837,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:9965,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:816,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:596,hsa:581,PPrel,inhibition,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:10681,hsa:2563,no_relation,no_relation,no_relation,no_relation,0.0
hsa:25,hsa:5587,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:285,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:91860,hsa:5534,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:2932,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1906,hsa:2550,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:81858,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6655,hsa:3845,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5500,hsa:23205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3913,hsa:3688,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:32,hsa:126129,PPrel,compound,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:817,hsa:1385,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:114,cpd:C00575,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2251,hsa:596,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3133,hsa:4731,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:4846,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6416,hsa:5599,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5155,hsa:817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:6196,hsa:3101,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6772,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4852,hsa:2308,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4723,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2771,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:8817,hsa:26007,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5532,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
cpd:C11310,hsa:5330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3030,hsa:2639,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:27006,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1950,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:3294,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:5605,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:1576,hsa:50487,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:3716,hsa:5879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5228,hsa:59345,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,hsa:5602,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2785,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:10645,hsa:5562,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:4909,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:801,hsa:8681,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80201,hsa:8789,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2904,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:114,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00025,hsa:2912,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:59345,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5568,hsa:2905,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:4914,hsa:1738,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:4728,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6196,hsa:5509,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:4261,hsa:3126,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:3479,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1907,hsa:3709,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4261,hsa:3127,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:108,cpd:C00575,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:5535,hsa:1813,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
cpd:C01996,hsa:1133,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4908,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:627,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00788,hsa:3674,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2893,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:7408,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:217,path:hsa00640,maplink,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:5594,hsa:4093,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:808,hsa:815,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6198,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:102723407,hsa:2214,PPrel,binding/association,path:hsa05140 Leishmaniasis,1,0.5
hsa:2776,hsa:387,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2248,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8503,hsa:207,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:3354,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5534,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:8471,hsa:5291,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2668,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1950,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:776,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:1147,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:53632,hsa:32,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:8324,hsa:1857,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2645,hsa:84152,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:3831,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8605,hsa:30,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3265,hsa:3798,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9586,hsa:3725,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:2770,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:2785,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:207,hsa:842,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5414,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:92579,path:hsa00051,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:79660,hsa:5837,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:2069,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1536,cpd:C00704,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:83439,hsa:3480,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90,hsa:4090,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:7297,hsa:6773,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5228,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5296,cpd:C05981,PCrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:4855,hsa:64764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23710,hsa:5320,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:1385,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:1147,hsa:4792,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:2932,hsa:2771,no_relation,no_relation,no_relation,no_relation,0.0
hsa:116,hsa:117,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:1908,hsa:5733,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3481,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9568,hsa:59345,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:1969,hsa:2778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5173,hsa:2906,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00076,hsa:10451,no_relation,no_relation,no_relation,no_relation,0.0
hsa:163688,hsa:5530,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:91860,hsa:10645,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4851,hsa:23493,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:2251,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1559,hsa:50487,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:26291,hsa:2787,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1388,hsa:2353,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:9370,hsa:79602,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:4893,hsa:5290,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:8822,hsa:6093,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5525,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2913,hsa:5602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7124,hsa:7132,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5579,hsa:5610,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5568,hsa:116444,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:207,hsa:1128,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1644,hsa:4128,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:7852,hsa:4539,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:5663,hsa:3763,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5295,cpd:C05981,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:3448,hsa:3455,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5208,hsa:25759,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:10846,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:10488,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9048,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C11310,hsa:3553,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5523,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26281,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:317,hsa:842,PPrel,activation,path:hsa05020 Prion disease,1,0.8
cpd:C00044,hsa:5908,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
hsa:7852,hsa:55970,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1435,hsa:2595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:151056,no_relation,no_relation,no_relation,no_relation,0.0
hsa:285,hsa:4087,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00165,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5609,hsa:5601,PPrel,phosphorylation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3913,hsa:572,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6750,hsa:154,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8822,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00788,hsa:1395,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10488,hsa:478,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:4846,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3362,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3661,hsa:3456,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:3098,hsa:5214,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:51806,hsa:108,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:91860,hsa:5535,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:7039,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5228,hsa:4792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3449,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
cpd:C00076,hsa:5578,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5522,hsa:6772,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:8471,hsa:5293,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:5605,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:6548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:108,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
cpd:C00076,hsa:810,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:8817,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2641,hsa:3362,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:163688,hsa:108,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2323,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:91860,hsa:5532,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:148022,hsa:3164,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:7249,PPrel,inhibition,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5908,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2906,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2251,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5970,hsa:92579,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00051,hsa:3099,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,3,0.5
hsa:5516,hsa:5516,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5516,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:2353,no_relation,no_relation,no_relation,no_relation,0.0
hsa:673,hsa:81616,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2668,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3033,hsa:3265,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:1128,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1908,hsa:5021,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10000,hsa:8517,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5879,hsa:56924,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:196883,cpd:C00575,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:55970,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:374,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1558,hsa:391013,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:5567,hsa:491,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8471,hsa:3091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2185,hsa:84699,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:90993,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:2081,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:5509,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3098,path:hsa00010,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:26508,hsa:595,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:5228,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3688,hsa:814,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01312,hsa:7253,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2914,hsa:2786,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:11345,hsa:2554,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:246,hsa:2554,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:116443,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4190,hsa:5106,ECrel,compound,path:hsa04964 Proximal tubule bicarbonate reclamation,1,0.5
hsa:2249,hsa:3451,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:115,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:208,hsa:4794,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C01312,hsa:3973,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1573,hsa:3447,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:815,hsa:90993,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5594,hsa:481,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:8823,hsa:10398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:283106,hsa:8398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:182,hsa:4851,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:4803,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:627,hsa:340156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5524,hsa:2892,no_relation,no_relation,no_relation,no_relation,0.0
hsa:64208,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3452,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:3973,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2932,hsa:4609,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:163688,hsa:115,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5608,hsa:2997,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11069,hsa:5908,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5970,hsa:6531,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51378,hsa:5156,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2248,hsa:3551,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3665,hsa:3456,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:26281,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5906,hsa:8503,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:27330,hsa:3845,PPrel,inhibition,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6197,hsa:3265,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00575,hsa:5567,PCrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:6934,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11035,hsa:815,PPrel,phosphorylation,path:hsa04217 Necroptosis,1,0.8
hsa:1459,hsa:64837,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:1435,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3354,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4254,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:25759,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2069,hsa:6514,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:84699,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2791,hsa:9586,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3448,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2639,hsa:1743,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:5021,hsa:2787,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2737,hsa:5727,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:246,hsa:26279,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:5533,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:196883,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9021,hsa:6233,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5565,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:2771,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2252,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:2309,PPrel,phosphorylation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:113,cpd:C00575,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8517,hsa:4792,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5565,hsa:92579,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:6714,hsa:9693,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2773,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:5534,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:255189,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3625,hsa:90,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:5063,hsa:3984,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1460,hsa:89953,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
cpd:C00533,hsa:2977,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:11035,hsa:2904,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:4718,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:10000,hsa:2308,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2788,hsa:3569,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5290,hsa:3845,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:51806,hsa:817,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5296,hsa:207,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3091,hsa:90673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7094,hsa:3690,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2247,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2251,hsa:79861,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:4846,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:116,hsa:7253,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2918,hsa:59345,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2248,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5599,hsa:1432,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:155,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:1856,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:4609,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:147700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91782,hsa:2560,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3716,hsa:6774,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:2309,hsa:356,GErel,expression,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5296,cpd:C05981,PCrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:6777,hsa:6514,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:3135,hsa:5506,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2247,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8517,hsa:8660,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:10411,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4217,hsa:6416,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C14819,hsa:7018,PCrel,binding/association,path:hsa04350 TGF-beta signaling pathway,1,0.5
hsa:1459,hsa:64837,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5908,hsa:5296,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5594,hsa:1385,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1557,hsa:1576,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
cpd:C07593,hsa:2559,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3815,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4254,hsa:8536,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4712,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2790,hsa:5211,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2323,hsa:1072,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23683,hsa:8517,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
cpd:C00165,hsa:25780,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:51806,hsa:112,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:80201,hsa:5209,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:5610,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:122809,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5601,hsa:2512,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:2247,hsa:3763,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:4793,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2791,hsa:3760,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5290,cpd:C05981,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:5170,hsa:10000,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3455,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:51380,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:114,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3481,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26508,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:59345,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:824,hsa:8851,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5602,hsa:64837,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2783,hsa:779,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:3066,hsa:55276,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:5170,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:9021,hsa:8660,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:4915,hsa:5332,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5564,hsa:5105,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5519,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8792,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:84152,hsa:5501,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1460,hsa:3831,PPrel,phosphorylation,path:hsa05020 Prion disease,1,0.8
hsa:5481,hsa:291,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2775,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:8651,hsa:5743,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5296,hsa:5590,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5608,hsa:5600,PPrel,phosphorylation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:2785,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6774,hsa:1374,GErel,expression,path:hsa04920 Adipocytokine signaling pathway,1,0.5
hsa:3717,hsa:6196,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3135,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:627,hsa:483,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:595,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:27,hsa:23683,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:3101,hsa:9945,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:810,hsa:5535,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:10488,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:779,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8324,hsa:1857,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:673,hsa:5604,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:3105,hsa:2261,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:5599,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2549,hsa:8503,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
cpd:C00584,hsa:5530,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4660,hsa:4637,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:163688,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9048,hsa:7277,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:815,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5501,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:4714,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00942,hsa:5140,PCrel,inhibition,path:hsa04924 Renin secretion,1,0.8
hsa:5523,hsa:208,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
path:hsa00010,hsa:1080,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8822,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5603,hsa:5595,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5906,hsa:5295,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3630,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4908,hsa:4217,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:5563,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:283106,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6712,hsa:814,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:2997,PPrel,inhibition,path:hsa04931 Insulin resistance,3,0.8
hsa:627,hsa:4915,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:816,hsa:4846,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:83660,hsa:3674,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:200186,hsa:208,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:57521,hsa:6198,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:10681,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5906,hsa:5894,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3630,hsa:5568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:2893,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:5594,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2782,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:11345,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5173,hsa:2550,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3630,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5734,hsa:2778,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:27006,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:2775,hsa:3760,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3459,hsa:3717,PPrel,binding/association,path:hsa05164 Influenza A,1,0.5
hsa:5228,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4137,hsa:3362,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27330,hsa:111,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:2740,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00780,hsa:5021,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2786,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:111,cpd:C00575,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2246,hsa:3309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27330,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:1649,PPrel,activation,path:hsa04141 Protein processing in endoplasmic reticulum,1,0.8
hsa:4902,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:9965,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:177,hsa:4893,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2249,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9217,hsa:22926,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5587,hsa:3551,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2917,hsa:657,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8324,hsa:2185,no_relation,no_relation,no_relation,no_relation,0.0
hsa:572,hsa:54205,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1956,hsa:5291,PPrel,activation,path:hsa05224 Breast cancer,2,0.8
hsa:56924,hsa:3985,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:26281,hsa:4208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:331,hsa:840,PPrel,inhibition,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:801,hsa:91807,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C01245,hsa:55062,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1385,hsa:596,GErel,expression,path:hsa04151 PI3K-Akt signaling pathway,1,0.5
hsa:3082,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3551,hsa:8660,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:9965,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C00076,hsa:808,PCrel,binding/association,path:hsa05031 Amphetamine addiction,2,0.5
hsa:3170,hsa:847,GErel,expression,path:hsa04213 Longevity regulating pathway - multiple species,1,0.5
hsa:1907,hsa:1909,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5567,hsa:1080,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6777,hsa:2645,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:2932,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2792,hsa:7133,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10000,hsa:2309,PPrel,phosphorylation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:91860,hsa:5532,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:3064,hsa:8678,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7074,hsa:5881,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2251,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:23683,hsa:59345,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1388,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5606,hsa:5603,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1435,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3667,hsa:5295,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:5293,hsa:477,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:90,hsa:3985,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1944,hsa:816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:116443,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:217,hsa:51380,ECrel,compound,path:hsa00770 Pantothenate and CoA biosynthesis,1,0.5
hsa:5155,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5605,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8651,hsa:6774,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:4803,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2787,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:8660,hsa:1386,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:572,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5568,hsa:2893,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:51806,hsa:5533,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
cpd:C00780,hsa:1813,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:808,hsa:7474,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3265,hsa:673,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5881,hsa:5058,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:6654,hsa:4893,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:7132,hsa:1956,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2776,hsa:5330,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5581,hsa:3643,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:2770,hsa:114,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1573,hsa:1576,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:1944,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:3553,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4261,hsa:3113,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:7040,hsa:7048,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:7976,hsa:1855,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5443,hsa:9568,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2785,hsa:3799,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:8503,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2776,hsa:5331,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5567,hsa:3283,GErel,expression,path:hsa04913 Ovarian steroidogenesis,1,0.5
cpd:C00076,hsa:5530,PCrel,activation,path:hsa05020 Prion disease,1,0.8
cpd:C00025,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5609,hsa:5602,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:4780,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C03758,hsa:154,PCrel,activation,path:hsa04024 cAMP signaling pathway,2,0.8
hsa:1558,hsa:8681,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:80310,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2254,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:208,hsa:111,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:4790,hsa:3553,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:2253,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5579,hsa:5338,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:137362,path:map00960,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:4776,hsa:5743,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:51196,cpd:C01245,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2247,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3481,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6804,hsa:775,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:23710,hsa:55879,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:2773,hsa:5293,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2247,hsa:1956,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2912,hsa:2785,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C00788,hsa:1816,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5213,hsa:230,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2254,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3452,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:85366,hsa:140465,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5595,hsa:2002,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:2790,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:2720,hsa:92579,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:5747,hsa:5293,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7252,hsa:3973,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:808,hsa:5530,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:83593,hsa:6772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5578,hsa:283748,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:53358,hsa:2885,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:153,hsa:778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:8681,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,1,0.8
hsa:805,hsa:5532,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7424,hsa:2064,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:818,hsa:10846,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10681,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5154,hsa:2790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:1605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:115,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:3909,hsa:3655,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:84812,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,cpd:C01245,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
cpd:C05981,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:340156,hsa:4637,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:32,hsa:2264,no_relation,no_relation,no_relation,no_relation,0.0
hsa:65018,hsa:4539,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:23710,hsa:2904,no_relation,no_relation,no_relation,no_relation,0.0
hsa:146850,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11345,hsa:2555,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:817,hsa:107,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:163688,hsa:23411,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51,hsa:314,no_relation,no_relation,no_relation,no_relation,0.0
hsa:399694,hsa:2885,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:5606,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7855,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2990,hsa:4193,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5599,hsa:8471,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
cpd:C00076,hsa:51806,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:4852,hsa:3350,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5290,hsa:4893,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3691,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C01245,hsa:3710,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:808,hsa:5535,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
path:hsa00010,hsa:80201,maplink,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
hsa:2641,hsa:1395,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2550,hsa:2771,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1573,hsa:8605,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:196883,cpd:C00575,PCrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2775,hsa:5295,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3082,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:3350,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1544,hsa:391013,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
cpd:C01312,hsa:5290,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5600,hsa:3592,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:9021,hsa:6776,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:54331,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:5607,hsa:5598,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1950,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6750,cpd:C00575,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3654,hsa:7189,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:801,hsa:109,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:81030,hsa:11035,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:8503,hsa:5170,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5604,hsa:4838,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:6464,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4790,hsa:51135,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55844,hsa:2944,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5515,hsa:6199,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:8817,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4254,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2277,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5595,hsa:148327,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:94235,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:8074,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2790,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:805,hsa:5530,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:25759,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:814,hsa:5142,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5332,cpd:C00165,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1573,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1956,hsa:3973,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1026,hsa:773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1558,hsa:2066,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:4713,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:90993,hsa:5144,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27006,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6195,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5571,hsa:779,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8817,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:808,hsa:8536,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:90,hsa:4090,PPrel,phosphorylation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:7039,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3665,hsa:3448,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:5594,hsa:6772,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:208,path:hsa00400,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:4715,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:815,hsa:5140,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1386,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:1386,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:7039,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10971,hsa:673,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:2250,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1536,hsa:8600,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4852,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5336,hsa:841,no_relation,no_relation,no_relation,no_relation,0.0
hsa:817,hsa:3763,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:331,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:11069,hsa:6237,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5567,hsa:4772,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2977,cpd:C00942,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6199,hsa:1975,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6494,hsa:5906,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5894,hsa:2918,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3625,hsa:3627,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,hsa:51380,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23493,hsa:4609,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:5154,hsa:4773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,hsa:1432,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2250,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3443,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:5021,hsa:779,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
path:hsa00350,hsa:5053,maplink,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:2918,hsa:7297,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5568,hsa:116443,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3479,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2246,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2784,hsa:115,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:207,hsa:2308,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2554,hsa:10243,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:1234,hsa:5603,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1234,hsa:10681,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2778,hsa:108,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10000,hsa:109,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2253,hsa:805,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5159,hsa:369,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:81616,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00035,hsa:5908,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
cpd:C07593,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1907,hsa:6752,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2783,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:7852,hsa:2787,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3135,hsa:4717,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:5580,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:2785,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:27123,hsa:7479,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2770,hsa:111,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:91860,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1908,hsa:3351,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5571,hsa:32,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:10023,hsa:1855,PPrel,binding/association,path:hsa05224 Breast cancer,1,0.5
hsa:3665,hsa:6199,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:2893,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7532,hsa:572,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6196,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5595,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:148327,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:22943,hsa:89780,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6196,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:841,hsa:637,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1432,hsa:3593,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:1573,hsa:50487,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
cpd:C00780,hsa:1129,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2773,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:4803,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5321,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:3665,hsa:3441,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:208,hsa:4792,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:80310,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C22381,hsa:91860,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4792,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:818,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:4908,hsa:2645,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6195,hsa:5499,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5605,hsa:5595,PPrel,activation,path:hsa05216 Thyroid cancer,2,0.8
hsa:3551,hsa:8471,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:5601,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5155,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8312,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9568,hsa:2783,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:1907,hsa:1909,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:7424,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2786,hsa:107,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:59345,hsa:776,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:94235,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
cpd:C00076,hsa:3454,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27121,hsa:7478,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3099,hsa:2324,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284,hsa:7010,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3099,hsa:5210,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:26281,hsa:5879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7417,hsa:54205,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8837,hsa:25865,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:5600,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5894,hsa:659,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26281,hsa:3643,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:808,hsa:109,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1573,hsa:8398,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:83729,hsa:2321,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8074,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5582,hsa:5594,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2932,hsa:8313,PPrel,binding/association,path:hsa05224 Breast cancer,1,0.5
hsa:817,hsa:111,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5533,hsa:572,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:54776,hsa:10398,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5336,cpd:C01245,PCrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:9586,hsa:10891,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5568,hsa:2308,PPrel,phosphorylation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:27006,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:4193,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:823,hsa:637,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5595,hsa:84699,PPrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:5335,hsa:801,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:2788,hsa:196883,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:3451,hsa:3455,PPrel,activation,path:hsa05164 Influenza A,1,0.8
cpd:C01996,hsa:6257,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:4724,no_relation,no_relation,no_relation,no_relation,0.0
hsa:208,hsa:1147,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5567,hsa:2906,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1946,hsa:2260,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5228,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2064,hsa:3667,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3661,hsa:3442,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:7424,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8660,hsa:5295,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
cpd:C00195,hsa:5579,PCrel,inhibition,path:hsa05140 Leishmaniasis,1,0.8
hsa:4908,hsa:5732,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:815,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C03758,hsa:135,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4902,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5567,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:23710,hsa:2565,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
cpd:C01245,hsa:3710,PCrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:5567,hsa:2903,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:208,hsa:4193,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5605,hsa:4881,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6464,hsa:2549,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:9451,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9451,hsa:1965,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5906,hsa:25865,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2253,hsa:2321,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6772,hsa:2099,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:2912,hsa:2773,PCrel,activation,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:4254,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C03758,hsa:7253,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:3134,hsa:6778,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5530,hsa:54979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:1956,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:2251,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:817,hsa:5141,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5566,hsa:2904,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2932,hsa:595,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:83729,hsa:7043,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:134,hsa:4804,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2246,hsa:5566,no_relation,no_relation,no_relation,no_relation,0.0
hsa:440275,hsa:1965,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:1942,hsa:4716,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C05981,hsa:1072,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5602,hsa:3716,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1909,hsa:23462,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5604,hsa:3708,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4088,hsa:4089,PPrel,binding/association,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:208,cpd:C00219,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1111,hsa:154,no_relation,no_relation,no_relation,no_relation,0.0
hsa:808,hsa:5530,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6198,hsa:3170,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2784,hsa:111,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
cpd:C00575,hsa:5567,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2782,hsa:112,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3091,hsa:5213,GErel,expression,path:hsa04919 Thyroid hormone signaling pathway,1,0.5
cpd:C00788,hsa:153,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10488,hsa:10891,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:7532,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5834,hsa:1436,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:23533,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:1558,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2905,hsa:1742,PCrel,binding/association,path:hsa04724 Glutamatergic synapse,1,0.5
hsa:5501,hsa:10488,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:23710,hsa:208,no_relation,no_relation,no_relation,no_relation,0.0
hsa:246,hsa:5319,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:27165,hsa:2746,ECrel,compound,path:hsa04964 Proximal tubule bicarbonate reclamation,1,0.5
cpd:C07593,hsa:4729,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1950,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:57818,path:hsa00010,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:4254,hsa:6774,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23710,hsa:2558,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:3480,hsa:399694,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:2277,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3064,hsa:6391,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5568,hsa:79602,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5331,cpd:C01245,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1942,hsa:2932,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3451,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:3099,hsa:5214,ECrel,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:8503,hsa:207,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:8737,hsa:291,PPrel,inhibition,path:hsa04217 Necroptosis,1,0.8
hsa:7157,hsa:1026,GErel,expression,path:hsa05160 Hepatitis C,1,0.5
hsa:2321,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4217,hsa:6300,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:374,hsa:4886,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:2905,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2185,hsa:1398,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:8325,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1942,hsa:89953,no_relation,no_relation,no_relation,no_relation,0.0
hsa:284217,hsa:2788,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00334,hsa:5159,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8503,cpd:C05981,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:7098,hsa:5563,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7424,hsa:5156,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3479,hsa:3791,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:10411,hsa:2920,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:3134,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5562,hsa:6513,PPrel,activation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:51378,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00025,hsa:2906,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7424,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2770,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2912,hsa:55970,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5880,hsa:10298,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:56034,hsa:2737,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2263,hsa:6300,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:1557,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:7297,hsa:6772,PPrel,phosphorylation,path:hsa05164 Influenza A,1,0.8
cpd:C00076,hsa:805,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5501,hsa:5587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7852,hsa:2773,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:1942,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8517,hsa:8471,PPrel,inhibition,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:4902,hsa:4233,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5293,hsa:23439,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:2250,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1571,hsa:100137049,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:3661,hsa:3443,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:2932,hsa:147700,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:810,hsa:5532,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5443,hsa:7124,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5587,hsa:8517,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:10000,hsa:64764,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5894,hsa:5604,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4855,hsa:2064,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:3460,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:5598,no_relation,no_relation,no_relation,no_relation,0.0
hsa:53358,hsa:2885,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5580,hsa:3667,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:1956,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1435,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C15231,hsa:109,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:5781,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1945,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1943,hsa:3480,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:824,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5879,hsa:4214,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:805,hsa:5534,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2645,hsa:55276,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,2,0.5
hsa:4780,hsa:108,no_relation,no_relation,no_relation,no_relation,0.0
hsa:572,hsa:598,PPrel,inhibition,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5578,hsa:5338,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:9021,hsa:29110,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10379,hsa:3760,no_relation,no_relation,no_relation,no_relation,0.0
path:hsa00052,hsa:441282,maplink,compound,path:hsa00051 Fructose and mannose metabolism,1,0.5
hsa:2792,hsa:5837,no_relation,no_relation,no_relation,no_relation,0.0
hsa:26291,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2793,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:7297,hsa:6773,PPrel,phosphorylation,path:hsa05164 Influenza A,1,0.8
hsa:10971,hsa:2309,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:801,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
hsa:2990,hsa:7364,ECrel,compound,path:hsa00860 Porphyrin metabolism,1,0.5
hsa:6898,hsa:5053,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:2254,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2915,hsa:4624,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2932,PPrel,phosphorylation,path:hsa05160 Hepatitis C,1,0.8
hsa:3447,hsa:3454,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:5290,hsa:207,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5908,hsa:4301,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3082,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1147,hsa:84335,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:816,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5170,hsa:208,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
cpd:C22381,hsa:3551,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:79444,hsa:842,PPrel,inhibition,path:hsa05145 Toxoplasmosis,1,0.8
hsa:4902,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1147,hsa:2790,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,hsa:5140,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6750,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5970,hsa:3452,GErel,expression,path:hsa05164 Influenza A,2,0.5
hsa:1459,hsa:3831,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:51378,hsa:3667,no_relation,no_relation,no_relation,no_relation,0.0
hsa:658,cpd:C05981,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:7054,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:2264,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2277,hsa:673,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5170,hsa:6199,PPrel,phosphorylation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3105,hsa:4129,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2740,hsa:2778,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:7422,hsa:1436,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4893,hsa:5293,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1944,hsa:5159,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2248,hsa:3791,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2821,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:108,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C05981,hsa:2065,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1435,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2247,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7132,hsa:5601,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:2253,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51378,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3717,hsa:6777,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:808,hsa:4838,no_relation,no_relation,no_relation,no_relation,0.0
hsa:572,hsa:596,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3064,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:116443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1573,hsa:2997,no_relation,no_relation,no_relation,no_relation,0.0
hsa:89869,path:hsa00640,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5900,hsa:5899,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5602,hsa:3800,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5296,hsa:480,PPrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:654,hsa:657,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:207,hsa:84699,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5602,hsa:374291,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,hsa:56901,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,hsa:673,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:3303,hsa:2998,no_relation,no_relation,no_relation,no_relation,0.0
hsa:816,hsa:5143,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00212,hsa:5834,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2740,hsa:55970,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23236,cpd:C00165,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6654,hsa:27330,no_relation,no_relation,no_relation,no_relation,0.0
hsa:572,hsa:5898,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5332,cpd:C00076,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:6776,hsa:5618,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:3624,hsa:4838,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:4638,hsa:116443,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2770,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:126129,hsa:54205,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:5293,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5605,hsa:5594,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2783,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2778,hsa:107,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5595,hsa:2353,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:1544,hsa:3448,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6750,hsa:3355,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10000,hsa:10818,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:112,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5481,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1544,hsa:59345,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5605,hsa:5595,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:1571,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5291,cpd:C05981,PCrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5525,hsa:123745,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6622,hsa:157,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:3643,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6416,hsa:10105,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1234,hsa:2786,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:51764,hsa:2792,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2788,hsa:3763,PPrel,activation,path:hsa04727 GABAergic synapse,1,0.8
hsa:2251,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:207,hsa:1027,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6777,hsa:3659,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:155,hsa:6548,no_relation,no_relation,no_relation,no_relation,0.0
hsa:91860,hsa:115,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2778,hsa:114,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:1460,hsa:64837,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:8517,hsa:3655,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6196,hsa:90673,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:5567,hsa:84876,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5530,hsa:572,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3667,hsa:8503,PPrel,phosphorylation,path:hsa04931 Insulin resistance,1,0.8
hsa:3442,hsa:3460,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:23462,hsa:64837,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00575,hsa:5567,PCrel,activation,path:hsa04918 Thyroid hormone synthesis,1,0.8
hsa:2778,hsa:196883,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2791,hsa:114,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:10645,hsa:51764,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11273,hsa:3710,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:9568,hsa:2790,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:285,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7332,hsa:3119,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2255,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:4790,hsa:2773,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5528,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4893,hsa:595,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:5732,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
cpd:C00584,hsa:3354,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5970,hsa:3552,GErel,expression,path:hsa05140 Leishmaniasis,1,0.5
hsa:10000,hsa:6262,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57132,hsa:197259,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
cpd:C00076,hsa:805,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5603,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:11069,hsa:5908,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2251,hsa:4233,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2932,hsa:64837,PPrel,inhibition,path:hsa05020 Prion disease,1,0.8
hsa:3265,hsa:5894,PPrel,activation,path:hsa05160 Hepatitis C,1,0.8
hsa:1081,hsa:5732,PPrel,activation,path:hsa04024 cAMP signaling pathway,3,0.8
hsa:5293,hsa:2915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:57818,hsa:2891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1946,hsa:3280,no_relation,no_relation,no_relation,no_relation,0.0
hsa:107,cpd:C00575,PCrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1111,hsa:494551,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:815,hsa:5142,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:11345,hsa:2556,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
cpd:C00076,hsa:5533,PCrel,activation,path:hsa05020 Prion disease,1,0.8
hsa:7097,hsa:5879,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3456,hsa:3459,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:4790,hsa:596,GErel,expression,path:hsa05145 Toxoplasmosis,1,0.5
hsa:3667,hsa:5290,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6622,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9306,hsa:6776,PPrel,inhibition,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:5578,hsa:1395,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6773,hsa:8737,GErel,expression,path:hsa04217 Necroptosis,1,0.5
cpd:C00575,hsa:64091,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:9564,hsa:1399,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2641,hsa:135,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5524,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6885,hsa:2260,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6714,hsa:8503,PPrel,activation,path:hsa04917 Prolactin signaling pathway,2,0.8
hsa:805,hsa:112,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:55970,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:7422,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5154,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
path:hsa00010,hsa:112,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00212,hsa:5170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3101,hsa:5236,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:2775,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:1813,hsa:2771,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2069,hsa:1855,no_relation,no_relation,no_relation,no_relation,0.0
hsa:801,hsa:5533,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:27006,hsa:5601,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2249,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:5350,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4261,hsa:3125,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:4790,hsa:9252,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3351,hsa:2773,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5021,hsa:27092,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2785,hsa:774,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:284,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2251,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C11310,hsa:4718,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1147,hsa:4792,PPrel,activation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:26281,hsa:5159,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:23586,hsa:3452,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2247,hsa:2260,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5837,cpd:C00031,PCrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:5970,hsa:113,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4615,hsa:3654,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:3441,hsa:3455,PPrel,activation,path:hsa05164 Influenza A,1,0.8
hsa:3630,hsa:2261,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2770,hsa:114,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:27123,hsa:7478,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:6774,hsa:1154,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
hsa:5291,hsa:4893,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3918,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2905,PPrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:10645,hsa:5571,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6622,hsa:4724,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:658,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5906,hsa:10451,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5608,hsa:5603,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2695,hsa:154,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4853,hsa:1147,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C11310,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4909,hsa:207,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2771,hsa:3105,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5519,hsa:1870,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:1026,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2902,PPrel,phosphorylation,path:hsa05031 Amphetamine addiction,2,0.8
hsa:808,hsa:91807,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:25978,hsa:197259,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:810,hsa:3459,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2247,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5603,hsa:3725,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:1459,hsa:140465,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2778,hsa:113,PPrel,activation,path:hsa04913 Ovarian steroidogenesis,2,0.8
hsa:5535,hsa:477,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4878,hsa:5293,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:3091,no_relation,no_relation,no_relation,no_relation,0.0
hsa:23710,hsa:2566,PPrel,binding/association,path:hsa04727 GABAergic synapse,1,0.5
hsa:2773,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:207,hsa:114,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2790,hsa:109,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:3626,cpd:C00165,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2918,hsa:5535,no_relation,no_relation,no_relation,no_relation,0.0
hsa:51806,hsa:818,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:5500,hsa:5837,PPrel,inhibition,path:hsa04931 Insulin resistance,1,0.8
hsa:818,hsa:5136,no_relation,no_relation,no_relation,no_relation,0.0
hsa:815,hsa:255189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7422,hsa:2261,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5566,hsa:3439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3667,hsa:196883,no_relation,no_relation,no_relation,no_relation,0.0
hsa:805,hsa:5605,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4803,hsa:3815,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5501,hsa:9817,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5881,hsa:56924,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:51422,hsa:1816,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5465,hsa:3593,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2793,hsa:3831,no_relation,no_relation,no_relation,no_relation,0.0
hsa:441282,hsa:2891,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5747,hsa:5291,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2821,hsa:5236,ECrel,compound,path:hsa00520 Amino sugar and nucleotide sugar metabolism,1,0.5
hsa:3454,hsa:4093,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:4792,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1908,hsa:154,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8074,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1571,hsa:3763,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54331,hsa:196883,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:8817,hsa:2263,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5071,hsa:5331,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:94235,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:4137,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,2,0.8
hsa:5533,hsa:4773,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2776,hsa:3397,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00547,hsa:155,PCrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:3265,hsa:2309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3064,hsa:440567,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5606,hsa:5600,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
cpd:C00025,hsa:2911,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:1943,hsa:2260,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3665,hsa:3439,GErel,expression,path:hsa05164 Influenza A,1,0.5
hsa:2249,hsa:1812,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80201,path:hsa00010,maplink,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:9568,hsa:2773,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:818,hsa:2791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3717,hsa:4193,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2791,hsa:2920,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5567,hsa:2893,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2783,hsa:5156,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00076,hsa:7297,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4853,hsa:23462,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:3446,hsa:2997,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5623,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:1946,hsa:1969,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00076,hsa:115,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4780,hsa:2950,GErel,expression,path:hsa05225 Hepatocellular carcinoma,1,0.5
hsa:5587,path:hsa00400,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1147,hsa:27035,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3106,hsa:6777,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9021,hsa:2770,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83729,hsa:3442,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00025,hsa:2893,PCrel,activation,path:hsa05031 Amphetamine addiction,2,0.8
cpd:C11310,hsa:3309,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1432,hsa:9261,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5604,hsa:5594,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:7422,hsa:7010,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2771,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:2915,hsa:2906,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:207,hsa:5571,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:10000,hsa:115,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:2773,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,2,0.8
hsa:5499,hsa:4914,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7318,hsa:7311,PPrel,binding/association,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.5
hsa:3265,hsa:5894,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:1544,hsa:30814,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:285,hsa:4914,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2246,hsa:3480,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:11035,hsa:5296,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3442,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:5894,hsa:5604,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:5598,hsa:2002,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
hsa:5319,hsa:1571,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:8660,hsa:5296,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:22943,hsa:4170,no_relation,no_relation,no_relation,no_relation,0.0
hsa:83729,hsa:2064,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1544,hsa:5594,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3661,hsa:3447,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:4893,cpd:C01245,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3551,hsa:4792,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C00165,hsa:5582,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:10379,hsa:10023,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5908,hsa:5293,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:9568,hsa:2770,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:54205,hsa:842,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:5568,hsa:2890,PPrel,activation,path:hsa05031 Amphetamine addiction,1,0.8
hsa:1268,hsa:2775,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5532,hsa:5106,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8823,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5582,hsa:952,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:2778,hsa:3397,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3242,hsa:2806,ECrel,compound,path:hsa00360 Phenylalanine metabolism,1,0.5
hsa:3667,hsa:5290,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,3,0.8
hsa:4893,hsa:8503,PPrel,activation,path:hsa04213 Longevity regulating pathway - multiple species,1,0.8
hsa:27121,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1943,hsa:2324,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8660,hsa:5290,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:64764,hsa:2353,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:5156,hsa:1398,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
cpd:C07593,hsa:4707,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2052,hsa:1645,ECrel,compound,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.5
hsa:285,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:51378,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:90673,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:114,PPrel,inhibition,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:2778,hsa:112,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5595,hsa:7157,PPrel,phosphorylation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5481,hsa:7010,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7423,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5605,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2790,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5610,hsa:2775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9103,hsa:6300,PPrel,activation,path:hsa05140 Leishmaniasis,1,0.8
hsa:11035,hsa:2746,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:1457,hsa:779,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:5604,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2254,cpd:C00942,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6777,hsa:2100,GErel,expression,path:hsa04917 Prolactin signaling pathway,1,0.5
cpd:C00165,hsa:5578,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:5594,hsa:123745,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3667,hsa:5296,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:3480,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:818,hsa:468,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
cpd:C07593,hsa:4537,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:4804,hsa:5293,PPrel,compound,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:5154,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:26281,hsa:148327,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3694,hsa:71,PPrel,binding/association,path:hsa05410 Hypertrophic cardiomyopathy,1,0.5
hsa:5894,hsa:5291,PPrel,activation,path:hsa04917 Prolactin signaling pathway,1,0.8
hsa:2792,hsa:5879,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:3625,hsa:7043,PPrel,inhibition,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:1576,hsa:8681,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:23236,cpd:C01245,PCrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:7048,hsa:3643,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5293,hsa:10000,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:60673,hsa:9821,PPrel,phosphorylation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:3082,hsa:4233,PPrel,activation,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5605,hsa:5594,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
hsa:3551,hsa:4794,PPrel,phosphorylation,path:hsa04920 Adipocytokine signaling pathway,1,0.8
hsa:3479,hsa:1436,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2260,hsa:6464,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:5534,hsa:2932,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:91860,hsa:816,PPrel,activation,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:207,hsa:4713,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9475,hsa:4696,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4855,hsa:57521,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5156,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3665,hsa:4915,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5594,hsa:6195,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:1571,hsa:151056,ECrel,compound,path:hsa00591 Linoleic acid metabolism,1,0.5
hsa:2786,hsa:5881,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2246,hsa:3123,no_relation,no_relation,no_relation,no_relation,0.0
hsa:810,hsa:115,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5594,hsa:9586,PPrel,phosphorylation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:10105,hsa:114,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5533,hsa:4776,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C03758,hsa:9568,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:5598,hsa:4775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:80310,hsa:4791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:3800,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4916,hsa:25759,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:10000,hsa:79444,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54567,hsa:4855,PPrel,activation,path:hsa05224 Breast cancer,1,0.8
hsa:122809,hsa:3280,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:1129,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:841,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:52,hsa:6714,PPrel,inhibition,path:hsa05208 Chemical carcinogenesis - reactive oxygen species,1,0.8
hsa:5535,hsa:2892,no_relation,no_relation,no_relation,no_relation,0.0
hsa:7297,hsa:6774,PPrel,activation,path:hsa05145 Toxoplasmosis,1,0.8
hsa:369,hsa:5605,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:5598,hsa:5743,GErel,expression,path:hsa04921 Oxytocin signaling pathway,1,0.5
cpd:C03758,hsa:847,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:81616,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2260,hsa:5331,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:10645,hsa:5563,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:5564,hsa:57521,PPrel,inhibition,path:hsa04213 Longevity regulating pathway - multiple species,2,0.8
hsa:27121,hsa:7474,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5894,hsa:5605,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5154,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:3480,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:374,hsa:2322,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:4855,hsa:2324,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:4878,hsa:815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3460,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10000,hsa:2549,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:5600,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:25865,hsa:1857,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2260,hsa:2885,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:80310,hsa:2264,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:6093,hsa:1909,no_relation,no_relation,no_relation,no_relation,0.0
hsa:70,hsa:2905,no_relation,no_relation,no_relation,no_relation,0.0
hsa:6654,hsa:3265,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:3033,hsa:39,ECrel,compound,path:hsa00310 Lysine degradation,1,0.5
hsa:2784,hsa:778,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:7423,hsa:81029,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1544,hsa:5979,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5606,hsa:5565,no_relation,no_relation,no_relation,no_relation,0.0
hsa:54518,hsa:345456,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:2254,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5566,cpd:C00031,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:6300,PPrel,phosphorylation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:808,hsa:109,PPrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:6256,hsa:5468,PPrel,binding/association,path:hsa05202 Transcriptional misregulation in cancer,1,0.5
hsa:5501,hsa:140465,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:6622,hsa:4702,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:112,hsa:7360,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C07593,hsa:3791,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1950,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:27102,hsa:6198,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:595,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:11035,hsa:2747,PPrel,activation,path:hsa04217 Necroptosis,1,0.8
hsa:56034,hsa:9261,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10681,hsa:775,PPrel,inhibition,path:hsa04727 GABAergic synapse,1,0.8
hsa:4854,hsa:2324,GErel,expression,path:hsa05224 Breast cancer,1,0.5
hsa:23236,cpd:C00165,PCrel,activation,path:hsa04919 Thyroid hormone signaling pathway,1,0.8
hsa:54205,hsa:317,PPrel,activation,path:hsa04215 Apoptosis - multiple species,1,0.8
hsa:814,hsa:3592,no_relation,no_relation,no_relation,no_relation,0.0
hsa:8326,hsa:7253,no_relation,no_relation,no_relation,no_relation,0.0
cpd:C00584,hsa:5021,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:284,hsa:775,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3304,hsa:7097,PPrel,binding/association,path:hsa05145 Toxoplasmosis,1,0.5
hsa:5970,hsa:3451,GErel,expression,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:7124,hsa:468,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5021,hsa:4772,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3845,hsa:673,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
cpd:C07593,hsa:100532726,PCrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:2277,hsa:836,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2885,hsa:6654,PPrel,activation,path:hsa05224 Breast cancer,3,0.8
hsa:8772,hsa:841,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:5581,hsa:10488,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4087,hsa:4089,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,3,0.8
hsa:2785,hsa:773,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:1576,hsa:5906,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10488,hsa:3725,GErel,expression,path:hsa04024 cAMP signaling pathway,1,0.5
hsa:7422,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:572,hsa:4700,no_relation,no_relation,no_relation,no_relation,0.0
hsa:130589,hsa:441282,ECrel,compound,path:hsa00052 Galactose metabolism,1,0.5
hsa:1942,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8823,hsa:2066,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2775,hsa:7189,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55970,hsa:113,PPrel,inhibition,path:hsa04727 GABAergic synapse,2,0.8
hsa:9475,hsa:54776,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:468,hsa:5587,no_relation,no_relation,no_relation,no_relation,0.0
hsa:90993,hsa:2353,GErel,expression,path:hsa05031 Amphetamine addiction,1,0.5
hsa:805,hsa:5530,PPrel,activation,path:hsa04924 Renin secretion,1,0.8
hsa:5500,hsa:5533,no_relation,no_relation,no_relation,no_relation,0.0
hsa:55626,hsa:2902,no_relation,no_relation,no_relation,no_relation,0.0
hsa:207,hsa:4794,PPrel,activation,path:hsa04722 Neurotrophin signaling pathway,1,0.8
hsa:6199,hsa:5058,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4254,hsa:5595,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3135,hsa:567,PPrel,binding/association,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.5
hsa:6654,hsa:3845,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5518,hsa:1965,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5894,hsa:2776,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4804,hsa:396,PPrel,binding/association,path:hsa04722 Neurotrophin signaling pathway,1,0.5
hsa:11285,hsa:126792,ECrel,compound,path:hsa00532 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,1,0.5
hsa:4846,cpd:C00533,PCrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
cpd:C00334,hsa:6752,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:284,hsa:4915,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2550,hsa:94235,PPrel,activation,path:hsa04727 GABAergic synapse,2,0.8
hsa:1573,hsa:283748,ECrel,compound,path:hsa00591 Linoleic acid metabolism,2,0.5
hsa:1544,hsa:1398,no_relation,no_relation,no_relation,no_relation,0.0
hsa:10971,hsa:369,PPrel,inhibition,path:hsa05160 Hepatitis C,1,0.8
hsa:10000,hsa:2475,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,2,0.8
cpd:C00212,cpd:C00044,no_relation,no_relation,no_relation,no_relation,0.0
hsa:9965,hsa:4804,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5499,hsa:10488,PPrel,inhibition,path:hsa05031 Amphetamine addiction,2,0.8
hsa:5499,hsa:1969,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5608,hsa:5600,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:808,hsa:815,PPrel,activation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3280,hsa:4137,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5499,hsa:10000,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4893,cpd:C00044,PCrel,binding/association,path:hsa04015 Rap1 signaling pathway,1,0.5
hsa:2260,hsa:5330,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1386,hsa:1958,GErel,expression,path:hsa05020 Prion disease,1,0.5
hsa:3082,hsa:1969,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1559,hsa:1111,no_relation,no_relation,no_relation,no_relation,0.0
hsa:598,hsa:2322,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3082,hsa:1956,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:8817,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2254,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:7976,hsa:1856,PPrel,activation,path:hsa05225 Hepatocellular carcinoma,1,0.8
hsa:5501,hsa:2998,PPrel,activation,path:hsa04931 Insulin resistance,2,0.8
hsa:6934,hsa:5139,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2932,hsa:4637,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2782,hsa:109,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:5529,hsa:10000,PPrel,inhibition,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2773,hsa:5296,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
cpd:C00076,hsa:23439,no_relation,no_relation,no_relation,no_relation,0.0
hsa:3454,hsa:2885,no_relation,no_relation,no_relation,no_relation,0.0
hsa:1856,hsa:5879,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2253,hsa:3815,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:163688,hsa:109,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5594,hsa:5321,PPrel,phosphorylation,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:207,hsa:4846,PPrel,activation,path:hsa04931 Insulin resistance,1,0.8
hsa:2771,hsa:115,PPrel,inhibition,path:hsa04921 Oxytocin signaling pathway,1,0.8
hsa:3551,hsa:4792,PPrel,phosphorylation,path:hsa05120 Epithelial cell signaling in Helicobacter pylori infection,1,0.8
hsa:29082,hsa:197259,PPrel,binding/association,path:hsa04217 Necroptosis,1,0.5
hsa:8200,hsa:659,PPrel,activation,path:hsa04350 TGF-beta signaling pathway,1,0.8
hsa:218,hsa:50487,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5330,cpd:C01245,PCrel,activation,path:hsa04724 Glutamatergic synapse,1,0.8
hsa:330,hsa:2263,no_relation,no_relation,no_relation,no_relation,0.0
hsa:5601,hsa:147700,PPrel,inhibition,path:hsa05022 Pathways of neurodegeneration - multiple diseases,1,0.8
hsa:5970,hsa:3815,no_relation,no_relation,no_relation,no_relation,0.0
hsa:4638,hsa:4939,no_relation,no_relation,no_relation,no_relation,0.0
hsa:2277,hsa:2324,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:5337,cpd:C00416,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:4909,hsa:5979,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
cpd:C00575,hsa:11149,PCrel,activation,path:hsa04024 cAMP signaling pathway,1,0.8
hsa:8822,hsa:4804,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1946,hsa:2321,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2846,hsa:2778,PPrel,activation,path:hsa04015 Rap1 signaling pathway,1,0.8
hsa:1942,hsa:2263,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:2246,hsa:2065,PPrel,activation,path:hsa04151 PI3K-Akt signaling pathway,1,0.8
hsa:5894,hsa:5604,PPrel,activation,path:hsa05170 Human immunodeficiency virus 1 infection,1,0.8
hsa:2785,hsa:108,PCrel,inhibition,path:hsa04724 Glutamatergic synapse,1,0.8
